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Abstract 
 
The liver is a unique tolerogenic organ with dual blood supply. Both regulatory 
lymphocytes and effector lymphocytes are present in the normal and inflamed liver along with 
innate immune cells. The balance between these two subsets of lymphocyte is crucial in 
maintaining immune homeostasis by adjusting either hepatic tolerance or mounting immunity 
against invading pathogens. Thus, it is important to understand the intrahepatic regulatory T cells 
phenotype and role played by distinct chemokine receptors expressed on regulatory T cells as 
they are major player in controlling hepatic tolerance. At the same time, it would be crucial to 
explore the role of new subset of Th17/Tc17 effector lymphocytes characteristic and their 
positioning in inflamed liver.  
This thesis demonstrates the crucial role of chemokine receptors in recruitment and 
positioning of both intrahepatic regulatory T lymphocytes and IL-17 secreting Th17/Tc17 
effector lymphocyte in both normal and inflamed human liver. 
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CHAPTER 1 INTRODUCTION 
 
 
 
 
 
 
 
 
 
 
 
1.1 The human immune system 
The mammalian immune system protects the host from a broad range of pathogenic 
microorganisms while avoiding misguided or excessive immune reactions that would be 
deleterious to the host. The innate and adaptive immune systems function together to recognize 
the invading pathogens and coordinate to mount a successful and efficient immune response.  
1.1.1 Innate immunity 
The innate immune response, which is the frontline of host defence, consists of cellular 
and biochemical defence mechanisms, which can recognise and neutralize invading pathogens 
within hours. The diversity of immune recognition for innate system is pre-programmed, limited 
and it does not possess immunological memory. The cells of the innate immune system include 
phagocytes (macrophages and neutrophils), dendritic cells, mast cells and natural killer cells. The 
innate immune system does not require previous exposure to pathogens to mount effective 
immune response because it is activated by conserved molecular patterns that indicate the 
presence of pathogens, Pathogen Associated Molecular Patterns (PAMPs) such as bacterial cell 
wall components or viral RNA or injury cellular stress, e.g. heat shock proteins. Pattern 
recognition receptors such as toll-like receptors, scavenger receptor and C type lectins (Aderem 
and Ulevitch, 2000) allow innate immune cells to recognise and respond to PAMPs. The innate 
immune response also incorporates secreted cytokines particularly those such as type 1 interferon 
that are secreted early in response to infection, the complement system and acute phase proteins 
and it’s response predominates in tissues at the interface with environment such as skin, the 
epithelial mucosa of the gut and lungs where the tissues are continuously exposed to 
antigens(Hoffmann et al., 1999).  
 
 
1.1.2  Adaptive immunity 
The cardinal features of the adaptive immune system are specificity, diversity and 
immunological memory. The adaptive immune response generates antigen specific lymphocytes 
that recognise a specific antigenic epitope. It has immunological memory in that a subsequent 
exposure to the same antigen leads to a more rapid, sustained and potent immune response. 
Lymphocytes with immunological memory i.e. cells that have been primed to recognise specific 
antigens are called memory lymphocytes and are widely distributed throughout the body via the 
blood to the secondary lymphoid tissues and peripheral tissues where they contribute to the 
process of immune surveillance. These lymphocytes must be rapidly recruited to the site of an 
infection to allow recognition of foreign antigen and the mounting of an immune response.  
The immune system comprises primary, secondary and tertiary structures comprising 
thymus and bone marrow (primary or central tissue) and lymph nodes, spleen, and mucosa- 
associated lymphoid tissue such as Peyer’s patches (peripheral or secondary lymphoid tissue). 
Professional antigen presenting cells, such as dendritic cells play a central role in orchestrating 
complex immune responses and help to determine the nature of an immune response e.g. 
whether it drives the effector or regulatory arm of the immune system. Antigens from invading 
pathogens are taken up by dendritic cells which patrol the peripheral tissues before being carried 
via lymph to secondary lymphoid tissues where antigens are presented to naive lymphocytes 
(Banchereau et al., 2000). Antigen exposed dendritic cells express high levels of MHC Class ΙΙ 
molecules, required to present the peptides and co-stimulatory molecules CD80/CD86 which are 
required for activation of naive T cells allowing them to fully activate naive T cells which can 
then mediate effector responses directly or provide T cell help for antibody production. This 
leads to cellular immunity by proliferation of T effector cells as well as humoral immunity by 
proliferation of antibody producing B cells. 
 
 
Lymphocytes have two distinct classes: B and T lymphocytes. B lymphocytes are 
characterised by the production of antibodies raised against specific antigens and participate in 
humoral immunity. T lymphocytes provide cell-mediated immunity and consist of cytotoxic T 
lymphocytes (Tc) and T helper lymphocytes (Th) based on their expression of the cell surface 
markers CD8 and CD4.  Cytotoxic T lymphocytes act on target cells presenting viral or tumour 
antigens in association MHC class-I molecules. T helper lymphocytes consist of Th1, Th2, Th9, 
Th17 and T regulatory cells (Bettelli et al., 2006;Mangan et al., 2006;Mosmann et al., 
1986;Sakaguchi et al., 1995;Veldhoen et al., 2006;Veldhoen et al., 2008b). They respond to 
antigen presented in association with MHC class II via APC, and subsequently help B cell 
production of antibody or differentiation of cytotoxic T cell precursors (Ashwell 1988). 
Immune system achieved the homeostasis by distinguishing between self and nonself and 
maintaining unresponsiveness to self or harmless antigens (immunological tolerance) whilst being 
able to rapidly recognize foreign antigen to eradicate invading pathogens. Breakdown in 
immunological self tolerance leads to autoimmunity (Sakaguchi et al., 1995;Sakaguchi, 2004). Self 
tolerance is maintained by central and peripheral mechanisms (Walker and Abbas, 2002). 
1.1.3 Central Tolerance 
Billingham, Brent and Medawar first described acquired tolerance by injecting allogenic 
tissues into foetal mice in utero and observing an impairment in their ability to reject skin grafts 
from the same allogeneic mouse strain when the mice reached maturity (Billingham et al., 1953). 
Subsequently, studies using TCR transgenic mice (Kisielow et al., 1988) that respond to mouse 
mammary tumour virus (Kappler et al., 1987) demonstrated that self reactive T lymphocytes can 
be clonally deleted in the thymus by an apoptotic process (Surh and Sprent, 1994). Central 
tolerance results from intrathymic selection and clonal deletion of T cells with high avidity for 
 
 
thymically expressed self-antigen(Kappler et al., 1987) and central tolerance to auto-antigens is 
programmed  in the thymus during lymphocyte development(Anderson et al., 2001).  
Thymic selection results in the release of high-affinity T cells specific for non-self-
antigens, low-affinity T cells specific for self-antigens, and natural Treg with an intermediate 
affinity to both self- and non-self-antigens into the circulation. Medullary thymic epithelial cells 
present self-antigens on MHC class Ι and class ΙΙ molecules to thymocytes (developing 
lymphocytes) and those that respond strongly to these self-antigens are deleted(Anderson et al., 
2006). The effective presentation of tissue specific self-antigens by medullary thymic epithelial 
cells is regulated by the autoimmune regulator gene known as AIRE. The AIRE protein is 
important for the maintenance of self tolerance (Nagamine, 1997) as demonstrated by the 
development of autoimmune diseases in both mice and humans with functional mutations in 
AIRE (Su et al., 2008;Su and Anderson, 2004). AIRE mutations lead to a breakdown of central 
tolerance associated with decreased expression of self antigens in the thymus. It humans AIRE 
mutations result in a rare autosomal recessive human autoimmune polyglandular syndrome type 1 
(APS type 1) also known as autoimmune polyendocrinopathy, candidosis, ectodermal dystrophy 
(APECED)(Nagamine, 1997).   
The role of the thymus in immune tolerance was demonstrated in mice in which neonatal 
thymectomy between day 2 and 4 after birth resulted in autoimmune destruction of ovaries 
(Nishizuka and Sakakura, 1969). Moreover, adult thymectomy of normal rats followed by sub 
lethal X-irradiation also results in autoimmune thyroiditis with anti-thyroglobulin autoantibody 
production (Penhale et al., 1973). 
 
 
1.1.4 Peripheral Tolerance 
Self- reactive T cells which escape from thymic deletion are controlled in the periphery to 
prevent autoimmunity. Many mechanisms contribute to peripheral tolerance. They include 
ignorance of self-antigens, the apparent absence of antigen recognition, deletion by activation-
induced cell death or apoptosis, and the induction of T cell anergy. In addition to these passive 
mechanisms, active suppression of self-reactive T cells is mediated by immunosuppressive cells 
the best described of which are regulatory T cells (Treg ) which express CD4 CD25high (Walker & 
Abbas, 2002).   
1.1.5 Tolerogenic environment of the liver  
The liver is a complex immune organ and its intrahepatic immune environment favour 
immune tolerance, yet it maintains the capacity to sustain effective immune responses against 
pathogens (Crispe, 2009). The first evidence of the tolerogenic properties of the liver came from 
experiments showing acceptance of pig liver allograft transplanted across MHC barriers by Calne 
and colleagues(Calne RY, 1969). The mechanisms of the effect are in part a consequence of the 
unique hepatic environment which is shaped by anatomy and by the continuous exposure of the 
liver to nutrients and microbial products derived from the intestinal bacteria (Benseler et al., 
2007). This exposure promotes the expression of cytokines, such as IL-10 and TGF-β that lead 
to the differentiation of antigen-presenting cells including not only dendritic cells (DCs) but also 
resident liver cells that tend to generate tolerance or anergy when they activate T cells within the 
liver.  However, full activation of T cells by DCs in draining lymph nodes results in a vigorous 
and full effector response (Bowen et al., 2004;Bowen et al., 2005;Crispe, 2003).  
The liver contains resident lymphocytes, among which CD8+ T cells outnumber CD4+T 
cells (Winnock et al., 1995).  It also contains a high frequency of CD56+ classical natural killer 
(NK) cells and a population of NK-like T cells expressing both a TCR αβ and NK cell marker 
 
 
NK1.1 which are found at low frequencies in the blood and most other tissues. The liver also 
includes myeloid lineage cells including resident tissue macrophages, kupffer cells, and myeloid 
and plasmacytoid dendritic cells. Antigen presenting  DCs and kupffer cells play a key role in 
regulating the tolerogenic environment (Klein et al., 2007) along with local regulatory T cells 
(Crispe, 2003;Klein et al., 2007). Hepatic regulatory T cells include naturally occurring, thymic 
derived Treg and possibly induced Treg in the TGF-β rich intra-hepatic cytokine milieu. In addition 
to DC, other cells can act as antigen presenting cells in the liver including kupffer cells, stellate 
cells, and sinusoidal endothelial cells and under some circumstances hepatocytes. The unique 
architecture of the liver allows T cells to interact directly with several resident liver cells types 
including hepatocytes which can access naive T cells in sinusoids by extending microprocesses 
through the fenestrations in sinusoidal endothelium. (Adams et al., 1989;Bowen et al., 
2004;Bowen et al., 2005;Goddard et al., 2004a).  The liver resident lymphocytes as well as 
circulating naïve CD8+ T cells make direct contact with hepatocytes through cytoplasmic 
extensions penetrating the endothelial fenestrations thereby interactions occur between 
lymphocytes and liver parenchyma cells(Warren, 2006). 
The fate of an immune response against intrahepatically expressed antigens depends on 
the dominant site of antigen expression. Where antigen is overwhelmingly presented to naive T 
cells within the liver, CD8+ T-cell tolerance ensues; however, if there is significant early antigen 
expression within the local draining lymph nodes, an effective CTL response is generated, 
resulting in hepatocellular injury (Bowen et al., 2005). The level of antigen expression is also 
crucial as the presence of high-level antigens within the liver lead to deletion of CD8+ T 
cell(Mehal, 2003). There are several mechanisms which contribute to the tolerogenic capacity of 
the liver. 
 
 
1.1.6 Intrahepatic lymphocytes in hepatic tolerance 
Populations of intrahepatic lymphocytes secrete immuno-regulatory cytokines interleukin-
10 and TGF-β and chemokines that maintain tolerance.  These may be derived not only from T 
cells but also from kupffer cells, and even stroma cells (Crispe, 2003). Furthermore, the liver 
could act as a graveyard or a killing field for activated T cells (Crispe et al., 2000;Crispe and 
Mehal, 1996). Specific activation induced by systemic administration of peptide results in 
selective accumulation and apoptosis of CD8+ T cells within the liver of T-cell receptor (TCR) 
transgenic mice (Huang et al., 1994). Again in transgenic mouse models, the liver is capable of 
supporting the primary antigen-specific activation of CD8+ T cells(Bertolino et al., 2001;Bowen 
et al., 2002) however, such intrahepatic activation is ineffectual and leads to impaired effector 
function and reduced CD8+ T-cell survival (Bowen et al., 2004).   
1.1.7 Hepatic dendritic cells and Kupffer cells 
Our group and others have demonstrated that intra-hepatic DC tend to act as tolerogenic 
cells and preferentially express IL-10 compared with for instance skin DC (Goddard et al., 
2004a;Thomson et al., 1995;Thomson and Lu, 1999a;Thomson and Lu, 1999b). The Liver is 
constantly exposed to bacterial LPS via portal blood and this may be responsible for down 
regulation of its receptor TLR4 on liver DC limiting their response to danger signals and resulting 
in reduced or altered activation of the hepatic adaptive immune responses (de et al., 2005a). DC 
also has the capacity to expand functional CD4+CD25+ T cells (Yamazaki et al., 2006a;Yamazaki 
et al., 2006b). Recent work in mice suggested that CCR9+ plasmacytoid DC (pDC) are more 
efficient than CCR9- pDCs in inducing regulatory T cells and inhibit antigen-specific immune 
responses both in vitro and in vivo (Hadeiba et al., 2008). TLR9 stimulation can also promote 
pDC-mediated generation of CD4+CD25+ Treg cells and pDC play an important role in the 
maintenance of immunological tolerance in human peripheral blood (Moseman et al., 2004). 
 
 
Activation of indolamine 2, 3-dioxygenase (IDO) in DCs inhibit T cell proliferation during 
antigen presentation by deprivation of tryptophan (Munn et al., 2004) and kupffer cells, resident 
macrophages of reticuloendothelial system, also contribute to generation of Treg via 
IDO.(Alabraba E,  et al, Manuscript in preparation) 
1.1.8 Hepatic sinusoidal endothelial cells 
Hepatic sinusoidal endothelial cells (HSEC) tolerize antigens from gut-derived bacterial 
degradation products such as lipopolysaccharide (LPS) carried by portal venous blood without 
inducing a local inflammatory reaction (Lalor et al., 2006;Lalor and Adams, 1999). HSEC react to 
LPS directly via its constitutive Toll-like receptor 4 (TLR4) expressions but gain a LPS-refractory 
state upon repetitive stimulation without loss of scavenger activity (Uhrig et al., 2005). In vitro 
evidence indicates that HSECs might activate naïve CD4+ T cells but fail to elicit a Th1 type 
response (Knolle et al., 1999). Thus, HSEC, non-professional APCs which express MHC II 
influence the outcome of intrahepatic CD4+ T-cell responses.  
  
 
 
 
Figure 1-1 Central and peripheral tolerance. 
Bone marrow derived haematopoietic precursors migrate to the thymus where they undergo 
positive and negative selection according to the nature of their TCR interactions with 
peptide/major histocompatibility complex. Some self-reactive T cells are deleted at this stage 
(central tolerance), but others escape to the periphery. They are controlled by multiple peripheral 
tolerance mechanisms acting either passively on the self-reactive T cell (T-cell intrinsic) or 
actively via regulatory T cells (T-cell extrinsic) or regulatory dendritic cells. 
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1.2 Lymphocyte lineage  
CD4 T helper lymphocytes (Th) are regulators of immune responses to infection and 
inflammation. They help B cells to make antibodies, secrete cytokines that polarise the immune 
response and contribute to the recruitment of other effector cells to site of infection or 
inflammation in an orchestrated immune responses. At least 7 different CD4 subsets have been 
shown to exist currently namely Th1, Th2, Th17, Th9, naturally occurring thymic derived Treg, 
peripherally induced Treg and follicular helper T cells.   
In 1986, Tim Mosmann & Robert Coffman first demonstrated that effector T cells can be 
categorized into two distinct subsets, T helper type 1 (Th1) and T helper type2 (Th2), based on 
their cytokine production profiles(Mosmann et al., 1986). Th1 cells produce large quantities of 
interferon-γ (IFN-γ), whereas Th2 cells produce interleukin 4 (IL-4), IL-5 and IL-13(Mosmann et 
al., 1986). Th1 cells elicit delayed-type hypersensitivity (DTH) responses, activate macrophages 
and are highly effective in clearing intracellular pathogens. DTH reactions were originally defined 
as cell-mediated immune reactions manifest by swelling, induration and redness appearing 24 to 
72 hours after intradermal injection of a challenge antigen equivalent to the tuberculin skin test to 
the purified protein derivative of Mycobacterium tuberculosis. Injection of Th1 clones result in 
footpad swelling (DTH) in naive mice after 24 hours whereas injection of Th2 clones do not 
cause swelling (Cher and Mosmann, 1987). Th2 cells, in contrast, are important for the 
production of immunoglobulin E and eosinophilic inflammation and induce humoral immune 
responses against helminths and allergic responses (Abbas et al., 1996). 
Naive CD4+ T cells proliferate and differentiate into various effector subsets after antigenic 
stimulation by professional APC such as dendritic cells. This is characterized by the production 
of distinct cytokines and by their distinct effector functions. DCs are located throughout the 
body to capture and internalize invading pathogens, subsequently process and present antigen on 
 
 
MHC class I and class II molecules to CD8+ and CD4+ T cells respectively (Steinman and 
Banchereau, 2007;Steinman and Young, 1991). Naive T cell activation normally requires two 
signals: T cell receptor (TCR) signals, and co stimulation through several accessory molecules. 
The main costimulatory molecule on T cells is CD28, which interacts with CD80 (B7-1) and 
CD86 (B7-2) expressed on mature DCs. The inducible costimulator (ICOS) is a member of the 
CD28 superfamily that also regulates naive CD4 T cell activation and effector differentiation. 
DCs then translate information of the invading pathogen into a cytokine gene expression profile 
directing the correct T helper cell differentiation pathway.  Thus, achievement of effective host 
defence against invading pathogens involves coordinating complex networks that link innate and 
adaptive immune systems. Initial T effector response is normally followed by a shift to T 
regulatory response to limit the collateral damage. 
  
 
 
 
Figure 1-2 T cell stimulation by antigen presenting dendritic cells with polarizing 
cytokines and co-stimulatory molecules. 
T-cell receptor (TCR) ligate to MHC class-II-associated peptides processed from pathogens 
(signal 1) and co-stimulatory molecule CD28 on lymphocyte bind to CD80 and CD86 expressed 
by dendritic cells (signal.2). Signal 3 is the polarizing signal that is mediated by various polarizing 
cytokines that promote the development of Th1, Th2, Th17 lymphocytes lineages. 
 
The cytokine milieu in the local microenvironment plays important role in the 
differentiation of different T cell subsets. IL-12 produced by innate immune cells and IFN-γ 
from NK and NKT cells polarize naive T cells towards the IFN-γ secreting Th1 cell 
differentiation via signal transduction and activator of transcription (STAT)-4 signalling and T 
box transcription factor T-bet and these Th1 cells are involved in cellular immunity against 
intracellular organisms(Mosmann et al., 1986). IL-4 signalling through STAT-6 and transcription 
factor GATA3  will transform naive T cells towards Th2 cells, which are required for humoral 
immunity to control helminths and other extracellular pathogens(Mosmann et al., 1990). The 
differentiation pathway also depends to some extent on the strength of the interaction of the T 
cell antigen receptor with antigen (Boyton and Altmann, 2002;Maldonado et al., 2004). 
 
 
IL-17-secreting T helper cells (Th17) are identified on the basis of the ability to produce 
IL-17A, IL-17F and IL-22 (Aggarwal et al., 2003;Harrington et al., 2005;Steinman, 2007). TGF-β 
stimulation in the presence of IL-6 facilitates naive T cell differentiation towards Th17 in mice 
(Veldhoen et al., 2006;Veldhoen and Stockinger, 2006a). The signature transcription factor for 
Th17 is RORγt (Ivanov et al., 2006), which in turn induces transcription of the genes encoding 
IL-17 and the related cytokine IL-17F in naïve CD4 T helper cells and is also required for their 
expression in response to IL-6 and TGF-β. IL-1β in combination with IL-6 (costa-Rodriguez et 
al., 2007a) and IL-23 is required for human Th17 differentiation (Wilson et al., 2007). TGF-β is 
now accepted as essential cytokine for the differentiation of human Th17 (Manel et al., 
2008;Volpe et al., 2008;Yang et al., 2008a). All these Th17 polarizing cytokines activate STAT3 
phosphorylation (Chen et al., 2007). Importantly, Th17 cells play crucial roles in the clearance of 
extracellular bacteria and fungi, especially at mucosal surfaces (Mangan et al., 2006). 
Regulation of effector T lymphocytes is necessary for avoidance of autoimmune disease 
and immunopathology. Effector T cells require control by regulatory T cells to maintain immune 
homeostasis and prevent collateral tissue damage once the pathogens has been removed. 
Regulatory T cells which are also crucial for the maintenance of the tolerogenic environment of 
the liver (Crispe et al., 2006).   There are two main types of Treg, thymic derived naturally occurring 
Treg and TGF-β induced Treg. FoxP3 transcription factor is the master regulator of Treg 
development and function of both types of Treg (Fontenot et al., 2003a;Hori et al., 2003;Khattri et 
al., 2003). Naturally occurring, thymic derived Treg are defined by expression of CD4, CD25high, 
FoxP3+ (Sakaguchi, 2004), and low expression of the IL-7 receptor/CD127low (Liu et al., 
2006;Sakaguchi, 2005;Seddiki et al., 2006). In vitro antigenic stimulation of naive T cells in the 
presence of TGF-β in the periphery results in transient FoxP3 expression and Treg function and 
these cells are known as induced Treg (Chen et al., 2003). TGF-β is also important for natural Treg 
 
 
development (Liu et al., 2008). TGF-β activates Smad3 while TCR stimulation induces NFAT 
activation and both collaborate in remodelling the Foxp3 enhancer region to promote FoxP3 
expression (Tone et al., 2008). IL-2 mediated STAT5 activation is also essential for the induction 
of FoxP3 expression (Burchill et al., 2007). 
A subset of T helper cells which secrete IL-9 known as Th9 was described in mice recently. 
IL-9 is a T-cell and mast cell growth factor and it is a multifunctional cytokine secreted by many 
cell types including T lymphocytes, oeosinophils, mast cells and neutrophils (Hultner et al., 
1990;Uyttenhove et al., 1988;van et al., 1989). Th9 cells are reprogrammed from Th2 cells under 
influence of TGF-β and IL-4. Thus, TGF-β constitutes a regulatory 'switch' that in combination 
with other cytokines can 'reprogram' effector T cell differentiation along different pathways 
(Dardalhon et al., 2008;Veldhoen et al., 2008b). IL-9 is involved in variety of allergic diseases 
including human airway inflammation and asthma (Gounni et al., 2004;Longphre et al., 
1999;Vermeer et al., 2003). IL-9 affects differentiation of Th17 cells and enhances the 
suppressive functions of FoxP3+ CD4+ Treg cells in vitro. Thus absence of IL-9 signalling weakens 
the suppressive activity of natural Treg in vivo, leading to an increase in effector cells and worsening 
of experimental autoimmune encephalomyelitis (Elyaman et al., 2009) 
Follicular helper T cells (Tfh) are a subset of helper T cells that regulate the maturation of 
B cells and specialize in the cognate control of antigen-specific B cell immunity. IL-21 cytokine is 
produced by Tfh cells and it stimulates the differentiation of B cells into antibody-forming cells 
through IL-21R. Deployment of CXCR5+ Tfh cells to B cell zones of lymph nodes and 
subsequent stable cognate interactions with B cells are central to the delivery of antigen-specific 
Tfh cell to generate high affinity antibody production (Fazilleau et al., 2009b). Consequently, 
dysregulation of Tfh cell function, and over or under-expression of Tfh cell associated molecules 
such as ICOS (Bauquet et al., 2009) or IL-21, contributes to the pathogenesis of certain 
 
 
autoimmune diseases or immunodeficiencies (King et al., 2008). Differentiation of these cells 
requires the cytokine IL-21 (Nurieva et al., 2008;Vogelzang et al., 2008) and may be dependent 
on the transcription repressor Bcl-6 (Fazilleau et al., 2009a;Nurieva et al., 2009). 
Thus, naive CD4+ T cells differentiation to different lineage programs depends on nature 
of antigen, types of antigen presenting cells, cell surface signals and polarizing cytokines 
produced by innate immune cells. 
  
 
 
 
 
Figure 1-3 T lymphocyte lineage.  
Cytokine-mediated amplification of effector CD4+ Th1, Th2, Th-17 and Th-9 cells. Once 
activated, naive T cells differentiate into distinct CD4+ helper T cell subsets depending on the 
cytokine milieu which drives a program of differentiation controlled by the induction of key 
transcription factors. Part of this differentiation programme imprints the subsets with specific 
combinations of chemokine receptors. Th1 cells express inflammatory type chemokine receptors, 
CCR5 and CXCR3; Th2 cells express CCR4 and CCR8; recently discovered Th17 cells express 
CCR4, CCR6, and CXCR3. Th9 subset differentiates from Th2 cells when they are stimulated by 
IL-4 and TGF-β. Naturally occurring, thymic derived regulatory T cells maintain the peripheral 
immune tolerance and prevent the excessive damage during infection and inflammation by 
controlling these T effectors cells. 
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1.3 Regulatory T cell  
The efficient functioning of mammalian immune system requires not only the ability to 
mount effector responses against pathogens but also to dampen down the system to maintain 
homeostasis. It protects the body from invading foreign pathogens whilst maintains the self 
tolerance. Breakdown in self-tolerance leads to auto-immunity (Sakaguchi, 2005). Immunological 
self-tolerance is achieved by two major mechanisms; central and peripheral tolerance. Central 
tolerance involves thymic deletion of self reactive T cells, however some of these auto reactive 
cells escaped to periphery. Peripheral tolerance is maintained by passive and active mechanism. 
Passive mechanism including ignorance, anergy and apoptosis are not sufficient, and active 
immunosuppression is required for auto reactive T cells to prevent auto-immunity. Regulatory T 
cells play an essential role in maintaining the peripheral tolerance (Walker & Abbas, 2002) by 
actively suppressing the auto-reactive T cells (Sakaguchi et al., 1995).  
Regulatory T cells were previously known as T suppressor cells. A proposed determinant 
of 'suppressor' T-cell function named I-J however, could not be found within the MHC 
(Steinmetz et al., 1982) which led to the concept of T suppressor cell being discredited until its 
re-emergence in the late 90s, under the new name of T regulatory cell (Treg) (Sakaguchi et al., 
1995;Sakaguchi, 2005). 
T-cell–mediated immunosuppression by naturally occurring regulatory T cells is crucial in 
regulating the immune system. They are key controller in the immunologic tolerance to 
alloantigen in organ transplantation (Wood and Sakaguchi, 2003). They also prevent excessive 
inflammation and collateral damage during chronic infection (Belkaid and Rouse, 2005;Sakaguchi, 
2005;Wood & Sakaguchi, 2003). There are different types of regulatory T cells which are 
described individually below. 
 
 
1.3.1 Naturally occurring regulatory T cell 
Treg constitute approximately 5–10% of peripheral lymphocytes. The role of naturally 
occurring thymic derived CD4+CD25+ Treg in immune homeostasis and peripheral tolerance was 
first described by Sakaguchi and colleagues. Transfer of lymphocytes depleted of CD4+CD25+ 
into athymic mice cause the development of various autoimmune diseases in the recipient 
whereas co-transfer of a small number of CD25+CD4+ T cells with the CD25- T cells inhibit the 
development of autoimmunity (Sakaguchi et al., 1995). Removal of CD25+CD4+ T cells not only 
provoked the development of autoimmune disease but also enhanced immune responses to non-
self antigens including soluble xenogeneic proteins and allograft, and reconstitution with 
CD25+CD4+ T cells normalized the responses (Sakaguchi et al., 1995). 
Naturally occurring Treg develop in the thymus under strong TCR engagement with self 
peptides and maintain peripheral self-tolerance and consequently immune homeostasis. They 
constitutively express CD25, the receptor for the IL-2α chain. IL-2, a 15 kDa α-helical cytokine, 
is produced almost exclusively by activated T cells and promotes proliferation of lymphocytes, 
macrophages, and NK cells (Walker et al., 1988). IL-2 which is a key growth and survival factor 
and functional cytokine for natural Treg and it acts on its receptor, CD25 (Almeida et al., 
2002;Schorle et al., 1991;Setoguchi et al., 2005;Suri-Payer et al., 1998;Willerford et al., 1995). The 
hallmark of CD4+CD25+ Treg is their functional hyporesponsiveness, low IL2 production and the 
ability to potently suppress proliferation of other CD4+ and CD8+ T cells in co-cultures 
stimulated with specific antigen or polyclonal TCR activation (Thornton and Shevach, 1998). 
CD25 is expressed not only on Treg but also on activated T cells which hampers the phenotypic 
assessment of Treg. Low level of expression of CD127, the IL-7 receptor α chain on Treg, allows 
discrimination between Treg and effector populations which express high levels of CD127. 
 
 
Expression of FoxP3 and the CD127low phenotype is thus highly correlated with CD4+CD25+ Treg 
and manifest suppressive activity in vitro (Liu et al., 2006;Seddiki et al., 2006).  
Fork head box P3 (FoxP3) is the master regulator transcription factor expressed by 
natural Treg which controls the development and function (Fontenot et al., 2003b;Hori et al., 
2003;Khattri et al., 2003). The Foxp3 gene was identified as the gene mutated in Scurfy mice, 
which have an X-linked recessive mutation that is lethal in homozygous male mice from severe 
autoimmunity/inflammation (Brunkow et al., 2001). Mutations of the human FOXP3 gene, the 
ortholog of murine Foxp3, lead to a similar human disease known as IPEX syndrome (immune 
dysregulation, polyendocrinopathy, enteropathy, X-linked syndrome), which is characterized by 
autoimmune disease in multiple endocrine organs (Type 1 diabetes and Thyroiditis), 
inflammatory bowel disease, and severe allergy in male children (Sakaguchi et al., 2006). 
Retroviral transduction of FoxP3 to normal CD4+CD25- T cells converted them into 
functional Treg with suppressive activity (Fontenot et al., 2003a;Hori et al., 2003). FoxP3 controls 
Treg functional activity by binding to other transcription factors such as NFAT ( nuclear factor of 
activated T cells) and AML1(acute leukaemia-1),  Runx1(runt-related transcription factor-1) and 
also repress the IL-2 gene in Treg rendering them highly dependent on exogenous IL-2 produced 
by activated non-Treg cells. FoxP3 also activates the genes encoding other molecules associated 
with Treg including CD25, CTLA-4 and GITR by binding to their respective promotors (Marson 
et al., 2007;Ono et al., 2007;Wu et al., 2006;Ziegler, 2005) and these molecules in turn directly 
suppress non-Treg cells or modulate the function of APC to activate non-Treg cells.  
IL-2, the major cytokine for T cells proliferation and cell growth is critical for Treg 
differentiation and function. Mice lacking IL-2 or its receptor CD25 (Malek et al., 1984), or a 
deficiency of STAT5 which mediate signalling from IL2 receptor to FoxP3 succumbs to lethal 
autoimmune diseases (Burchill et al., 2003;Burchill et al., 2007;Yao et al., 2007). Neutralization of 
 
 
IL-2 with anti-IL2 (Setoguchi et al., 2005) also reduces Treg numbers resulting in autoimmune 
disease.  
CTLA-4 is a potent negative regulator of T-cell immune response (Walunas et al., 
1994;Waterhouse et al., 1995) that has been implicated in Treg suppression mechanism. Both 
murine and human Treg express CTLA-4 constitutively (Takahashi et al.). CTLA-4 knockout (KO) 
mice die prematurely from multi-organ inflammation (Waterhouse et al., 1995) and blockade of 
CTLA-4 with antibody results in autoimmunity, inflammatory bowel disease, enhance anti-
tumour immunity (Sansom and Walker, 2006). It also prevents regulation of allogenic effectors 
by alloantigen-specific CD4+CD25+ Treg (Kingsley et al., 2002). Signalling through CTLA-4 play a 
role in the induction of peripheral tolerance (Chen et al., 1998) by stimulating secretion of the 
immunosuppressive cytokine TGF-β (Perez et al., 1997). Treg also express the glucocorticoid-
induced TNF receptor family related protein (GITR). Stimulation of GITR abrogates Treg 
mediated suppression and removal of GITR-expressing T cells or administration of antibody to 
GITR produced organ-specific autoimmune disease (Shimizu et al., 2002). 
The outcome of immune response depends on the balance between Treg and T effector 
cells. In the context of liver disease, chronicity of viral hepatitis and failure to mount effective 
immune responses against hepatocellular carcinoma may be due to dominance in the regulatory 
arm whereas in autoimmune hepatitis and graft rejection the effector arm may outweigh the 
regulatory arm (Fig.1.4). 
 
 
 
 
Figure 1-4 Effector arm and regulatory arm balance in the liver. 
The balance between effector lymphocytes and regulatory lymphocytes generally decide the final 
outcome of immune response. In hepatocellular carcinoma and chronic viral hepatitis, the T 
regulatory response is dominant and T effector arm outweigh the regulatory arm in post-
transplant rejection and autoimmune hepatitis. 
  
 
 
Treg can also develop outside the thymus and such cells are developmentally, 
phenotypically and functionally different from natural Treg. They are named as induced or 
adaptive Treg. Adaptive Treg are induced from naïve T cells by antigenic stimulation in a specific 
cytokine milieu. They include IL-10 secreting type1 T regulatory cells ( Tr1 ) and TGF-β secreting 
T helper Th3 cells, and CD8+ CD28- T cells ( Table.1). They all play a pivotal role in the control 
of autoimmunity and organ transplantation tolerance in rodents and human.  
1.3.2 Different subsets of Regulatory T cells 
1.3.2.1 Induced Treg 
In peripheral tissues, antigenic stimulation of naive T cells in the presence of TGF-β leads 
to the acquisition of FoxP3 expression and consequently Treg function (Chen et al., 2003). Human 
naïve T cells transiently express FoxP3 upon TCR stimulation (Gavin et al., 2006) although the 
expression is generally much lower and more transient than natural Treg (Yagi et al., 2004). In 
mice, the Foxp3 gene is more widely demethylated in natural Treg compared with TGF-β induced 
Treg suggesting that natural Treg are more stable than the induced cells (Floess et al., 2007). Induced 
Treg can combine with natural Treg to augment the peripheral pool of FoxP3+ Treg. 
1.3.2.2 Tr1 cells 
Type 1 T regulatory cells (Tr1) differentiate from both human and murine naïve antigen 
specific CD4+ T cell when they are stimulated in vitro and in vivo in the presence of IL-10 and 
APC. They have a low proliferative capacity due to autocrine production of IL-10. Tr1 cells have 
a distinct cytokine profile that is different from Th1 or Th2 cells as they produce high levels of 
IL-10 and TGF-β but low amounts of IL-2, IFN-γ and no IL-4 (Groux et al., 1997). These 
antigen-specific T-cell clones suppress the proliferation of CD4+ T cells in response to antigen, 
 
 
and prevent colitis induced in SCID mice by pathogenic CD4+CD45RBhigh splenic T cells (Groux 
et al., 1997).  
Tr1 cells can be generated in a variety of different tolerogenic microenvironments. The 
presence of vitamin D and dexamethasone facilitates the in-vitro induction of Tr1 cells from naïve 
CD4+ T cells by IL-10 (Barrat et al., 2002;Levings et al., 2001). Naïve CD4+ T cells stimulated by 
CD3 and the human complement regulator CD46 in the presence of  IL-2 also differentiate into 
Tr1 cells in vitro (Kemper et al., 2003). Again, cord blood derived CD4+ T cells stimulated by 
allogeneic immature DCs give rise to Tr1 cells (Jonuleit et al.). Furthermore,  in-vivo generation of 
tolerogenic Tr1 cells was achieved in diabetic mice by administering IL-10 and rapamycin after 
pancreatic islet transplantation and antigen-specific tolerance could be transferred to naïve mice 
by adoptive transfer of Tr1 cells from the mice with tolerance (Battaglia et al., 2006).  
Tr1 cells do not express FoxP3, however their properties in vitro are similar to those of 
FoxP3 Treg. They exhibit diminished proliferation in response to antigen, exert cell contact-
dependent suppression, produce very little IL-2, display an activated cell-surface phenotype 
(Vieira et al., 2004) and suppress both naïve and memory T cell responses. They are inducible, 
antigen specific, and require activation via TCR to exert their suppressive functions. However, 
once activated, Tr1 cells exert not only antigen-specific suppression but bystander suppression as 
well. This bystander suppression is mediated by the local release of IL-10 and TGF-β (Roncarolo 
et al., 2006).  
1.3.2.3 Th3 cells 
TGF-β–producing Th3 cells have been identified as regulators in oral tolerance (oral 
administration of antigens to induce tolerance) both in vivo and in vitro (Faria and Weiner, 2005). 
Oral administration of myelin basic protein leads to the generation of CD4+ clones in the 
mesenteric lymph nodes which produce TGF-β, IL-4 and IL-10 (Chen et al., 1994). Thus, 
 
 
mucosal derived Th2-like clones induced by oral antigen can actively regulate immune responses 
in vivo.  
There are a number of differences between naturally occurring Treg , induced Treg, Tr1 and 
Th3 in their origin, mode of suppression and these are described in Table 1.1. 
Types Origin Phenotypic 
characteristic 
Mechanism 
of 
suppression 
Homing 
behaviour 
Typical 
features 
Naturally 
occurring 
Treg 
Thymus CD4+CD25high 
CD127low 
FoxP3+ 
Cell to cell 
contact in vitro
Down 
regulation of 
IL-2 
transcription in 
Target T cells 
Secondary 
lymphoid 
organ  or  
site of 
inflammation 
Anergic in 
vitro 
 
Tr1 
 
 
Periphery IL-4- IL-5+ 1L-
10+ IFN-γlow 
TGF-β+  
IL-10, TGF-β 
mediated  
Site of 
inflammation 
Anergic in 
vitro 
Differentiate 
with 
exogenous 
IL-10 with 
IFN-α and 
APCs 
Th3 Periphery 
 
Oral antigen 
CD4+ FoxP3+ TGF-β Mucosal 
surface,  
site of 
inflammation 
Oral antigen 
Inducible 
Treg 
 
Periphery 
Plasmacytoid 
DC 
TGF-β 
 
CD4+CD25high  
Foxp3+ 
  ?contact 
dependent 
  
Table 1-1 Types of Treg, origin, phenotype and mode of suppression.  
Different types of regulatory T cells, their origin, phenotype and mechanism of suppression are 
shown in the table. Both naturally occurring Treg and periphery derived Treg maintain the immune 
homeostasis by controlling the T effectors cells 
Abbreviation: Tr1- T regulatory cell type1; Th3- T helper cells type3; IL- interleukin, TGF-
Transforming growth factor; FoxP3- fork-head, winged helix box P3. 
  
 
 
1.3.3 Suppressive function of regulatory T cells  and mechanism of 
suppression 
Inadequate immune suppression results in autoimmunity and allergy on the other hand, 
too much suppression leads host susceptible to infection. During microbial infection in 
particular, Treg suppression needs to be attenuated to allow effective anti-microbial immune 
responses whilst suppressing unwanted immunopathological tissue damage. This involves a 
cascade of suppressive interactions orchestrated by Treg to control the effector activities of 
differentiated CD4+ and CD8+ T cells, natural killer cells, natural killer T cells (Miyara and 
Sakaguchi, 2007a). Once activated by a particular antigen, Treg can suppress responder T cells 
irrespective of  whether they share antigen specificity with the Treg i.e. they can mediate bystander 
suppression. 
1.3.3.1 Contact dependent suppression 
Naturally occurring CD4+CD25+ Treg suppress the proliferation of CD4 and CD8 T 
effectors in vitro via cell-cell contact-dependent mechanisms (Jonuleit et al., 2001;Ng et al., 2001). 
Treg suppression is abolished when Treg and responder cells are separated by a semi-permeable 
membrane (Takahashi et al., 1998;Thornton & Shevach, 1998). Several accessory molecules, such 
as CTLA-4 (CD152) and lymphocyte-activation gene 3 (LAG3), expressed by Treg, and CD80 and 
CD86 co-stimulatory molecules expressed by APCs contribute to contact-dependent suppression 
(Huang et al., 2004;Sakaguchi, 2004).  Treg are more mobile than naïve T cells in vitro therefore, 
when Treg and CD4+CD25− naïve T cells are co cultured with TCR stimulation, the Treg out-
compete the CD4+CD25− in aggregating around DCs. Treg can then down-regulate the expression 
of CD80/CD86 on DCs before naive T cells can interact with them thereby preventing the 
activation of T effector cells by DC (Onishi et al., 2008).  
 
 
1.3.3.2 LAG-3  
LAG-3 (CD4 related lymphocyte activation gene 3, CD223) is a CD4 associated adhesion 
molecule that binds to major histocompatibility complex(MHC) class 2 molecules. LAG3 is 
expressed on Treg upon activation and mediates suppression of APC via MHC class ІІ molecules 
expressed on DCs, B cells, monocots, macrophages (Huang et al., 2004).  
1.3.3.3 CTLA-4 and IDO 
CTLA‐4 and CD28 expressed by T lymphocytes interact with two ligands (CD80 and 
CD86) on antigen‐presenting cells. Although they are structurally similar, the functions of CD28 
and CTLA‐4 are opposite, with CD28 playing an important role in promoting T‐lymphocyte 
responses, whilst CTLA‐4 acts as an essential inhibitor (Sansom, 2006). CD25+CD4+ natural Treg 
constitutively express CTLA-4 (CD152), whereas naïve T cells express this molecule only after 
activation (Sakaguchi, 2005). The expression of CTLA-4 is augmented by Treg stimulation 
(Sakaguchi, 2005). FoxP3 controls the expression of CTLA-4 and CTLA-4 blockade abrogates 
suppression(Sansom, 2006). CTLA-4 on CD4+CD25+ Treg is able to up-regulate indolamine 2,3-
dioxygenase (IDO) expression in dendritic cells, through interaction with CD80 and CD86 
(Fallarino et al., 2006). IDO catabolise the essential amino acid  tryptophan into kynurenine and 
other metabolite, which are toxic to T cells (Fallarino et al., 2006).  
In vivo studies demonstrate that antigen-activated Treg with high expression of LFA-1 are 
recruited around dendritic cells and out-compete antigen-specific naive T cells thereby hampering 
activation of other T cells by dendritic cells. Treg then modulate dendritic cell function by down 
regulating CD80 and CD86 on DC by CTLA-4-dependent mechanism (Misra, 2004;Waterhouse 
et al., 1995;Wing et al., 2008). In vitro, Treg suppress the proliferation and cytokine production of 
responder T cells when the two populations are co cultured and stimulated by antigen in the 
presence of APC (Takahashi et al., 1998;Waterhouse et al., 1995). Alternatively, CTLA-4 on Treg 
 
 
ligate CD80 and, to a lesser extent, CD86 expressed by activated responder T cells and directly 
transduce a negative signal to the responder T cells (Paust et al., 2004). In addition, activation of 
Toll like receptors (TLRs) on DCs can also modulate the suppressive function of CD4+CD25+ 
Treg(Pasare and Medzhitov, 2003).  
1.3.3.4 Cytotoxicity by Perforin and granzyme B 
Up-regulation of granzyme B on CD4+CD25+ Treg correlates with their suppressive 
activity, and CD4+CD25+ Treg from granzyme B knockout mice have less suppressive capacity 
compared with Treg from wild type mice, suggesting granzyme B is of functional importance 
allowing the Treg to kill target cells (Gondek et al., 2005). In humans, CD4+CD25+ Treg can also 
use a perforin-dependent cytotoxic pathway to induce target cell death (Grossman et al., 2004). 
1.3.3.5 Immunosuppressive cytokines 
The immunosuppressive cytokines TGF-β and IL-10 play an important role in 
suppression by CD4+CD25+ Treg. Neutralizing antibodies against TGF-β and IL-10 abrogate the 
suppression in experimental settings (Sakaguchi, 2005). Foxp3+ natural Treg also predominantly 
produce the immunosuppressive IL-35, a new member of the IL-12 family(Collison et al., 2007). 
Alternatively, absorption of cytokine such as IL-2 by Treg induces cytokine-deprived apoptosis in 
responder T cells (Pandiyan et al., 2007).Adenosine nucleosides 
Treg express the cell surface ectoenzymes CD39 (ectonucleoside triphosphate 
diphosphohydrolase1) and CD73 (ecto-5'-nucleotidase) and this distinguishes them from other T 
cells. CD39 and CD73 generate pericellular adenosine by catalysing extracellular nucleotides and 
adenosine activate the adenosine A2A receptor on activated T effector cells to increase 
intracellular cyclic AMP  (cAMP) leading to inhibition of T cell proliferation and IL-2 production 
(Deaglio et al., 2007;Novak and Rothenberg, 1990). This is mediated through protein kinase 
blockade of nuclear factor κB activity or the activation of the transcriptional repressor ICER( 
 
 
inducible cyclic AMP repressor)(Bodor et al., 2006). Treg can also increase cAMP  levels in the 
target responder cells by directly delivering them via gap junction (Bopp et al., 2007).  
Thus, several mechanisms are involved in Treg mediated suppression and more than one 
mechanism of suppression may operate for the control of a particular immune response in a 
synergistic and sequential manner.  
 
Figure 1-5 Mechanism of suppression of regulatory T cells.  
Multiple mechanisms of Treg suppression include both contact dependent interactions with T 
effector cells and also via dendritic cells. Treg also secrete inhibitory cytokines including 
interleukin-10 (IL-10), transforming growth factor-β (TGF-β), and interleukin-35 (IL-35). In 
addition, they can lyse T effector cells via granzyme-B and perforin-dependent killing. Metabolic 
disruption includes creating cyclic AMP in the vicinity of T effector by ectoenzymes CD39 and 
CD73. Treg also acts via dendritic cells to modulate DC maturation and function through 
lymphocyte-activation gene 3 ( LAG3/CD223)-MHC-class II mediated suppression of DC 
maturation. Treg will also act via cytotoxic T-lymphocyte antigen-4 (CTLA-4) and CD80/CD86 
mediated induction of  indolamine 2,3-dioxygenase( IDO) which leads to tryptophan deprivation 
to T effector cells.  
 
 
1.3.4 Regulatory T cell trafficking  
Expression of distinct homing chemokine receptors and adhesion molecules (Huehn et al., 
2005) by Treg is critical for their recruitment and localization either to inflamed tissue or regional 
lymphoid tissue. Antigen-specific Treg migrate to regional lymph nodes (Samy et al., 2005) where 
they become activated by tissue-specific self-antigens or microbial antigens presented by dendritic 
cells (Scheinecker et al., 2002). FoxP3+ Treg in lymph nodes express high levels of the lymph node 
homing receptors CCR7 and L-selectin. Once they are activated, they migrate into inflamed 
tissues, infectious sites, and tumours (Belkaid & Rouse, 2005).  
The chemokine receptors expressed by Treg depend upon the site of the tissue, and the 
cytokine milieu in which they are activated. Treg can express patterns of homing receptors that 
overlap with T effector cells; Th1 cells (CXCR3, CCR5 and CXCR6), Th2 cells (CCR4 and 
CCR8) and Th-17 cells (CCR4, CCR6, CCR2 and CXCR3) and Tc17 cells (CXCR6) allowing Treg 
cells to co-localize with different effector T cells to suppress a wide range of inflammatory 
conditions(Lee et al., 2007). Our group reported that effector T  lymphocytes (Curbishley et al., 
2005) and a population of Treg (Eksteen et al., 2006) in the inflamed human liver express CXCR3 
which they use to enter the liver via hepatic sinusoids whereas CCR10 expressed by the Treg is 
important for interactions with biliary epithelium where its ligand CCL28 is expressed (Eksteen et 
al., 2006). Many other groups also reported that CCR4+ Treg and effector T cells accumulate in the 
inflamed skin (Sather et al., 2007), ovarian tumours (Curiel et al., 2004) and allograft (Lee et al., 
2005a), CCR5+ Treg preferentially migrate to cutaneous lesions of Leishmania major infection 
(Yurchenko et al., 2006) and GVHD target organs (Wysocki et al., 2005), CCR6+ Treg and Th17 
are elevated in inflamed joints of murine model of rheumatoid arthritis (Hirota et al., 2007), 
CCR7+ CD62Lhigh Treg migrate to regional lymph nodes (Szanya et al., 2002). Moreover, CD103+ 
/integrin αE β7 Treg interacts with E-cadherin expressed by epithelial cells and Treg expressing 
 
 
CD103 are able to control colitis in murine model (Uhlig et al., 2006). They also efficiently 
migrate into inflammatory sites to suppress peripheral inflammation (Huehn et al., 
2004;Lehmann et al., 2002) such as Leishmania major infection(Suffia et al., 2005). Thus, 
appropriate migration to and retention within specific tissues is required for the effective Treg 
mediated suppression in the microenvironment where regulation is required. 
 
Figure 1-6 Human regulatory T cell trafficking.  
Homing of Treg depends on their expression of chemokine receptors that recognise tissue specific 
chemokines secreted at the site of migration by the resident and infiltrating cells and also by the 
injury or inflammation of the tissue. Treg could have more than one chemokine receptors and 
individual receptor may have a defined role in different steps of Treg recruitment, retention and 
positioning at site of hepatic inflammation. 
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1.4 Reciprocal relationship between Treg and Th17 
There is reciprocity between the Th17 and Treg developmental programs in which IL-6 
plays a pivotal role in dictating whether the immune response is dominated by proinflammatory 
Th17 cells or protective Treg(Bettelli et al., 2006;Mucida et al., 2007). TGF-β is a cytokine 
produced by natural Treg and cells of the innate immune system. It has broad inhibitory effects on 
the entire immune system (Li et al., 2006). Naive T cell expresses FoxP3 and becomes Treg on 
TCR stimulation in the presence of TGF-β alone (Gavin et al., 2006) on the other hand, TGF-β 
and IL-6 together favour Th17 development and Treg developmental pathway is inhibited. Thus, 
IL-6 hampers the differentiation of naive T cells to FoxP3+ cells (Bettelli et al., 2006;Veldhoen et 
al., 2006). IL-6 KO mice have severe defect in the generation of Th17 cells and also have increase 
numbers of Treg in the periphery (Bettelli et al., 2006;Korn et al., 2007;Korn et al., 2008). In 
addition to IL6, IL-2, retinoic acids and ligands for the aryl hydrocarbon receptor (AHR) all play 
crucial roles in Th17 or Treg differentiation pathway.  
IL-2, an essential cytokine for Treg(Sakaguchi et al., 1995) and it inhibits the generation of 
Th17 cells and promotes the generation of Treg in the peripheral immune compartment in vivo 
(Laurence et al., 2007a;Laurence et al., 2007b). In the tumour microenvironment, IL-2 reduces 
Th17 differentiation in favour of enhanced Treg development (Kryczek et al., 2007). IL-2 and 
TGF-β also down-regulate IL-6 receptor expression and IL-6 signalling in induced Treg thus 
promoting induced Treg resistant to Th17 conversion in an inflammatory milieu (Zheng et al., 
2008).  
Retinoic acid, a vitamin A metabolite also regulates the balance between proinflammatory 
Th17 and anti-inflammatory Treg. All trans retinoic acid is generated by a subset of dendritic cells 
in gut-associated lymphoid tissue. In the presence of TGF-β, retinoic acid facilitates the 
differentiation of naive T cells to FoxP3+ Treg (Mucida et al., 2007;Yagi et al., 2004). In an 
 
 
inflammatory setting, retinoic acid inhibits the generation of Th17 whilst enhancing the de novo 
generation of Treg(Mucida et al., 2007;Xiao et al., 2008). Retinoic acid acts directly on naive T cells 
to enhance TGF-β signalling whilst inhibiting IL-6 signalling and it also suppresses the up 
regulation of IRF4 and IL-23R, resulting in decreased generation of Th17 cells (Xiao et al., 2008). 
Furthermore, binding of retinoic acid by its nuclear receptor RARα also increases FoxP3 
promoter activity leading to Treg  differentiation (Kang et al., 2007)  
The aryl hydrocarbon receptor (AHR) was found to be highly expressed in both Th17 cells 
(Veldhoen et al., 2008a) and Treg (Hill et al., 2007). AHR engagement by its ligand controls the 
generation of Th17 in vitro and in vivo. Th17 generation is modulated in vitro by endogenous AHR 
agonists in culture medium such as Iscove's modified Dulbecco's medium which is rich in 
aromatic amino acids that bind AHR thus yields more Th17 expansion in both mouse and 
humans (Veldhoen et al., 2009). A nonmetabolizable ligand of AHR, 2,3,7,8-tetrachlorodibenzo-
p-dioxin, induce the expression of FoxP3, resulting in the generation of functional Treg ,whereas 
6-formylindolo[3,2-b] carbazole, another ligand of AHR, promote the expression of Th17 cells 
(Quintana et al., 2008;Veldhoen et al., 2008a). 
Differentiation of both Th17 and Treg requires TGF-β but depends on distinct transcription 
factors: RORγt for Th17 cells and FoxP3 for Treg cells(Chen et al., 2003;Ivanov et al., 
2006;Veldhoen et al., 2006). At low concentrations, TGF-β synergizes with IL-6 and IL-21(Korn 
et al., 2007;Nurieva et al., 2007;Zhou et al., 2007) to promote IL-23 receptor expression, 
favouring Th17 differentiation, however high concentrations of TGF-β repress IL23 receptor 
expression and favour FoxP3+ Treg cells(Zhou et al., 2008). RORγt and FoxP3 are co-expressed in 
naive CD4+ T cells exposed to TGF-β (Zhou et al., 2008). Moreover, Runx1 influences Th17 
differentiation by inducing RORγt expression and by binding to and acting together with RORγt 
 
 
during IL-17 transcription. However, Runx1 also interacts with FoxP3, and this interaction is 
necessary for the negative effect of FoxP3 on Th17 differentiation(Zhang et al., 2008). 
Thus, inflammatory cytokine milieu, retinoic acids, AHR ligands, types of antigen 
presenting cells and transcription factors all in combination influence the reciprocal relation 
between this two types of cells.  
  
 
 
1.5 Interleukin 17 secreting lymphocytes (Th17&Tc17) in the 
immune system  
The CD4+ mediated immune response is highly heterogeneous, depending on the 
development of distinct subsets which are characterized by cytokine production. After antigen 
stimulation, CD4+ T cells differentiate into either Th1 or Th2  effector subsets in both mice and 
humans (Mossman et al., 1988). Th1 cells differentiate from naive T cells in response to IL-12, 
IFN-γ and they are characterized by IFN-γ production. They protect against intracellular 
microbes and mediate cellular immunity. In contrast, Th2 cells originate from naive T cells in the 
presence of IL-4, secrete IL-4, IL-5, IL-9 and IL-13 and drive humoral immunity and responses 
against parasites and  also implicated in allergic disorders (Mossman et al., 1988).  Th17 are a 
separate lineage of CD4+ T helper cells that selectively produce proinflammatory cytokines 
interleukin-17A and 17F and have been linked to the pathogenesis of autoimmune disease, a 
function previously attributed to Th1 cells and IFN-γ (Bettelli et al., 2007). 
1.5.1 Murine Th17 cells 
The Th17 lineage was initially discovered in mice and implicated in experimental 
autoimmune encephalomyelitis (EAE) and collagen-induced arthritis (CIA) (Cua et al., 
2003;Langrish et al., 2005;Murphy et al., 2003). EAE and CIA were previously believed to be 
associated with unchecked Th1 response. However,  IFN-γ- and IFN-γ receptor deficient mice, 
as well as mice that lack other molecules involved in Th1 differentiation such as IL-12p35 (IL-12 
receptor-β2) were not protected from EAE, but rather developed more severe disease (Gran et 
al., 2002;Krakowski and Owens, 1996;Tran et al., 2000;Zhang et al., 2003). In addition, IFN-γ 
deficient or IFN-γ receptor deficient mice are still susceptible to EAE and CIA (Ferber et al., 
1996). This led to the discovery of Th17 cells and their role in EAE, CIA and other organ-
 
 
specific autoimmune diseases. IFN-γ inhibits the development of Th17 cells(Weaver et al., 2006) 
suggests that Th1 responses can in some circumstances be protective rather than pro-
inflammatory. EAE, driven by IL-23 and IL-17 worsens with administration of neutralizing 
antibody to IFN-γ as Th1 cells act as an anti-inflammatory brake(Cua et al., 2003).  
IL-23 is crucial for Th17 growth, survival and expansion of Th17 rather than for lineage 
commitment. It is a new member of the IL-12 family which is a heterodimer that shares the p40 
subunit with IL-12 associated with p19 rather than p35 (Oppmann et al.). The IL-12 heterodimer 
is composed of p40 and p35 subunits, and IL-23 is composed of p40 and p19. EAE and CIA do 
not develop in mice lacking IL-23 p19 subunit, whereas both diseases develop in IL-12 p35 
subunit deficient mice (Cua et al., 2003;Murphy et al., 2003). EAE severity is greatly reduced, 
upon treatment with a monoclonal antibody to IL-17 (Langrish et al., 2005) and mice treated with 
antibodies to IL-23 also failed to develop EAE(Chen et al., 2006).  
The differentiation of naive T cells into Th17 cells depend on the interaction with 
professional APC which express TCR ligands, costimulatory molecules and secrete specific 
cytokines. DC secretes IL-23 when stimulated with hyphae from Candida albicans and its 
derivatives zymosan (a TLR2 and Dectin-1 agonist) and β-glucan, a selective Dectin-1 agonist 
(costa-Rodriguez et al., 2007b;Gerosa et al., 2008). Monocyte derived dendritic cells also produce 
IL-23 on exposure to Mycobacterium tuberculosis H37Rv or a combination of nucleotide-binding 
oligodimerization domain and Toll-like receptor 2 ligands which mimics activation by M. 
Tuberculoisis (Gerosa et al., 2008). 
Th17 differentiation in mice is driven by TGF-β in association with IL-6 and this induces 
a distinct transcriptional program (Bettelli et al., 2006;Mangan et al., 2006;Veldhoen and 
Stockinger, 2006b). IL-6 is produced by the innate immune cells including DCs, monocytes, 
macrophages, B cells, activated T cells, fibroblasts, epithelial cells and tumour cells (van, 1990). 
 
 
Naive T cells have functional IL-6 receptors composed of IL-6α and the signalling subunit gp130 
(Taga and Kishimoto, 1997). Engagement of the IL-6R by IL-6 causes activation of gp130 and 
activation of STAT3 (Harris et al., 2007) which is necessary for the induction of transcription 
factors RORγt and RORα (Yang et al., 2008c).  
IL-21 is a cytokine produced by NKT and activated T cells (Parrish-Novak et al., 2000). 
It is secreted by Th17 cells and act as an autocrine amplification loop to regulate its 
differentiation (Korn et al., 2007;Korn et al., 2009;Nurieva et al., 2007;Nurieva and Dong, 
2008;Zhou et al., 2007). Differentiation of murine Th17 cells from naive T cells is directed by 
two lineage specific transcription factors, retinoic acid-related orphan receptor, RORγt and 
RORα. RORγt is the transcription factor which acts as the Th17 master regulator (Ivanov et al., 
2006) and RORα which is induced by TGF-β and IL-6 (Yang et al., 2008c). RORγt and RORα co 
expression synergise to drive greater Th17 differentiation and double deficiencies in RORγt and 
RORα globally impair Th17 generation and completely protect mice against EAE (Yang et al., 
2008c).  
STAT3 is necessary for Th17 differentiation by regulating RORγt and RORα (Yang et al., 
2008b) on the other hand Th17 generation is constrained by IL-2 signalling via STAT5 (Laurence 
et al., 2007a). Regulatory T cells also control Th17 in a STAT3 dependent manner (Chaudhry et 
al., 2009).  Figure 1.7 shows the cytokines involved in murine Th17 differentiation from naive T 
cells and cytokines secreted by the Th17 cells. 
 
 
 
 
 
Figure 1-7 Murine Th17 cells differentiation. 
IL-6 and TGF-β induce Th17 differentiation and IL-23 is required for the maintenance of Th17. 
IL-21 which is secreted by Th17 cells act as an autocrine loop in its lineage differentiation. Th17 
cells secrete IL-17A, IL-17F, IL21, IL22, IL-6, TNF-α, GMCSF and CCL20 to recruit both 
innate and adaptive immune cells. 
 
1.5.2 Human Th17 cells 
The differentiation of Th17 cells in humans is similar to mice. IL-1β in combination with 
IL-6 and/or IL-23 is essential for the differentiation of human naive T cells to Th17 (costa-
Rodriguez et al., 2007a;Wilson et al., 2007). TGF-β is also essential for the differentiation of 
human Th17 cells from naive T cells in serum free culture conditions (Manel et al., 2008;Volpe et 
al., 2008;Yang et al., 2008a) and required to induce RORC (the human homolog of RORγt). 
However, TGF-β in high doses in both humans and mice inhibits Th17 differentiation by 
antagonizing RORγt function (Zhou et al., 2008) and an absence of TGF-β induce a shift from a 
Th17 to a Th1 profile. (Volpe et al., 2008). Thus, TGF-β, IL-23, IL-1β, and IL-6 are all essential 
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and Dong, 2009;Moseley et al., 2003). IL17RA is expressed at high levels on haematopoietic cells, 
and at low levels on osteoblasts, fibroblasts, endothelial cells and epithelial cells. Activation of IL-
17RA induces expression of various cytokines including TNF-α, IL-1β, IL-6, GM-CSF, G-CSF, 
the chemokines CXCL1, CXCL8, CXCL10 and metalloproteinases (Awane et al., 1999;Fossiez et 
al., 1996;Jovanovic et al., 1998;Laan et al., 1999;Martel-Pelletier et al., 1999;Witowski et al., 
2000;Yao et al., 1995). Human Th17 cells produce CCL20 themselves (Wilson et al., 2007), the 
ligand for CCR6 a signature chemokine receptor for Th17 cells (costa-Rodriguez et al., 2007b). 
IL17A and IL17F are key cytokines for linking innate and adaptive immunity. Activation of IL-
17RA on stroma cells results in CXCL8 secretion and recruitment of neutrophils to the site of 
inflammation (Aggarwal and Gurney, 2002;Gaffen, 2009). IL-22 is another cytokine secreted by 
Th17 cells (McGeachy et al., 2007;McGeachy et al., 2009) and its receptor, a heterodimer of the 
specific IL-22R and the IL-10R2 (Kotenko et al., 2001;Xie et al., 2000) is expressed widely on 
epithelial and endothelial cells. IL-22 is hepato-protective in liver inflammation (Zenewicz et al., 
2007) and promote epithelial repair of the gut (Sugimoto et al., 2008a) thus it is important in 
epithelial and endothelial barrier having a dual function in promoting tissue inflammation and 
repair (Pickert et al., 2009;Sugimoto et al., 2008b). 
 
1.5.3 Origin and phenotypic characterization of human Th17 cells 
Human IL-17 producing cells originate from CD161+ T cell precursors in both umbilical 
cord blood and thymus (Cosmi et al., 2008). CD161-  CD4+  naive T cells from both umbilical 
cord blood and thymus could be induced to Th1 or Th2 with polarizing cytokines however they 
do not differentiate to IL-17 producing cells(Cosmi et al., 2008). CD161 also known as NKR-
P1A is the human homologue of  murine NK1.1 (Lanier et al., 1994). CD161 is expressed on 
most NK cells, NKT cells, and also on some T cells and thymocytes.  Human CD161+ Th17  
 
 
cells have a broad TCR repertoire with MHC Class ΙΙ restriction and are not CD1d- restricted 
NKT cells(Godfrey et al., 2004).   
IL-17 producing cells are found only in the memory pool of CD4+ T cells (Annunziato et 
al., 2007;Singh et al., 2008). Stimulation of Th17 cells in the presence of IL-12 down-regulates 
RORγt and the production of IL-17, and induces IFN-γ suggesting the flexibility of Th17 cells 
towards Th1 cells(Annunziato et al., 2007). Two distinct subsets of human Th17 cells can be 
identified based on chemokine receptors expression: high expression of CCR4 and CCR6 defines 
IL-17 and IL-22 secreting cells and co-existence of CCR6 and CXCR3 is the hallmark of 
Th17/Th1 cells which produce IL-17 and IFN-γ (Annunziato et al., 2007;costa-Rodriguez et al., 
2007b). Both clones selectively express IL-23R, CCR6, and the transcription factor ROR γt. They 
also help B cells to produce IgG, IgM, IgA but not IgE, express poor proliferative capacity, poor 
cytotoxicity and are less susceptible to regulation by autologous Treg.  
 
1.5.4 Th17 in immunopathology 
Th17 have been implicated in human immunopathology particularly autoimmune and 
chronic inflammatory diseases. IL17RA, the cognate receptor for IL-17A is widely expressed on 
haemopoietic cells, osteoblast, fibroblast, endothelial and epithelial cells (Kolls & Linden, 
2004;Yao et al., 1995). The interaction of IL17 and its receptor result in chemokines, cytokines 
and metalloproteinase production by tissue cells. These responses promote the recruitment of 
lymphocytes, granulocytes and activated monocytes and facilitate matrix destruction (Miossec et 
al., 2009;Park et al., 2005;van den Berg and Miossec, 2009;Yao et al., 1995). Anti-microbial 
immunity mediated by Th17 cells is particularly important at epithelial and mucosal surfaces 
(Aujla et al., 2008;Ye et al., 2001).  
 
 
Human psoriatic skin lesions consist predominantly of Th17 cells recruited by the action 
of CCL20 on CCR6 (Pene et al., 2008). Th17 cytokines IL-17A, IL-17F, IL-22 and IL-26 are 
overexpressed in serum and psoriatic skin lesions and there is increase expression of RORC, IL-
6, IL-23 and IL-1β in psoriatic skin (Wilson et al., 2007). Th17 promoting cytokine IL-23 is also 
expressed in monocytes and dendritic cells in psoriatic skin lesions (Chan et al., 2006;Lee et al., 
2004;Piskin et al., 2006). An addition, IL-22 secretion from these cells induces epidermal 
hyperplasia and acanthosis in psoriasis(Zheng et al., 2007). Treatment with ustekinumab, 
monoclonal antibody targeting p40 (polypeptide common to both IL-12 and IL-23) is extremely 
efficient in reducing affected psoriatic skin area (Krueger et al., 2007;Papp et al., 2008). 
In rheumatoid arthritis patients, IL-17 expression by synovial cells is predictive of joint 
destruction (Kirkham et al., 2006) and IL-17 receptor is ubiquitously expressed on monocytes, 
macrophages, dendritic cells, chondrocytes, osteoblasts and fibroblasts. IL-17 acts on these cells 
leading to production of matrix proteinases, upregulation of proinflammatory cytokines and 
chemokines resulting in the recruitment of immune  cells and pathological bone erosion and 
cartilage damage. Th17 cells secrete TNF-α, IL-1, and IL-6 which provide positive feedback for 
the further generation, expansion and recruitment of Th17 cells to the joint microenvironment. 
L-23p19 deficient mice do not develop collagen induced arthritis, while IL-12p35 deficient mice 
actually develop more severe disease suggesting the crucial role of Th17 rather than Th1 in CIA 
(Murphy et al., 2003).  
In the pathogenesis of multiple sclerosis (MS) IL-17 and IL-6 genes are among the most 
highly expressed genes at the area of MS lesions (Lock et al., 2002) and IL-17 is elevated in the 
serum and cerebrospinal fluid of multiple sclerosis patients(Matusevicius et al., 1999). IL-17 and 
IL-22 receptors are expressed on endothelium at the blood brain barrier through which Th17 
cells transmigrate to infiltrate the CNS parenchyma (Kebir et al., 2007). Monocyte-derived DCs 
 
 
from multiple sclerosis patients also show increased expression of IL-23p19 (Vaknin-Dembinsky 
et al., 2006). IL-23 neutralizing antibody in mice also delays the onset and also decrease the 
severity of EAE, (Chen et al., 2006) human equivalent of multiple sclerosis. 
Th17 and IL-23 are also involved in inflammatory bowel disease (IBD). A single 
nucleotide polymorphism in the IL-23 receptor (Arg381Gln) is significantly associated with 
Crohn’s disease (Duerr et al., 2006). Clinical remission of Crohn’s disease is mediated by 
antibodies against the p40 subunit which is shared by both IL-23 and IL-12 (Mannon et al., 
2004). In murine models of IBD, IL-23 not IL-12 is essential for intestinal inflammation (Hue et 
al., 2006;Izcue et al., 2008;Kullberg et al., 2006;Yen et al., 2006).   
Large numbers of Th17 cells are present in human cancers including hepatocellular 
carcinoma, renal and ovarian carcinoma. Expression of IL-23 is increased in human tumours and 
IL-23 upregulates matrix metalloprotease 9 and increases angiogenesis whilst reducing CD8 T-
cell infiltration (Langowski et al., 2006). In ovarian tumour local polarizing cytokine milieu leads 
to expansion of Th17cells (Miyahara et al., 2008). Tumour infiltrating Th17 cells are 
polyfunctional effector cells and though synergistic actions between IL-17 and IFN-γ, they 
stimulate CXCL9 and CXCL10 production to recruit more effector T cells to the tumour 
microenvironment (Kryczek et al., 2009). In hepatocellular carcinoma accumulations of intra-
tumour IL-17-producing cells promote tumour progression through fostering angiogenesis 
(Zhang et al., 2009a). Tumour cells and tumour-derived fibroblasts secrete CCL5 and CCL-2 to 
recruit Th17 cells and also produce a proinflammatory cytokine milieu to facilitate the generation 
and expansion of Th17cells(Su et al., 2009).  
 
 
1.5.5 Tc17 cells 
IL-17 secreting cells are not restricted to the CD4 subset, but also found in CD8 T cells 
when they are known as T cytotoxic IL-17 secreting cells (Tc17) (Kondo et al., 2009). Naïve 
CD8+ T cells differentiate into cytotoxic killers (Tc1) in response predominantly to intracellular 
pathogens. Human Tc17 cells are a minor population of CD8+  T cells and their frequency is 
lower than that of CD4 T cells producing IL-17. Tc17 cells share similar developmental 
characteristics with Th17 cells (Ciric et al., 2009).  
Culture of CD8 T cells in polarizing conditions with IL-1β, IL-6 and IL-23 results in IL-
17 secretion and Tc17 generation although such cells lack cytolytic function and express low level 
of cytotoxic T lymphocyte markers (Huber et al., 2009). They express a similar pattern of cell 
surface proteins to Th17. STAT3 is again important for Tc17 polarization both in vitro and in vivo 
(Huber et al., 2009;Yen et al., 2009) and Tc17 cells express other hallmark molecules of the Th17 
program including RORγt, RORα, IL-21 and IL-23 receptor (Huber et al., 2009).  
Tc17 are predominantly found in the CD27− /+ CD28+ CD45RA− memory subsets which 
differentiate from the CD27+ CD28+ CD45RA+ naive subset. They express CCR6 and a high 
level of CCR5. Most Tc17 cells produce IFN-γ and differentiate from the same precursors that 
differentiate into IFN-γ-producing CD8+ T cells(Kondo et al., 2009). Protection against lethal 
influenza via IFN-γ dependent mechanisms is mediated by Tc17 cells which lead to neutrophil 
influx into the lung in mice (Hamada et al., 2009).  
There is little data on Tc17 cells in human liver diseases. Recent report by Klenerman and 
colleagues suggest that Tc17 cells in healthy donors and HCV patients are restricted to the 
CD161high population similar to Th17 subsets (Billerbeck et al., 2010). CD161high Tc17 express 
cytokines IL-17, IL-22, transcription factors RORγt, RUNX2, IL-23R, IL-18R, chemokine 
 
 
receptors CCR6, CXCR6 and CCR2. CD161high Tc17 cells are markedly enriched in tissue. They 
co-express IL-17 with high levels of IFN-γ, and/or IL-22. These Tc17 cells represent up to 1 in 6 
circulating CD8+ T cells in normal humans and a substantial fraction of tissue-infiltrating CD8+ T 
cells in chronic hepatitis C (Yu-Hoi Khan, 2010).  
 
  
 
 
1.6 Anatomy and functions of the human liver  
Embryologically, the liver is derived from the hepatic diverticulum which arises from the 
endodermal bud of the foregut. It is the largest solid organ in the human body weighing between 
1.2 and 1.5 kg (Dawson, 1985).  There are two anatomical lobes, the right six times larger than 
left and separated anteriorly by the falciform ligament and posteriorly by the fissure for 
ligamentum venosum and ligamentum teres. Functionally, depending on the independent 
vascular supply and biliary drainage it has eight segments. The caudate lobe is the equivalent of 
segment 1 and is separate from the other segments and has its own vascular supply.  
The liver receives a dual blood supply, around 75% coming from the portal vein which 
brings venous blood containing digestive products and toxins absorbed from the alimentary canal 
(Lalor & Adams 2002) and 25% oxygenated blood via hepatic artery which arise from the coeliac 
axis. The portal vein is about 8 cm in length, and is formed at the level of the second lumbar 
vertebra by the union of the superior mesenteric vein and splenic vein behind the neck of the 
pancreas. In the liver it ramifies like an artery and ends in capillary-like vessels termed sinusoids. 
Biliary drainage from the liver originates from bile canaliculi formed by adjacent hepatocytes 
which collect and drain the bile towards the portal tracts. Hepatic artery, portal vein and common 
bile duct travel along the free edge of the lesser omentum, which is the anterior margin of 
“Foramen of Winslow” (Gray’s Anatomy). The portal tracts, also known as portal triad or 
Glisson’s capsule contain three essential structures; branches of bile ducts, portal vein and 
hepatic artery. Intrahepatic bile ducts converge ultimately to form the right and left hepatic ducts 
which unite at porta hepatis to form the common hepatic duct, which later in conjunction with 
the cystic duct from the gall bladder become the common bile duct. The common bile duct along 
with the portal vein and hepatic artery runs along the free margin of the lesser omentum, in front 
 
 
of the “foramen of Winslow” to join the pancreatic duct and finally drains into the second part of 
the duodenum via the ampulla of Varter (Sherlock, 1948) 
The venous drainage of the liver is via the three main hepatic veins (right, middle and left) 
which drain directly into the inferior vena cava. The hepatic nerve supply accompanies the 
hepatic artery and bile ducts into their portal tracts and hepatic parenchyma and it arise from  
hepatic nerve plexus which contains fibres from T7-T10 sympathetic ganglia and the right and 
left vagus nerve for parasympathetic nerve supply and both synapse at the coeliac plexus. The 
lymphatic vessels draining the liver terminate in the portal hepatic lymph nodes and from there 
drains to the coeliac nodes. 
1.6.1 Hepatic parenchyma 
The hepatocytes or liver cells comprise about 60-80% of the liver( Sherlock 1993). They 
are polygonal with a single nucleus. They are organised into plates which are one cell thick and 
separated by the sinusoids. The hepatocyte has three surfaces: the basolateral surface facing the 
hepatic sinusoid and space of Disse, the apical surface facing the canaliculi and the third facing 
neighbouring hepatocytes. 
1.6.2 Hepatic sinusoid 
The human hepatic sinusoids are lined by functionally and phenotypically unique hepatic 
sinusoidal endothelial cells which lack tight junctions and classical basement membrane but 
contain fenestrations arranged into sieve plates (Adams, 1996b;Adams and Eksteen, 
2006;Smedsrod et al., 1994). Associated with  sinusoids are kupffer cells, phagocytic cells of the 
reticulo-endothelial system and resident liver macrophages involved in taking up pathogens and 
particulate matter in portal blood (Burt et al., 1993). The space of Disse is a subendothelial tissue 
space between hepatocytes on one side and the sinusoidal lining cells on the other containing a 
 
 
loose extracellular matrix (Sherlock & Dooley 1993). The hepatic stellate cell or Ito cell resides in 
the space of Disse. They are characterised by the presence of vitamin A storing cytoplasmic fat 
droplets (Friedman, 1996) which are lost on activation in response to injury when they 
transdifferentiate into myofibroblasts which play a key role in fibrogenesis in liver diseases 
(Iredale 2001; Iredale 2003).  Hepatic sinusoidal endothelial cells are the first point of contact for 
lymphocytes circulating through the sinusoids. The presence of numerous adhesion molecules 
and chemokines presented on the surface, serves as a mechanism by which leukocytes are 
recruited to the liver parenchyma, particularly in inflammatory liver diseases (Lalor & Adams, 
1999). 
1.6.3 Metabolic and detoxification function 
The hepatocytes are involved in protein, carbohydrate and fat metabolism. They synthesize 
albumin which is crucial for plasma oncotic pressure maintenance and transport of hormones 
and drugs. The liver also synthesize vitamin K dependant clotting factors ΙΙ, VΙΙ, ΙΧ , Χ and 
fibrinogen thus it is involved in maintaining coagulation which can be assessed by monitoring the 
intrinsic pathways of the coagulation cascades or prothrombin time. In the clinical setting, these 
two parameters, albumin and prothrombin time, are used to access hepatocyte synthetic function. 
The liver maintains glucose homeostasis by synthesizing, storing and breaking down 
glycogen. During the fasting state, glycolysis and glucogenolysis release stored glucose and 
hepatocytes can also synthesize glucose from non- carbohydrate source such as amino acids, 
glycerol, lactate and pyruvate via gluconeogensis.  
The liver also plays a role in lipid metabolism. It secretes bile across the canalicular 
membrane of the hepatocytes which is then stored in the gall bladder until required for digestion 
when it is secreted into the small intestine via cholecystokinin dependent contraction of the gall 
 
 
bladder. Bile is essential for hydrophobic fat absorption by the formation of chylomicrons using 
bile acids which are synthesised from cholesterol by hepatocytes. The liver synthesizes VLDL, 
HDL, cholesterol and phospholipids. In the liver, triacylglycerol is packaged with cholesterol, 
cholesteryl esters, phospholipid, and protein (apoB-100) to form VLDL which when secreted 
into blood deliver the newly synthesized lipids to the peripheral tissues. Hepatocytes also oxidize 
triglycerides to produce energy and synthesize fatty acids and triglycerides from carbohydrate and 
amino acids. It plays a central role in the regulation of cholesterol by denovo synthesis, receiving 
dietary cholesterol via chylomicrons from the gut and from extra hepatic tissues. It eliminates 
cholesterol in the bile or as a component of plasma protein or as bile salts secreted into the 
intestinal lumen. Impaired liver function results in steatorrhoea due to fat malabsorption. 
Hepatocytes are also crucial in detoxifying xenobiotics via p450 cytochromes in the 
endoplasmic reticulum which are crucial for the biotransformation of drugs by glucoronidation 
and sulphation. Those drugs metabolites which are destined for urinary elimination are 
transported back to the sinusoids and blood whereas organic lipophilic drugs undergo biliary 
excretion. Hepatocytes also detoxify ammonia by the synthesis of urea through the Krebs-
Henseleit cycle. Thus patients with acute liver failure (massive hepatic necrosis)  and chronic 
decompensated liver diseases(associated with porto-systemic shunting) have high levels of serum 
ammonia and  manifest clinical features of hepatic encephalopathy due to lack of hepatic 
detoxification of ammonia products from gut. 
 Bilirubin secreted in bile is the end product of  haem metabolism by kupffer cells and it 
is one of the AHR ligands. UDP-glucuronosyltransferase1A1 (UGT1A1) conjugates bilirubin to 
make it water soluble. Activation of the AHR induces the reporter gene UGT1A1 in HepG2 
cells. High bilirubin in neonates is removed after UGT1A1 induction to prevent jaundice(Togawa 
et al., 2008). 
 
 
1.6.4 Immunological aspects of the liver 
The liver is the site of T cell tolerance to harmless food antigens, yet maintains the 
capacity to sustain effective immune response against pathogens. The liver acts as a ‘sieve’ for the 
bacterial and other antigens, carried to it via the portal supply from the gastrointestinal tract. The 
mechanism driving hepatic tolerance is likely to be the continuous exposure of diverse liver cell 
types to endotoxin, derived from the intestinal bacteria. This exposure promotes the expression 
of a set of cytokines, antigen-presenting molecules, and costimulatory signals that impose T-cell 
inactivation, partly via effects on liver antigen-presenting cells. The first report of immunological 
tolerance in the liver was made by Sir Roy Calne who described liver allograft acceptance across 
MHC mismatch in the pig in the late 1960s (Calne RY, 1969;Calne and Davies, 1994). 
The liver contains an unusual population of resident lymphocytes, which constitute upto 
25% of the non-parenchyma cell. CD8+ T cells usually outnumber CD4+T cells, and the blood 
ratio of CD4:CD8 T cells are reversed(Warnock et al., 1998). Intrahepatic T cells are nearly all 
memory cells and are scattered throughout parenchyma and also found in portal tracts. The 
average human liver contains approximately 1010 lymphocytes, which include conventional (CD8+ 
and CD4+ T cells) and unconventional lymphocyte subpopulations of the innate (NKT and NK 
cells) and adaptive immune systems (T and B cells). Conventional T cells display a diverse 
repertoire of T cells receptors. About 30% of the total blood circulate through the liver every 
minute (Sheth and Bankey, 2001) carrying approximately 108 peripheral blood lymphocytes in 24 
hours (Wick et al., 2002) thus the immune system is continually interacting with the liver. 
Regulatory T cells play a key role in the induction and maintenance of hepatic tolerance 
(Bluestone, 2005;Oo and Adams, 2009;Sakaguchi, 2008;Walker & Abbas, 2002). They interact 
with resident tolerogenic dendritic cells which may maintain them within the liver or induce their 
local differentiation. Both hepatic DCs and intrahepatic lymphocytes secrete cytokines that 
 
 
promote tolerance particularly interleukin-10 (Abel et al., 2006;Bliss et al., 2003;Nelson et al., 
2003).  
Hepatic antigen presenting cells (APC) include both professional antigen presenting cells 
(myeloid and plasmacytoid dendritic cells) and non-professional APCs of epithelial and 
endothelial lineage (hepatocytes, HSEC and stellate cells). Kupffer cells, which accounts for 20% 
of non parenchyma cells (Gale et al., 1978) are resident hepatic macrophages. Many are long lived 
although there is a slow turnover and replacement derived from circulating monocytes (Gale et 
al., 1978;Klein et al., 2007). They reside within the sinusoid predominantly concentrate around 
the periportal area although they migrate actively throughout the sinusoids. They clear endotoxins 
and phagocytose debris and microorganisms. They express low levels of costimulatory molecules 
and are poor antigen presenters thus their major role being the phagocytosis of particulates and 
pathogens and the secretion of cytokines. The unique architecture of the liver and low flow rates 
within the sinusoids allows T lymphocytes to interact with kupffer cells, sinusoidal endothelial 
cells and even hepatocytes which can extend microvilli through the endothelial fenestrations to 
interact directly with lymphocytes at the sinusoidal endothelial surface (Bowen et al., 2004;Bowen 
et al., 2005).  
Hepatic dendritic cells have an immature phenotype expressing lower levels of 
costimulatory molecules when compared with langerhands cells in skin. They also preferentially 
secrete IL-10 (Goddard et al., 2004b). Both of these properties mean that they create a 
tolerogenic environment in the liver and skew T cell differentiation towards tolerance and 
regulatory T cell differentiation. The liver lies directly downstream from the gut, and is thus 
constantly exposed to bacterial LPS, a TLR4 ligand. Low expression of TLR4 by kupffer cells 
and liver DC and relative tolerance to TLR4 stimulation limit their response to LPS resulting in 
reduced hepatic adaptive immune responses (Bamboat et al., 2009;de et al., 2005b). Tolerogenic 
 
 
dendritic cells include the CCR9+ plasmacytoid DC, which has an immature phenotype reside in 
secondary lymphoid tissue and are potent inducers of regulatory T cells (Hadeiba et al., 2008). In 
the context of hepatic inflammation, the site of tolerance induction could be within the liver, 
particularly the portal tracts or within draining lymph nodes. Interactions with immature DCs 
within the liver inhibit the proliferation and cytokine production of interacting lymphocytes 
through CTLA-4 and PD-1(Probst et al., 2005). 
Hepatic sinusoidal endothelial cells (HSEC) constitute 50% of the nonparenchymal cells 
in the liver. HSEC express molecules that promote antigen uptake, such as mannose receptor and 
the scavenger receptor, and molecules that promote antigen presentation like MHC class Ι and ΙΙ 
and co-stimulatory molecules CD40, CD80 and CD86 (Knolle et al., 1999;Lohse et al., 1996). 
Moreover they can take up and present antigens to CD4 T cells and by cross presentation to 
CD8 T cells. Although HSEC express constitutive Toll-like receptor 4 (TLR4)/CD14 they gain a 
LPS-refractory state as a consequence of repetitive stimulation without loss of scavenger activity 
(Uhrig et al., 2005). When naive CD4 T cells are activated by HSEC they fail to elicit a Th1 type 
response (Knolle et al., 1999). Thus, MHC II-expressing intrahepatic APCs, such as HSECs and 
DCs skew local immune activation towards tolerance. 
 
 
 
 
Figure 1-9 Lymphocytes circulation and transmigration across HSEC.  
The liver is continuous exposed to gut-derived microbial and foreign antigen. During hepatic 
inflammation, liver resident dendritic cells sample the foreign antigens and carry them to local 
portal lymph nodes where antigens are presented to naive T cells recruited via high endothelial 
venules of lymph nodes. Following antigen presentation, different types of T effector and T 
regulatory cells leave the regional lymph nodes and drain back to systemic circulation. These 
antigen experienced lymphocytes are finally recruited towards the site of hepatic inflammation via 
the low flow hepatic sinusoidal endothelial vascular bed. 
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1.7 Leukocyte recruitment  
Lymphocytes are recruited from the circulation to inflamed or normal tissues to respond to 
infection and to perform homeostatic immunosurveillance (Imhof & Dunon 1995). The 
recruitment process involves adhesion molecules on vascular endothelium that support 
recruitment through endothelium and interactions with extracellular matrix components within 
tissues (Hauzenberger et al. 1995). The recruitment of leukocytes to the liver occurs via several 
sites: a) vascular endothelial cells lining the portal vein terminal branches or b) central vein 
branches or c) through hepatic sinusoidal endothelium which lines the liver parenchyma. Elegant 
studies in rats suggest that the route of recruitment is through the sinusoidal endothelium with 
cells either migrating directly into the parenchyma or along the sinusoids to portal tracts (Xu, 
2008). 
In general, the recruitment of leukocytes through vascular endothelium into the underlying 
tissue follows a defined four stage process. Initially, free flowing leukocytes are captured and 
tethered to the endothelium by transient interactions mediated usually by selectins and 
glycosylated ligands (Rosen, 1985;Rosen, 2004). This dramatically reduces leukocyte velocity 
inducing them to roll on the vessel wall and thereby to scan the surface of the endothelium for 
the presence of activation factor such as chemokines (Mackay, 2001) suspended on proteoglycans 
(Tanaka et al., 1993a). This leads to the clustering and conformational activation of leucocytes 
integrins allowing them to support firm adhesion and arrest mediated by immunoglobulin 
superfamily members on the endothelium. The next step is intravascular crawling mediated by 
chemokines and integrins followed by diapedesis or trans-endothelial migration through 
endothelium. In most vascular beds the leucocytes then has to cross the basement membrane 
although in the liver this is missing and they cross the loose matricellular network of the space of 
 
 
Disse before migrating to the site of inflammation along chemokine concentration gradients 
within tissue (Ley, 2007). 
Hepatic sinusoidal endothelium lacks selectins and they play a minimal role in leukocyte 
capture in the liver (Wong et al., 1997). Rolling on hepatic sinusoids is greatly attenuated, as a 
consequence of the low shear stress in hepatic sinusoids (Adams et al., 1996;Wong et al., 1997). 
Other molecules may mediate capture on sinusoids including vascular adhesion protein-1 
(McNab, 1996) and VCAM-1 which is expressed on inflamed sinusoids and can support rolling 
adhesion by interacting with VLA-4 on the lymphocyte (Alon et al., 1995;Lalor, 1997;Steinhoff et 
al., 1993). 
Chemokines are crucial for leukocyte recruitment via endothelium. They activate cognate 
G protein coupled receptors resulting in not only activation of leukocyte integrins but also the 
induction of a migratory response and a motile phenotype. Chemokines secreted by other cells in 
the microenvironment can be taken up and undergo transcytosis across endothelial cells for 
presentation on the endothelial glycocalyx thereby localising chemokines to specific sites in the 
vasculature (Middleton et al., 1997). Chemokines are immobilized and presented via interactions 
with heparin binding domains on proteoglycans in the glycocalyx (Campbell et al., 1996;Luster, 
1998;Springer, 1994;Tanaka et al., 1993a;Tanaka et al., 1993b). A group of promiscuous non-
signalling chemokine receptors termed interceptors act as a sump to remove chemokines or in 
the case of D6 promote their disposal via lymphatics (Nibbs et al., 2003). Thus one such 
receptor, DARC, when expressed on endothelium promotes chemokine transcytosis and 
retention whereas on red cells in retains chemokines in the circulation thereby preventing random 
activation of circulating leukocytes (Colditz et al., 2007). 
Stable adhesion is mediated by the activated leukocyte integrins VLA-4 and LFA-1 
binding to their respective ligands from immunoglobulin superfamily, VCAM-1 for  VLA-4 and 
 
 
ICAM-1 or ICAM-2 for LFA-1 on the endothelium resulting in arrest of the lymphocyte on the 
sinusoidal endothelium (Springer, 1990). Both ICAM1 & ICAM-2 have been demonstrated on 
resting sinusoidal endothelial cells and ICAM-1 substantially upregulated in inflammation whilst 
VCAM-1 is only expressed on activated sinusoids (Adams et al., 1993;Steinhoff et al., 1993). 
Stable arrest depends on rapid increases in integrin affinity in response to chemokines displayed 
on proteoglycans on the endothelial glycocalyx (Tanaka et al., 1993a).  
The control of hepatic transendothelial migration is poorly understood. Chemotatic 
signals remain important in transmigration into tissue (Muller and Randolph, 1999). VAP-1, a 
homodimeric transmembrane protein of the amine oxidase family plays a role in recruitment to 
the liver (Lalor et al., 2002a). It is expressed on human hepatic sinusoidal endothelium and 
supports T cell adhesion to human hepatic endothelium in tissue sections (McNab, 1996;Yoong 
et al., 1998). Moreover, VAP-1 is also involved in transmigration (Lalor et al., 2002a).  
During diapedesis leukocytes migrate across the endothelium and basement membrane to 
enter tissue (Ley, 2007;Yadav et al., 2003). In most tissues diapedesis is regulated by adhesion 
receptors that localize to endothelial junctions through which the majority of migrating 
leukocytes cross. However, hepatic sinusoids lack conventional tight junctions and the signals 
required for transmigration may differ in the sinusoids (Lee and Kubes, 2008) and how cells 
traverse the space of Disse is poorly understood. Once they have transmigrated into tissue, the 
subsequent migration, and retention of effector and regulatory lymphocytes to site of 
inflammation depends on stroma tissue (Adams and Shaw, 1994;Buckley et al., 2001;Edwards et 
al., 2005) and microenvironment signals which will also influence the survival of different subsets 
of recruited lymphocytes (Oo & Adams, 2009).  
A multi-stage paradigm (Springer 1994) has been described (Figure 1.10) to elucidate the 
processes involved in the recruitment of a fast moving blood borne leukocyte into tissue.
 
 
 
Figure 1-10 The multi-step model of leukocyte recruitment in the liver.  
Leukocyte extravasation into tissue involves multiple steps. First of all, lymphocytes are captured 
by carbohydrate-dependent tethering (which in the liver may be mediated by VAP-1 rather than 
selectins which are absent from the hepatic sinusoids) allowing the flowing cells to contact the 
vessel wall where arrest can be triggered by chemokines immobilized on endothelial 
proteoglycans that activate lymphocyte integrins and binding to endothelial ligands such as 
ICAM-1 and VCAM-1. During this stage, the leukocyte arrests on the vessel wall and undergo 
intravascular crawling to sites of transendothelial migration. Once in the tissue, the cell follows 
chemokine gradients to sites of  hepatic inflammation, using chemokine-mediated changes in the 
actin cytoskeleton, and adhesion molecules to propel migration. 
Abbreviations: CXCR, chemokine (C-X-C motif) receptor; ICAM-1, intercellular cell adhesion molecule 1; IFN-γ, 
interferon-γ; TNF-α, tumour necrosis factor α; VCAM-1, vascular cell adhesion molecule 1. VAP-1, vascular 
adhesion protein-1; CXCR3 ligands- MIG, IP-10, I-TAC. HSEC= hepatic sinusoidal endothelial cells. 
  
 
 
1.8 Lymphocyte Adhesion molecules. 
1.8.1 The selectins 
In most vascular beds the initial interactions between circulating lymphocytes and 
endothelium, the rolling or tethering phase is mediated by selectins. The selectins family contains 
three member named according to the cell type on which they were discovered: L-selectin 
(Leukocyte selectin, CD62L) (Rosen, 1985), E-selectin (Endothelial selectin, CD62E) which are 
detected on endothelial surface (Bevilacqua et al., 1987;Bevilacqua et al., 1989) and P-selectin 
(platelet selectin, CD62P) (Hsu-Lin et al., 1984;Springer, 1995).  
Each selectin molecule is a single chain transmembrane glycoprotein with a similar 
modular structure. The N terminal amino acid, expressed extracellularly, is related to the family 
of mammalian carbohydrate binding protein known as C-type lectins as ligand binding by 
selectins is calcium dependent. The lectin domain is followed by a domain homologous to part of 
the epidermal growth factor (EGF), which in turn is followed by a number of consensus repeats 
(CR) with homology to structures previously identified as complement regulatory protein. The 
EGF domain and CR elements mediates adhesion by allowing ligands binding (Jutila et al., 
1992;Jutila, 1992;Siegelman et al., 1990). The short CR is followed by a hydrophobic 
transmembrane region and a short cytoplasmic carboxyl terminal tail which is required for 
signalling and subsequent cytoskeletal rearrangement. 
  
 
 
 
 
Selectin 
 
Size 
 
Distribution 
 
Selectin ligands 
 
 
L- selectin 
(CD62-L) 
 
90-110 KD  
( varies depending on 
glycosylation) 
 
Microvilli of naive 
lymphocytes (High) 
Effector & memory 
lymphocyte (low) 
 
GlyCAM-1 
CD34 
PSGL-1 
MadCAM-1 
 
E-selectin 
(CD62E) 
 
110 KD 
 
Activated 
endothelium 
 
CLA-1 
 
P-selectin 
(CD62P) 
 
140 KD 
 
Storage granules and 
surface of 
endothelium and 
platelets 
 
CD24 
PSGL-1 
 
CD34 and GlyCAM-1 which possess frucosylated, sulphated and Lewisx structure is also known as PNAd or 
peripheral node addressin which is the ligands on high endothelial venules in lymph node 
Table 1-2 Selectins and selectin ligands 
  
 
 
L-selectin assist the entry of lymphocytes to secondary lymphoid tissues via high 
endothelial venules with their ligands, namely; GlyCAM-1, CD34 or MAdCAM-1(Rosen, 2004). 
L-selectin is located on the microvilli of lymphocyte (Ala et al., 2003), for optimal rolling effect 
and its shedding occurs once it is activated (Hafezi-Moghadam et al., 2001;Hafezi-Moghadam 
and Ley, 1999) by proteolytic cleavages mediated by zinc dependant metalloproteinases (Chen et 
al., 1995). The importance of L-selectin for lymphocyte recruitment to secondary lymph node 
was demonstrated when L-selectin deficient mice were shown to have impair lymphocyte homing 
to lymph nodes (Arbones et al., 1994;Xu et al., 1996).  
Endothelial expression of E -selectin is activated by inflammatory stimuli (Lasky, 1995) 
and it is constitutively expressed in the skin in dermal endothelium (Picker et al., 1991). E-selectin 
is not detected on resting hepatic sinusoidal endothelium in vivo or in vitro, but is upregulated with 
inflammation (Adams et al., 1994a;Adams & Shaw, 1994). P-selectin is stored in specialised 
granules (Weibel-Palade bodies) in endothelium which are absent from sinusoidal endothelium 
and in α granules in platelets (McEver, 2001;McEver et al., 1989). In mice E-selectin and P-
selectin deficiency leads to defective leukocyte recruitment to most sites of inflammation but not 
the liver (Jung and Ley, 1999). Table.1.2 
  
 
 
1.8.2 Integrins and their ligands 
Integrins are transmembrane heterodimeric proteins that mediate interactions between 
adhesion molecules on cells to adjacent cells and/or the extracellular matrix (Tamkun et al., 
1986). They are involved in haematopoiesis, haemostasis, immune regulation, inflammatory 
response and also necessary for cell motility & migration across endothelium and to the site of 
infection/inflammation. Additionally, they are crucial for embryonic development, influencing 
cellular survival, proliferation, and differentiation (Danen and Sonnenberg, 2003). Integrin were 
first described in the late 1980s by Tamkun and colleagues as a protein complex which was 
integral to the transmembrane connection between the extracellular matrix and the cytoskeleton 
(Tamkun et al., 1986). Deficiency of many integrins is embryonically lethal (Rosenkranz and 
Mayadas, 1999). 
The integrins are membrane bound α β heterodimers and are divided into families 
according to their β-chain (Springer and Wang, 2004). Both α subunit  and β subunit are non-
covalently bonded. Most β-subunits interact with more than one α-subunits and there are at least 
18α subunits and 8β subunits in human thus pair to forms 24 different combinations (Hynes, 
1992;Shaw and Adams, 1993). The β1 integrins chains can associate with α1 to α9 and they are 
named VLA or very late integrins; the β2 integrins consist of αLβ2, αMβ2, αXβ2 and αDβ2 and the β7 
family consists of α4β7 and αEβ7. Integrins are expressed by many subgroups and shape their 
migratory responses. VLA-4 of β1 integrins family, LFA-1 of β2 integrins family and LPAM-1 of 
β7 family are major players involved in lymphocyte homing. 
Integrins which are important for leukocyte recruitment via endothelium includes αLβ2   
(LFA-1, CD11a/CD18) & αMβ2  which react its ligands ICAM-1 & ICAM-2 on endothelium, and 
α4β1 (VLA-4, CD49d/CD29), α4β7 (LPAM-1, CD49d/cd104) via its ligands VCAM-1 and 
MadCAM-1 (Butcher and Picker, 1996). Some integrins are limited to one cell lineage; for 
 
 
example αEβ7 is expressed on  mucosal lymphocytes (Kilshaw, 1999;Kilshaw and Murant, 1990) 
and this selective expression promote tissue specific homing (Butcher et al., 1999). An autosomal 
recessive inherited deficiency in LFA-1, Mac-1, and p150.95 proteins, known as type 1 leukocyte 
adhesion deficiency (LAD-1) leads to profound defects in adherence-dependent leukocytes 
function and susceptibility to sepsis (Anderson and Springer, 1987). 
The large extracellular domains of α and β subunits combine to form a globular head 
which contains the ligand binding site and a short cytoplasmic tail (Hynes, 1992). Integrins exist 
in inactive conformation with low affinity for ligand until activated. Chemokine binding to its 
appropriate receptor leads to activation of lymphocyte integrins (Campbell and Butcher, 2000), 
which cluster on the cells surface and in turn leads to a intracellular signalling and conformational 
activation of the integrin and fully activation of ligand bindin (Dransfield and Hogg, 
1989a;Dransfield and Hogg, 1989b) known as inside out signalling. This is followed by increase 
in the avidity leading to strong endothelial adhesion against sheer stress from blood flow and 
resulting in successful migration of cells across endothelium. 
  
 
 
 
Integrins 
 
Name 
 
Ligands 
 
Function 
α4β1 
(CD49d/CD29) 
 
VLA-4, 
 
VCAM-1, Fibronectin 
Cell- matrix adhesion; lymphocyte 
homing 
αLβ2 
(CD11a/CD18)   
 
LFA-1 
 
ICAM-1-4 
Leukocyte adhesion to 
endothelium;  
T cell-APC adhesion 
αMβ2  
(CD11b/CD18) 
 
MAC-1 
Fibrinogen, FactorΧ, 
ICAM-1, iC3b 
Leukocyte adhesion 
Cell-matrix adhesion 
α4β7 
(CD49d/cd104) 
 
LPAM-1 
Fibronectin, VCAM-1, 
MadCAM-1 
Lymphocyte homing to mucosal 
tissue 
αEβ7 
(CD103) 
 
HML-1 
 
E-cadherin 
 
Retention of intraepithelial cells 
 
Abbreviations: APC, Antigen presenting cell; iC3b, inactivated Complement 3b; ICAM, 
intracellular adhesion molecules; VCAM-1, vascular adhesion molecules-1; LFA-1, leukocyte 
function-associated antigen; MadCAM-1, mucosal addressin cell adhesion molecules-1; LPAM-1, 
lymphocyte Peyer’s patch adhesion molecules-1 
 
Table 1-3 Human lymphocyte integrins and their ligands 
 
  
 
 
Integrins binds to ligands that are either cell surface immunoglobulin superfamily 
members or matrix components. IgSF include ICAM-1, ICAM-2, VCAM-1, CD31 and 
MAdCAM-1 and they are constitutively expressed or induced on the surface of endothelial cells 
following stimulation with proinflammatory cytokines (Ala et al., 2003). ICAM-1 is expressed not 
only on leucocytes also on the endothelium at inflamed sites but ICAM-2 is constitutively 
expressed on endothelium. Both ICAM-1 & ICAM-2 bind to LFA-1. VCAM-1 is normally 
expressed at low levels on endothelium and its expression is upregulated during inflammation 
and also expressed on stroma and epithelial cells which are crucial for post endothelial migration 
and retention of lymphocytes at site of infection or inflammation. MAdCAM-1 is constitutively 
expressed in vessels in the gastrointestinal tract and also on HEV in small intestine Peyer’s 
patches and mesenteric lymph nodes (Adams & Eksteen, 2006;Nakache et al., 1989). 
Th1 cells, by secreting IFN-γ, may make the vascular endothelium at the site of 
inflammation more adherent to intravascular lymphocytes. IFN-γ and TNF-α secreted by Th1 
cells play a key role in the induction of VCAM-1. VCAM-1 binds lymphocytes with α4 integrin, 
and this step is a critical in pathophysiology of experimental autoimmune diseases, including 
EAE, type 1 diabetes mellitus in NOD mouse, and collagen induced arthritis (Yang et al., 
1993;Yang et al., 1994;Yednock et al., 1992). Blockade of α4 integrin has led to the most effective 
therapy to date for MS (Steinman, 2005;Yednock et al., 1992) and has been shown to be effective 
in the treatment of rheumatoid arthritis and Crohn's disease. 
The major functions of lymphocyte integrins are to mediate adhesion to endothelial cells, 
antigen presenting cell, target cells during cytolysis and extracellular matrix. The expression of 
integrins on lymphocytes is increased after activation and their ability to bind to matrix molecules 
is responsible for the retention of antigen primed T cells in lymphoid organs and at peripheral 
sites of infection.  
 
 
1.9   Chemokines 
Chemokines are 8–12 kDa heparin binding cytokines with the ability to attract leucocytes 
subsets to specific sites and thereby to shape the outcome of immune responses including 
intrahepatic inflammation. An efficient immune reaction requires leukocytes to be at the right 
place at the right time and thus needs a system to regulate the migration and positioning in 
lymphoid and non-lymphoid tissues (von Andrian and Mackay, 2000). The chemokine system 
provides cues for the recruitment of effector and regulatory subsets and is central to the 
pathogenesis of inflammatory diseases. 
Chemokines are generally classified into two functional groups, inflammatory and 
homeostatic/constitutive based on whether they are induced by inflammation or constitutively 
expressed and involved in homeostatic immune regulation (Table 1.4). Inflammatory chemokines 
are expressed in inflamed tissues by resident and infiltrating cells on stimulation by pro-
inflammatory cytokines or during contact with pathogenic agents (Rot, 2004). These chemokines 
are secreted early after infection in response to activation of pattern recognition receptors on 
epithelial, stroma, and immune cells. They recruit the initial wave of innate immune cells which 
express inflammatory chemokine receptors and immature DCs that provide the link between 
innate and adaptive immunity (Luster, 2005). After antigen-specific activation of lymphocytes by 
activated DCs inflammatory chemokines then attract antigen-specific effector T cells to the 
inflammatory site (Heydtmann and Adams, 2002). At the same time, regulatory cells are also 
recruited and the balance between effector and regulatory cell recruitment determines the 
outcome of the local inflammation.  
In contrast, homeostatic chemokines are produced in discrete microenvironments within 
lymphoid (bone marrow, thymus, and secondary lymphoid organs) or non-lymphoid tissues such 
as the skin and mucosa. These constitutively produced chemokines are involved in physiological 
 
 
trafficking and positioning of cells, antigen sampling in secondary lymphoid tissue and immune 
surveillance. 
1.9.1 The human chemokine system 
The human chemokine system includes more than 50 chemokines and 20 chemokine 
receptors (Table1.4) that can be divided into structural subsets based on the presence of NH2-
terminal cysteine-motifs (Moser and Loetscher, 2001;Zlotnik and Yoshie). The large CC 
chemokine family consists of chemokines in which the first two cysteine residues are adjacent, 
whereas in CXC chemokines they are separated by a single amino acid residue. Fractalkine 
(CX3CL1) is the only member of the CX3C chemokine family, in which three amino acid 
residues separate the first two cysteines. Finally, two related chemokines, XCL1 and XCL2 both 
of which bind the XCR1 receptor, lack two adjacent cysteine residues. Chemokines and their 
receptors also undergo post-translational modifications which alter their function allowing them 
to provide almost limitless potential receptor ligand pairs to bring exquisite specificity to the 
control of leukocyte homing and positioning in tissues (Rot, 2004). Dysregulated expression of 
chemokines and their receptors is involved in the development of many human diseases, 
including autoimmune and chronic inflammatory diseases as well as immunodeficiency and 
cancer. 
 
 
 
 
 
Chemokine 
Receptors 
 
 
Chemokines 
systematic 
names 
 
 
Functions 
 
Distributions of 
Chemokine receptors
 
CXC subgroup 
 
 
  CXCR1 CXCL6, 
CXCL7,CXCL8 
Neutrophil migration; innate immunity; acute 
inflammation
PMN, Monocytes,Mast cells 
  CXCR2 CXCL1-3; 
CXCL5-8 
Neutrophil migration; innate immunity; acute 
inflammation; angiogenesis 
PMN, Monocytes, Mast 
cells 
  CXCR3 CXCL9, 
CXCL10, 
CXCL11 
T cell recruitment; adaptive immunity; 
Th1,Th2,Th17,Treg inflammation 
Memory T 
cells,Th1,Th2,Th17,Treg, 
NKT  
  CXCR4 CXCL12 Stem cell migration;B cell lymphopoiesis; 
bone marrow myelopoiesis; Embryogenesis;  
HIV infection 
T cells, B cells,  
Macrohpages, Monocytes, 
Stem cells,NKT 
 
  CXCR5 CXCL13 B cell  homing in lymphoid organ B cellls 
  CXCR6 CXCL16 T cell migration Memory T cells, Th1,NK, 
NKT  
  CXCR7    
 
CC subgroup 
 
 
  CCR1 CCL3, CCL5, 
CCL7, CCL8, 
CCL13-16, 
CCL23 
T cell and monocyte migration; 
Hypersenstivity; innate and adaptive 
immunity; inflammation 
Monocytes, Memory T 
cells,Th1, NK  
  CCR2 CCL2, CCL7, 
CCL8, CCL13 
T cell and monocyte migration; innate and 
adaptive immunity; Th1 inflammation 
Monocytes, Memory T 
cells,  Basophils, pDC 
  CCR3 CCL5, CCL7;  
CCL11, 
CCL15,16; 
CCL24, CCL26 
Eosinophil, basophil, migration; allergic 
inflammation;Th2 response 
 Eosinophils, Basophils 
  CCR4 CCL17, CCL22 T cell and monocyte  migration; allergic 
inflammation; Regularoty T cells retention; 
Skin homing; expressed on CD4 Th2 cells
 Th2 cells, Treg 
Eosinophils,Basophils, DC 
Regulatory T cells
  CCR5 CCL3; CCL4;  
CCL5; CCL8 
Th1 response, adaptive immunity; 
inflammation, HIV infection 
Monocytes, Th1 cells, Treg, 
DC, NK 
  CCR6 CCL20 Dendritic cell migration, memory T cells, 
Th17 cells at site of inflammation 
Memory T cells, B cells, 
Th17, immature mDC  
  CCR7 CCL19, CCL21 T cell and dendritic cells homing to 
secondary lymphoid tissue; lymphoid 
development 
Naive T, B, mature mDC, 
Th1,Th2, Treg 
  CCR8 CCL1 T cell trafficking; Th2 response Monocytes, Th2, Treg, NK 
  CCR9 CCL25 T cell homing to gut and Thymus 
Tolerogenic Dendritic cells 
DC, Memory T cells, 
Thymocytes 
  CCR10 CCL27, CCL28 T cell homing to skin and  bowel Memory Tcells,Treg
 
CX3C and XC family 
 
 
  CX3CR1 CX3CL1 T cell and NK cell trafficking and adhesion; 
innate and adaptive immunity; Th1 
inflammation 
Monocytes, Th1, NK 
  XCR1 XCL1-2 NK cell recruitment  NK 
 
 
 
 
 
 
Table 1-4 Chemokine nomenclature 
Chemokine receptors can be divided into subfamilies on the basis of the position of conserved 
cysteine residues within a conserved tetracysteine motif. In CC chemokines, the first two 
consensus cysteines are next to each other; in CXC chemokines, they are separated by a 
nonconserved amino acid. These two subfamilies account for all but three of the known 
chemokines, the others being CX3CL1 (three intervening amino acids between the first cysteines) 
and XCL1 and XCL2, which lack two of four canonical cysteines.  
Human chemokines and chemokine receptors could also be classified according to their function; 
inflammatory (pale blue), homeostatic (yellow). Chemokines and its receptors belongs to both 
subfamilies are shown in green. 
Abbreviations: CCL, chemokine (C-C motif) ligand; CCR, chemokine (C-C motif) receptor; CXCL, chemokine (C-
X-C motif) ligand; CXCR, chemokine (C-X-C motif) receptor; CX3CL, chemokine (C-X3-C motif) ligand; CX3CR, 
chemokine (C-X3-C motif) receptor; imm, immature; mat, mature; mDC, myeloid dendritic cell; Mo, monocyte; NK, 
natural killer; NKT, natural killer T; pDC, plasmacytoid dendritic cell; PMN, polymorphs; T mem, memory T cell; T 
naïve, naïve T cell; Th1, T helper 1; Th2, T helper 2; Th17, T helper 17; T reg, regulatory T cell. 
 
 
 
Chemokines exert their chemotactic functions by binding to specific G protein–coupled 
receptors (GPCRs), seven-transmembrane-spanning proteins coupled to heterotrimeric G 
proteins (Figure.1.11). Chemokine binding to chemokine receptors dissociates GαI, and Gβγ 
subunits of the heterotrimeric G proteins, leading to calcium flux and activation of the 
phosphatidylinositol 3-kinase (PI3K) and the small Rho GTPases signalling pathways (Mellado et 
al., 2001). Consistent with Gi association, the majority of chemokine responses are inhibited by 
treatment with pertussis toxin (PTx) (Goldman et al., 1985)which blocks the global G protein 
receptor. 
 
 
Figure 1-11 Schematic diagram of G- protein coupled receptor (GPCR). 
Chemokine receptors are seven-transmembrane molecules coupled to heterotrimeric G proteins. 
When the chemokine interacts with its cognate receptors, the β- and γ-subunits are assembled 
into βγ dimers that act as functional units. The α-subunits bind guanine nucleotides, being active 
when GTP is bound. The G proteins are usually classified into four classes. αi, αs, αq, and α12/13 by 
the nature of their α-subunit. Chemokine receptors can signal through different Gα-protein 
families, leading to distinct transduction pathways and downstream biological effects.  
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1.9.2 Roles of chemokines in the context of hepatic inflammation 
Immune surveillance in the liver is provided by both resident and blood-borne 
lymphocytes and macrophages (Lalor & Adams, 1999). During hepatic inflammation the rate of 
lymphocyte recruitment via sinusoidal endothelium increases. They are retained within the liver 
by localisation at sites of inflammation or at epithelial surfaces resulting in chronic hepatitis and 
persistent inflammation (Valiante et al., 2000). Chronic HCV infection and primary biliary 
cirrhosis are both dominated by Th1 immune responses (Bertoletti et al., 1997;Napoli et al., 
1996;Shields et al., 1999) whereas there is some evidence for Th2 involvement in primary 
sclerosing cholangitis. Recent studies suggest that alcoholic hepatitis involve Th17 responses 
which may explain the characteristic neutrophil rich infiltrate (Lemmers, 2009). However, unlike 
some murine models human chronic inflammatory diseases cannot so easily be assigned to Th1 
vs. Th2 vs. Th17 dominated responses and it is likely that overlapping mechanism are involved in 
most situations. Most effector T cell infiltrating the chronically inflamed human liver express high 
levels of CXCR3, CXCR6, CCR1 and CCR5 consistent with a Th1 predominance and a tissue-
infiltrating phenotype (Boisvert et al., 2003;Heydtmann et al., 2006;Kunkel et al., 2002;Leroy et 
al., 2003;Shields et al., 1999). In addition to recruiting different subsets of lymphocytes there is 
evidence for compartmentalization of recruitment as well.  CCR5 may have a particular role in 
recruitment to portal tracts whereas CXCR3 appears to be essential for recruitment into the 
parenchyma (Ajuebor et al., 2004;Curbishley et al., 2005;Harvey et al., 2003;Murai et al., 1999). 
Expression of CXCR3 on T cells is closely linked to Th1 function and its ligands CXCL9, 
CXCL10 and CXCL11 are induced by the Th1 cytokines IFN-γ and TNF-α. Studies reported 
increase levels of CXCR3 ligands in chronic hepatitis and increased CXCR3 on CD4 and CD8 
effector cells within the liver (Apolinario et al., 2002;Arai et al., 2002;Diago et al., 2006;Dumoulin 
et al., 1997). Increased levels of hepatic CXCR3 ligands are characteristic of many chronic 
 
 
inflammatory liver diseases suggesting they play a generic role in effector cell recruitment to the 
inflamed liver (Butera et al., 2005;Curbishley et al., 2005;Nishioji et al., 2001). The sources of 
CXCR3 ligands in liver inflammation include hepatocytes, stellate cells, sinusoidal endothelial 
cells and infiltrating leukocytes. The expression of CXCR3 ligands requires stimulation with IFN-
γ and TNF-α which are released by activated hepatic macrophages and kupffer cells and the 
initial wave of infiltrating innate immune cells. An additional contribution comes from activated 
CD4+ T cells themselves which release CXCR3 ligands after activation within the liver (Cruise et 
al., 2006) thereby providing a feedback loop in which antigen-specific cells maintain the 
expression of the chemokines required for effector cell recruitment. CXCR3 ligands on the 
sinusoidal wall can originate from neighbouring and then be taken up and transcytosed to the 
endothelial surface (Middleton et al., 2002). In addition, chemokines secreted upstream by other 
cell types including cholangiocytes in portal tracts can be captured from the slow-flowing 
sinusoidal blood by proteoglycans within the endothelial cell glycocalyx and presented at the 
endothelial surface (Curbishley et al., 2005). Thus local presentation of chemokines on the 
sinusoids will be the result of cross-talk between sinusoidal endothelial cells and stellate cells, 
kupffer cells, cholangiocytes and hepatocytes, all of which secrete chemokines on appropriate 
stimulation (Maher, 1995;Morland et al., 1997b;Shiratori et al., 1993). Hepatocytes not only 
secrete chemokines but also sensitize the endothelium to respond to low levels of TNF-α by 
increasing chemokine secretion and adhesion molecule expression (Edwards et al., 2005).  
In chronic hepatitis many of the infiltrating cells are probably not antigen-specific but 
rather bystander lymphocytes recruited as part of a broad immune response. Both antigen-
dependent and independent infiltrating effector cells express high levels of CD154 whose ligand, 
CD40, is expressed on hepatocytes, cholangiocytes and kupffer cells.  Activation of CD40 on 
these liver cells triggers NFκB-dependent secretion of CXCR3 ligands(Ahmed-Choudhury et al., 
 
 
2003;Alabraba et al., 2007) demonstrating another mechanism by which local chemokine 
gradients can be amplified during the evolution of the anti-viral immune response. Treg also use 
CXCR3 to enter liver tissue (Santodomingo-Garzon, 2008), although other signals may determine 
where they migrate to within the inflamed liver and hence where they mediate their anti-
inflammatory effects (Eksteen et al., 2006). 
In human blood CXCR6 is expressed on Th1 cells and effector CD8 T cells and our 
group and others have reported high levels of CXCR6 on CD4 and CD8 T cells within the 
inflamed human liver (Heydtmann et al., 2005). The CXCR6 ligand CXCL16 is one of only two 
chemokines that exists in a transmembrane form (Heydtmann et al., 2005;Matloubian et al., 
2000;Wilbanks et al., 2001). CXCL16 is upregulated on inflamed bile ducts and hepatocytes and 
is also expressed by sinusoidal endothelium. The engagement of CXCR6 on T cells by CXCL16 
on epithelial cells promotes β1 integrin-dependent adhesion which we believe is important for the 
positioning, retention and survival of effector cells in the inflamed liver (Germanov et al., 2008). 
Klenerman and colleagues have recently reported a unique subset of HCV-specific CXCR6+ 
liver-infiltrating CD8 T cells which express the C-type lectin CD161 secrete Il-17 and IFN-γ (Yu 
Hoi Khan et al, PNAS, 2010) and these cells may represent an important liver-specific subsets of 
effector cells (Northfield et al., 2008).  
Other chemokines involved in retaining T cells within the liver include CXCL12 (Terada 
et al., 2003;Wald et al., 2004) and the other transmembrane chemokine CX3CL1 (fractalkine) 
both of which are expressed on inflamed bile ducts (Efsen et al., 2002;Isse et al., 2005). The 
fractalkine receptor CX3CR1 is expressed by Th1 cells and help to retain these cells at sites of 
epithelial inflammation. Increased expression of CCL28 on cholangiocytes in a variety of liver 
diseases and increased numbers of T cells expressing the CCL28 receptor, CCR10, was also 
reported in the inflamed human liver (Eksteen et al., 2006). A high proportion of these cells were 
 
 
FoxP3+CD4 cells that secrete IL-10 and suppress T cell activation.  Thus CCL28 appears to 
recruit regulatory rather than effector cells to bile ducts.  When compared with Treg in blood the 
CCR10+ liver-derived Treg express high levels of CXCR3 and low levels of CCR7 consistent with 
a tissue-infiltrating phenotype. CCL28 was originally isolated from the gut but is widely expressed 
at mucosal surfaces throughout the body (Kunkel et al., 2003;Pan et al., 2000). 
CCR1, CCR2 and CCR5 have all been implicated in hepatic inflammation and their 
expression is characteristic of memory T cells and CCR5 is also expressed on Th1 cells (Qin et 
al., 1998;Viola and Luster, 2008). CCR2 and CCR5 expressing CD8 T cells are enriched in the 
inflamed human liver and CCR1 is important in the regulation of hepatic inflammation in murine 
models (Boisvert et al., 2003;Shields et al., 1999). The three receptors share chemokine ligands; 
CCR5 interacts with CCL3, CCL4, CCL5 and CCL8; CCR2 with CCL2, CCL13, CCL7 and CCL8 
and CCR1 with CCL3, CCL5, CCL7, CCL23 and CCL14-16 (Rot, 2004;Viola & Luster, 2008). 
All of these chemokines have been detected in the liver (Leroy et al., 2003;Lichterfeld et al., 
2002;Nattermann et al., 2008;Nischalke et al., 2004;Shields et al., 1999).  
CCR5 ligands are strongly expressed on portal and vascular endothelium (Goddard et al., 
2001) and in murine models of graft versus host disease CCR5 and CCL3 support effector cell 
recruitment to portal tracts (Murai et al., 1999;Murai et al., 2003). Although other murine models 
of liver inflammation are characterized by intrahepatic CCR5+ lymphocytes (Ajuebor et al., 
2005;Moreno et al., 2005) mice that lack CCR5 are more susceptible to Con A-induced hepatitis 
and exhibit extensive inflammation mediated by CCR1+ effectors (Ajuebor et al., 2004;Ajuebor et 
al., 2005). This emphasizes the complexity of chemokine networks and suggests that under some 
conditions CCR5 recruits anti-inflammatory as well as effector cells (Moreno et al., 2005).  
 
 
1.9.3 Homeostatic chemokines and lymphocyte egress from the liver 
Homeostatic chemokines can be upregulated at sites of inflammation where they play 
important roles in regulating leukocyte trafficking particularly through the formation of tertiary 
neolymphoid structures (Grant et al., 2002;Hjelmstrom et al.). Neolymphoid follicles that express 
CCL19 and CCL21 are a feature of many chronic inflammatory liver diseases particularly PBC, 
PSC and HCV infection (Heydtmann et al., 2006). They may be sites for ongoing lymphocyte 
recruitment and provide survival signals to maintain the chronic inflammatory infiltrate within 
the liver (Bonacchi et al., 2003;Mondelli, 2003;Terada et al., 2003;Wald et al., 2004). The CCR7 
receptor is expressed by naive T cells and a subset of central memory cells to promote their 
recirculation through secondary lymphoid tissues. CCR7+ T cells are detected in livers from 
patients with chronic autoimmune liver disease and chronic HCV infection (Bonacchi et al., 
2003). However, most of these cells were memory rather than naïve cells (Faint et al., 
2001;Heydtmann et al., 2006) thus CCR7+ CD8 T cells in the HCV infected liver were CD62Llow 
and LFA-1high characteristic of memory cells. Because CCL19 and CCL21 are expressed on 
sinusoids and lymphatic vessels in portal tracts (Grant et al., 2002;Heydtmann et al., 2006). These 
cells use CCR7 to migrate out of the liver via afferent lymphatics to draining lymph nodes where 
they are either removed during the resolution of infection or restimulated to maintain chronic 
hepatitis. This pathway may be defective in HCV infection because the numbers of intrahepatic 
CCR7+ memory T cells are reduced. Others groups have reported an important role for CCR7 in 
promoting resolution of inflammation and a lack of CCR7 in mice leads to enhanced 
inflammation (Bromley et al., 2005;Forster et al., 2008;Schneider et al., 2007). 
 
 
 
1.9.4 Interstitial migration and position of recruited lymphocytes 
Once lymphocytes have crossed the endothelial barrier, these infiltrating cells find cues to 
position themselves in tissue and chemokine can provide such coordinated directed migration 
signals (Cyster, 2005) particularly when acting as a surface-bound gradient in extracellular matrix 
(ECM) and stroma cells(Miyasaka and Tanaka, 2004;von Andrian and Mempel, 2003). The 
stroma can also modulate the function of the overlying endothelium, emphasizing the importance 
of the tissue microenvironment in shaping recruitment (Mantovani et al., 2004). Leukocyte 
migration within interstitial tissue in vitro and in vivo is only partially integrin-dependent, being 
directed instead by chemokine dependent migration along the confining ECM scaffold. In the 
setting of hepatic inflammation, once the lymphocytes are recruited into the inflamed tissue the 
liver stroma cell network (stellate cells and activated liver myofibroblast) direct the post-
endothelial migration (Adams et al., 1994b;Hathaway et al., 1993) which is partly chemokine 
dependent but also involves chemokine-independent mechanisms (Holt et al., 2009). 
Thus, chemokines have the ability to induce migration of both effectors and regulatory 
cells and are critical regulators of immunity and inflammation in human liver diseases. They play 
a central role in the generation of cellular inflammation, both in the protective responses to 
invading pathogens and in the pathological processes associated with infection and immune-
mediated diseases.  
 
 
1.10 Aims of the thesis 
 
Hypothesis: Specific chemokine receptors will regulate the recruitment and positioning of 
regulatory T cells in the inflamed human liver. 
 
To address this hypothesis I have  
1) Carried out a detailed phenotyping of regulatory T cells infiltrating human liver 
2) Investigated the molecular basis for the recruitment of Treg across primary human hepatic 
sinusoidal endothelium under conditions of physiological flow 
3) Investigated signals responsible for positioning Treg in tissue and the role of dendritic cells 
in this process 
4) During the thesis the close relationship between Th17 cells and Treg became apparent and 
I thus extended my work to phenotype liver infiltrating Th17CD4 cells and Tc17CD8 
cells in different inflammatory liver diseases and to determine signals involved in the 
recruitment and positioning of these cells within the inflamed liver  
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CHAPTER 2 MATERIALS AND METHODS 
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2.1 Human tissue samples 
All liver tissue and matched pre transplant peripheral blood samples were obtained from 
patients attending the Queen Elizabeth Hospital, Birmingham, UK. Blood samples were also 
obtained from haemochromatosis patients who underwent regular venesection in liver outpatient 
clinics or from healthy controls. Diseased liver tissue was collected from explanted livers from 
patients undergoing orthotopic liver transplantation for a variety of inflammatory conditions.  
Non-diseased normal liver tissue was from donor material surplus to surgical requirements or 
from normal areas of liver removed following partial hepatectomy for hepatic tumour or benign 
focal disease. Lymph nodes were obtained from unused donor/ diseased hepatic nodes. All 
human samples were collected in accordance with local ethics committee approval and with the 
consent of patients. 
 
2.2  Isolation of primary human cells 
2.2.1 Isolation of peripheral blood lymphocytes & peripheral blood 
regulatory T cells 
Peripheral venous blood was collected from healthy volunteers or haemochromatosis 
patients into EDTA (ethylenediamine tetra-acetic acid; BD Biosciences, Oxford, UK).  The 
mononuclear fraction was purified by density gradient centrifugation over Lympholyte (VH Bio) 
for 30 minutes at 550g for 25 minutes. The band at the interface between plasma and gradient 
material (mononuclear fraction) was removed, resuspended in RPMI /10 % foetal calf serum 
(FCS) and sedimented by centrifugation at 550Xg for 5 minutes. Harvested lymphocytes were 
washed and resuspended in RPMI 1640 /10% FCS (Invitrogen) and incubated on plastic for 20 
minutes to allow adherence of monocytes before aspiration of the lymphocyte enriched 
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supernatant.  Following one further wash, lymphocytes were resuspended in media containing 
RPMI-1640/10% FCS. The viability of isolated cells (usually>95%) was determined by 
assessment of trypan blue exclusion for each sample. 
Regulatory T cells were isolated using a CD4 CD25 isolation kit (Invitrogen). Briefly, 
1X108 freshly isolated lymphocytes were resuspended in 500µl of isolation buffer and 200 µl of 
FCS and 200 µl of human CD4 antibody mix (mouse IgG antibodies against CD14, CD16, 
CD56, CD8 & CD19) were added. The cells were incubated for 20 min at 4ºC, washed with cold 
isolation buffer (PBS with 0.1%BSA and 2mM EDTA) for 8 minutes at 350Xg and the 
supernatant was discarded. Then 1ml of Depletion Myone Dynabeads from the Treg isolation kit 
was added and the cells were incubated for 15 minutes at room temperature with constant 
agitation. Next, the bead bound cells were resuspended vigorously and bead-free CD4+  fraction 
was removed by immunomagnetic selection and the CD4+ cells were counted with a 
haemocytometer.  200µl of CD25 Dynabeads were added to every 15x106 negatively selected 
CD4 cells and cells were incubated for 30 min at 4ºC with constant rolling. Positive magnetic 
selection was performed to isolate the bead-bound CD4+ CD25+ fraction. This fraction was used 
for suppression assay and FoxP3 expression on this CD4+ CD25+ cells population was 
phenotyped on flow cytometry and more than 90% of these cells are FoxP3 positive regulatory T 
cells. The CD4+ CD25- effector cells fraction was kept aside for future functional suppression 
experiments.  
 
2.2.2 Isolation of monocyte-derived dendritic cells 
Monocyte derived dendritic cells (MoDC) from peripheral blood were isolated from 
buffy coats prepared from whole blood by centrifugation at 900Xg for 20 minutes. 4ml of 
OptiPrep was added to 10ml of leukocyte rich plasma; LRP (harvested buffy coat in plasma 
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supernatant) resulting in a density of approximately 1.1g/ml. Two solutions of 1.068g/ml and 
1.084g/ml of Optiprep were prepared by mixing OptiPrep and RPMI/10%FCS at one in five 
and one in four ratios. Next the mixed LRP/OptiPrep was over layered with 7.5ml of the 
1.084g/ml solution and 20 ml of the 1.068g/ml solution in 50ml tube and with a final 2ml of 
RPMI/ 10% FCS layered on top. The 50ml tube was centrifuged at 750Xg for 20minutes without 
a brake, and the monocytes that floated into the 1.068g/ml layer were collected. These 
monocytes were cultured for 5 days in dendritic cells (DC) media containing RPMI, 5%FCS and 
IL-4 with GMCSF. These immature DC were then stimulated with TNF (Peperotec) for 24 
hours on day 5 to obtain mature DC. To obtain highly pure dendritic cells, these DC were further 
selected by using CD11c positive magnetic selection by using Dynal beads (Invitrogen) according 
to manufacturer instructions. Some of these cells were stimulated with lipopolysaccharide 
(LPS/1µg/ml; Sigma) and cells were stored in RNA-later (Sigma) for future PCR experiments. 
Supernatants collected from stimulated and unstimulated DC were stored at -20ºC for ELISA 
experiments. 
 
2.2.3 Isolation of primary human liver derived cells 
This whole project is based on primary human liver derived cells. Therefore, the liver 
infiltrating lymphocytes (LIL), Liver infiltrating dendritic cells (LIDC), Hepatic Sinusoidal 
Endothelial Cells (HSEC), and Biliary Epithelial Cells (BEC) were isolated from explanted human 
liver tissue using a variety of isolation methods (mechanical, enzymatic, immunomagnetic 
selection) to select for different cell types. 
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2.2.3.1 Isolation of liver infiltrating lymphocytes & liver infiltrating regulatory T cells 
Explanted human liver tissue was chopped into small pieces (5 mm x 5 mm) washed in 
PBS/10% (v/v) 2%FCS to remove any peripheral blood and resuspended in 200 ml RPMI-
1640/10% (v/v) FCS.  This suspension was then homogenized for 6 minutes at 260 rpm in a 
Stomacher® 400 circulator (Seward, Norfolk, UK) before being filtered through a fine (60 µm) 
nylon mesh.  The resulting heterogeneous cell population was reduced to a volume of 80 ml by 
successive wash steps in RPMI-1640/10% FCS, layered onto Lympholyte  (VH Bio) in a 50ml 
tube (20 ml of cell suspension/30ml of Lympholyte) and centrifuged at 720 g for 25 minutes.  
Separated liver derived lymphocytes at the interface were aspirated, washed twice more in RPMI-
1640/10% FCS and resuspend in culture media containing RPMI-1640/10% FCS supplemented 
with 2 mM L-glutamine, 60 µg ml-1 benzylpenicillin, 100 µg/ml streptomycin, and 50 ng/ml 
amphotericin. Liver infiltrating regulatory T cells were then isolated by negative selection of CD4 
cells followed by a positive selection of CD25 as described above. Isolated liver infiltrating Treg 
were cultured in round-bottom 96 well plates with Treg media (see later) and CD3 CD28 beads 
(2.5µl/105 cells) until use in suppression assays. In contrast, chemotaxis assays were performed 
with freshly isolated liver infiltrating regulatory T cells. 
 
2.2.3.2 Liver derived dendritic cells (LDDC) isolation  
Liver derived dendritic cells were isolated from diseased liver using methodology 
previously established in our laboratory (Lai et al., 2007). Briefly after isolation of liver derived 
lymphocytes, a further 13.5% Optiprep gradient (Axis Shield ) was used to obtain the liver 
infiltrating dendritic cells and then CD11c positive selection with magnetic beads (Invitrogen) 
was used as described above to generate a highly purified dendritic cells population. 
 
82 
 
2.2.3.3 Hepatic sinusoidal endothelial cells isolation 
HSEC were isolated from explanted human liver tissue using an established method 
available in our laboratory (Lalor et al., 2002a).  Approximately 150 g of liver tissue was cut into 
fine pieces and enzymatically digested with Type-1A collagenase (2 mg/ml, Sigma Aldrich, UK) 
for 30 minutes at 37ºC. Undigested tissue was removed by filtering the suspension through a 
sterile fine mesh with excess PBS and the cell suspension was then layered onto a 33/77% 
Percoll gradient (Amersham Biosciences) and centrifuged at 450 g for 25 minutes. The cells layer 
at the interface were collected, washed and resuspended in PBS. Biliary epithelial cells were 
removed by indirect immuno-magnetic separation using an antibody raised against the epithelial 
specific cell-surface glycoprotein HEA-125 (50µg/ml, Progen Biotechnic, Germany) for 30 
minutes at 37º followed by incubation with a secondary antibody conjugated to magnetic beads 
(10µl/ prep, sheep anti-mouse Dynabeads®, Dynal, UK) for 30 min at 4ºC. The remaining 
suspension was sedimented by centrifugation and sinusoidal endothelial cells isolated by using 
positive immuno-magnetic selection by incubation with primary antibody raised against CD31 
(10 µg/ml, Dynal, UK)  for 30 min at 4ºC with occasional agitation to resuspend the beads 
followed by a positive magnetic selection to select the bead coated sinusoidal cells. The final cells 
population was resuspended in endothelial media (see later) and cells were cultured in collagen 
coated T25 flask until a confluent monolayer was obtained. 
 
2.2.3.4 Isolation of biliary epithelial cells 
Biliary epithelial cells (BEC) were isolated with the help of Gill Muirhead in our laboratory 
according to previously described methods used by our group (Afford, 2001). Briefly, liver tissue 
was finely chopped and digested enzymatically using Collagenase type 1-A (Sigma-Aldrich, UK) 
for one hour at 37ºC. The digested sample was passed through a sterile metal sieve and the 
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effluent was centrifuged and the cells pellet was resuspended in PBS with 10 %( v/v) FCS 
(Sigma) and purified by density gradient centrifugation over 25% metrizamide (Nycomed, UK) at 
450Xg for 20 minutes. The cells at the interface between PBS and metrizamide were harvested, 
washed in PBS and centrifuged 650Xg with brake for 10 minutes to remove the residual 
metrizamide. BEC were then isolated by positive magnetic selection using antibody raised against 
the epithelial specific cell-surface glycoprotein HEA-125(10µg/ml, Progen, Germany) followed 
by adding secondary antibody conjugated to magnetic beads (sheep anti-mouse Dynabeads, 
Dynal, UK). Subsequently, isolated BEC were plated in rat tail collagen coated 25cm2 tissue 
culture flasks (Corning, UK).  
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2.3 Preparation of media and culture of primary human liver cells 
 
All cell types were cultured on collagen-coated plastic in a humidified incubator at 37ºC 
with a 5 % CO2 atmosphere.  Cells were maintained in tissue culture grade filtered flasks 
(Corning Costar, UK) 
2.3.1 Preparation of rat tail collagen 
Frozen rat tails were washed in PBS and collagen fibres were stripped out mechanically, 
washed in PBS and weighed. They were then sterilised for 10 minutes in 70 % ethanol (Fisher 
Scientific, UK) and collagen fibres were dissolved in 4 %  acetic acid (1 g of wet collagen per 100 
ml 4% acetic acid; BDH, Poole, UK) at 4ºC for 2 days with constant stirring. The resulting 
solution was first passed through a fine nylon mesh followed by high speed centrifugation 
(45,000 g for 30 minutes at 4ºC) to remove debris. This purified rat tail collagen (RTC) solution 
was stored at 4ºC till use for future coating of tissue culture flasks to grow HSEC, BEC and for 
coating microslides for flow based adhesion assays. Flasks were allowed to air dry in a sterile 
environment and stored for up to 4 weeks before use and microslides were left air dry for 2 
hours. 
  
2.3.2 HSEC culture 
Isolated HSEC were cultured in complete medium consisting of basal endothelial 
medium (EBM;  Invitrogen, UK) supplemented with 10% heat-inactivated normal human AB 
serum (HD Supplies, Bucks, UK), 10ng/ml hepatocyte growth factor (HGF), 10 ng/ml vascular 
endothelial growth factor (VEGF; both from Peprotec, UK), 2 mM L-glutamine, 60µg/ml 
benzylpenicillin and 100 µg/ml streptomycin.  When confluent, monolayer’s were dissociated 
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with try sin EDTA (0.05% in 0.53 mom EDTA; Nitrogen) and sub-cultured at 1:3 ratios. Briefly. 
HSEC media was removed and monolayers were washed with PBS before addition of 5 ml 
trypsin EDTA. Sinusoidal endothelial cells were then incubated for 1–2 minutes to allow 
dissociation before being collected into PBS/10% FCS to stop any remaining trypsin activity.  
Following centrifugation at 550Xg for 5 minutes, cells were resuspended in new media and 
divided between collagen coated T-75 flasks. Cells were used for flow based adhesion assay 
between passage 2-4 to ensure preservation of integrin ligand and chemokine expression. 
 
2.3.3 Regulatory T cell culture 
Regulatory T cells were cultured in U-bottom 96 well plates (Becton&Dickinson, 353077) with 
Treg media containing RPMI, 10% human serum, L- glutamine, 500 IU/ml of IL-2 and CD3 
CD28 beads (Dynal, Invitrogen) were added to culture for T cell receptor (TCR) and co-
stimulatory signalling. Cells were fed on alternate days and transferred to 24 well plates after 2 
weeks. Purity of cultures (typically more than 97%) was determined by flow cytometry. 
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Figure 2-1 Culture of isolated Regulatory T cells 
Regulatory T cells were cultured in IL-2 containing Treg media (RPMI+10%Human 
serum+glutamine) in 24 well plate with CD3 CD28 beads for T cell receptor stimulation and co-
stimulation. Proliferating Treg clusters attached to CD3 CD28 beads were shown with black 
arrow. The beads can be observed as black dots. 
 
2.3.4 DC culture 
Isolated dendritic cells were cultured in DC media containing RPMI, 5%FCS and IL-
4(100U/ml) with GCSF (100U/ml). The immature DCs were stimulated with TNF-α for 24 
hours on day 5 of culture to obtain mature DC. 
 
2.3.5 BEC culture 
BEC were cultured in Dulbecco’s Modified Eagle medium, Hams F12 (50%(v/v); 
Invitrogen,UK) supplemented with 10% heat-inactivated human AB serum, 10ng/ml epidermal 
growth factor (EGF; R&D Systems, UK), 10ng/ml HGF, 10ng/ml VEGF, 2mg/ml 
hydrocortisone, 10ng/ml choleratoxin, 0.124U/ml insulin, 2Nm tri-iodo-thyronine, 2mM L-
glutamine, 60µg/ml benzylpenicillin and 100µg/ml streptomycin (all reagents from Sigma). BEC 
Proliferating Treg 
with Beads 
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cell phenotype was confirmed by high level expression of cytokeratin-19. Cells were cultured to 
confluence and media was changed every other day or as required. Cells between passage 2-4 
were used for flow cytometry, ELISA, PCR and chemotaxis experiments. 
 
2.4 Suppression of proliferation assay 
RPMI 1640 medium with L-glutamine (Bio Whittaker, Verviers, Belgium) supplemented 
with 10% human serum (Department of Immunohematology and Blood bank, Leiden University 
Medical Centre, Leiden, The Netherlands), 100 g/ml penicillin, and 100  g/ml streptomycin 
(Gibco, Paisley, UK) was used for T regulatory cell culture. 
Allogeneic irradiated dendritic cells (1:100 ratios) or 5 µl/ml anti-human CD3/CD28 beads (1:1 
ratio, Dynal Biotech) were mixed with autologous CD4+CD25- responder T cells in 96-well 
round-bottom plates (Nune). All cells were cultured in triplicate in a final volume of 200µl of 
RPMI 1640 medium with L-glutamine, 100U/ml penicillin, 100µl/ml of streptomycin and 10% 
Human AB serum without IL-2. Suppression of proliferation was determined by adding reducing 
numbers of liver derived CD4+CD25+ Treg cells and autologous CD4+CD25- responder cells  
(1:1 to 1:16 ratio). At day 5, cultures were pulsed with [3H] thymidine (Amersham, Little 
Chalfont, UK) for last 16 hours and plate were harvested. Proliferation was assessed by 
measuring radioactivity with a liquid scintillation counter (Wallac). Cultures were performed in 
triplicate and results for radioactive thymidine update are reported in ccpm. 
 
2.5 Cytokines treatment of cultured cells 
TNF-α & IFN-γ in combination were used to stimulate cultured HSEC monolayers and 
other cells to mimic the condition in the inflamed liver environment. All stimulations were 
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performed in culture media relevant to the cells being treated with the exception that human 
serum was removed as a possible source of endogenous chemokine contamination.  Cells were 
cultured to confluence as described previously in RTC coated T75 flasks. For test samples all 
culture medium was removed and replaced with unstimulated media (control) or stimulated 
media containing TNF-α and IFN-γ. Cytokine concentrations were chosen based upon previous 
experience in our group and are shown in Table.2.1 
Supernatants from BEC and liver derived dendritic cells were collected for sandwich ELISA. 
BEC were grown to confluence in collagen coated 24 well plates and either left unstimulated 
(basal conditions) or stimulated  with TNF-α, IFNγ, IL-1β and IL-17 prior to collection of 
supernatant for detection of cytokine and chemokine production. Human liver derived dendritic 
cells were cultured in 48 well plates and stimulated with LPS 1µg/ml. Following 24 hours 
stimulation with the above cytokines, supernatant were collected for ELISA and cells were 
harvested into RNA-Later for future PCR experiments. 
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Cytokines/ reagents 
used for stimulation 
 
Final Concentration 
 
Source 
 
TNF-α 
 
10 ng/ml 
 
Pepro Tech 
 
IFN-γ 
 
10 ng/ml 
 
Pepro Tech 
 
IL-1β 
 
10 ng/ml 
 
Pepro Tech 
 
IL-6 
 
10 ng/ml 
 
Pepro Tech 
 
LPS 
 
1 μg/ml 
 
Sigma Aldrich Ltd. 
 
IL-17 
 
10 ng/ml 
 
Pepro Tech 
 
Table 2-1 Reagents used and their concentration for stimulation of cultured HSEC, BEC 
and DC.  
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2.6 Histology 
Tissue was processed from normal and diseased liver into 1cm3 blocks and snap- frozen in 
liquid nitrogen before 5µm cryostat sections were cut using a BRIGHT(model OTF) cryostat for 
immunohistochemistry and immunofluorescence. These sections were mounted onto poly-lysine 
coated microscope slides (BDH) and then fixed for 5 minutes in acetone (Fisher Scientific, UK) 
before storage at 20ºC until staining. Concentrations of primary and secondary antibodies used 
for staining are detailed in Tables 2.2 and 2.3 
 
2.6.1 Immunohistochemistry 
2.6.1.1 Immunohistochemistry on frozen tissue sections  
Tissue sections were warmed up to room temperature for 30 minutes and they were re-
fixed in acetone for 5 minutes. All staining was carried out in humidified chamber at room 
temperature to prevent evaporation. Endogenous peroxidase was blocked with 0.3% Hydrogen 
peroxide in methanol for 10 minutes. Subsequently, the sections were incubated with 10% 
normal horse serum in Tris buffered saline (TBS, pH 7.6, 0.1% Tween) for 30 minutes. The 
“Vector Elite” Avidin Biotin staining set was used for amplification and detection steps. Briefly, 
sections were incubated with an avidin/biotin blocking kit (Vector lab, according to instruction) 
for 15 min and washed in TBS/ 0.1% Tween buffer. Slides were incubated with mouse anti-
human monoclonal primary antibody FoxP3(Abcam) and mouse anti-human monoclonal CD3 
(DAKO) in blocking buffer for 60 minutes at 37°C in a humidified container. Control sections 
were incubated with a relevant isotype-matched control antibody (IgG1, DAKO). Signal 
amplification was then performed with a biotin- conjugated goat anti-mouse secondary antibody 
(Vector ABC Elite Kit) in blocking buffer according to manufacturer’s instructions. Antibody 
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localisation was visualised with 3-amino-9-ethylcarbazole (AEC) or ImmPACT DAB (Both from 
Vector Lab). The sections were washed in distilled water, counterstained with haematoxylin, and 
then slides were mounted in aqueous mount.  Positive staining was identified by the presence of a 
red colour/brown colour reaction product. All washes were performed with Tris-buffered saline, 
pH 7.6.  
 
2.6.1.2  Immunohistochemical staining of paraffin-embedded liver tissue 
2.6.1.2.1 Single colour immunohistochemical staining 
Paraffin-embedded, formalin-fixed liver tissue was cut into 5-µm sections and placed on 
poly-lysine-coated slides. Slides were initially de-waxed with Xylene for 5 minutes. The sections 
were then incubated through different strengths of IMS (100%, 96%, 70%, 50%) for 5 minutes 
each and then distilled water for 3 minutes. Endogenous peroxidase was blocked with 0.3% H2O2 
for 25 minutes and then slides were washed in TBS/ 0.1%Tween (500ml TBS pH 7.6: 500 µl of 
Tween) for 5 minutes. Antigen retrieval was achieved via microwave cooking for 20 min in 
EDTA buffer (EDTA buffer pH 8 was pre-heated on full power in the microwave using 10% 
EDTA; 70ml EDTA: 630ml distilled water) for 5 minutes. The slides were then placed into a 
plastic rack, placed in the pre-heated EDTA buffer and microwave for a further 15 minutes at 
full power. Then the slides were allowed to stand for 10 minutes and cold water was added until 
room temperature was reached. Slides were then washed in TBS/Tween for 5 minutes and 
incubated in 2% casein blocking solution (Vector) for 20 minutes. Slides were then incubated 
with primary antibodies (CD3, FoxP3, IL17, phosphoSTAT-5, HEA-125) or relevant control in 
blocking buffer for 1 hour in a humidified container. Then slides were then washed in 
TBS/Tween for 5 minutes and incubated in Vector Immpress secondary antibody reagent for 30 
minutes (Vector Goat/Mouse/Rabbit Impress Kit, used according to primary antibody species). 
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After a further wash, Vector ImmPACT DAB substrate (SK4105, used according to 
manufacturers recommendations) was applied for 2.5 minutes or VIP substrate (Vector Lab) for 
4 minutes or NovaRed substrate (Vector Lab) for 8 minutes was used to visualize the staining. 
Slides were then washed in tap water for 5 minutes and counter-stained with haematoxylin. 
Finally slides were dehydrated in dilutions of IMS as before for 5 minutes each and then placed in 
Xylene for 5 minutes and mounted using DPX. For the enumeration of positive lymphocytes, 
CD3 lymphocytes were counted in three low-powered fields (lpf; x100). High-powered fields 
(hpf; x400) were used for counting FoxP3+, phosphoSTAT-5 and, IL-17 positive cells because of 
the lower abundance of these cells in the liver. To investigate frequency estimate of FoxP3 vs 
CD3 or IL-17 vs CD3, cells were counted five high power fields and average was calculated. 
 
2.6.1.2.2 Dual colour immunohistochemical staining 
For double immunostaining, two primary antibodies raised in two different and non-
cross-reacting species, or primary antibodies of different isotypes were used. Formalin fixed 
paraffin embedded tissue sections were dewaxed, rehydrated, endogenous peroxidase blocked, 
antigen retrieval with EDTA buffer and incubated with 2% casein as described above. Primary 
mouse monoclonal antibodies, (FoxP3, IL-17 or CD11c) were applied for 30 minutes. Control 
sections were incubated with same isotype control antibodies at matched concentrations. After a 
TBS/Tween wash, secondary reagent (ImmPRESS Peroxidase) anti-mouse or anti-goat reagent 
(Vector Laboratories, UK), was applied for 30 minutes. After 2 further TBS/ 0.1% Tween 
washes the reaction was visualized with ImmPACT DAB (Vector Laboratories, UK) for 2 
minutes. Following a wash in water and TBS/Tween, sections were again incubated with 
2%casein for 10 minutes. Then a second round of primary antibodies CD3, HEA-125, CCL22 or 
MDC, was applied for an hour. After one more wash ImmPRESS universal reagent (Vector), was 
applied for 30 minutes. After 2 further washes the reaction was visualized with Vector 
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NovaRed/VIP for 5-8 minutes and, sections were counterstained in heamatoxylin, dehydrated 
through graded alcohol, placed into xylene and finally mounted in DPX. 
Dual staining for IL17 and HEA was done by using Goat ImmPRESS Kit and Mouse 
ImmPRESS kit; dual staining for CD11c & CCL22 was done by using Universal Mouse & Rabbit 
ImmPRESS kit. DAB chromogen (2 minutes) was used for detection of first antigen and VIP (10 
minutes)/ NovaRed (8 minutes) were used for detection of second antigen. All substrates are 
purchased from Vector Laboratories.  
 
2.6.2 Immunofluorescent staining 
Here, frozen sections were stained as described above but incubated with biotin-
conjugated secondary antibody in TBS pH 7.4 for 60 min at 37ºC. Next, strepavidin-FITC mAb 
(DAKO) was added in TBS pH 7.4 for 60 min at 37ºC.  All washing steps in the procedure were 
performed in TBS containing 2% human serum and 0.1% sodium azide and slides were protected 
from light throughout by covering the humidified chamber. Slides were mounted in DAKO 
immunofluorescent mount to retard fading. Immunofluorescent images were captured on a Zeiss 
Axioscope microscope using AxioVision software (Zeiss, Germany).  
 
2.6.3 Confocal microscopy 
2.6.3.1 Detection of regulatory T cells in human liver tissue  
Frozen human liver tissue sections were used for this experiments. Tissue sections were 
deforzed for 30 minutes before staining and rehydrate in Phosphate buffered solution for 10 
minutes to rehydrate the slides. PBS 1% BSA was used as a staining buffer. Then the slides were 
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incubated with blocking buffer (10% horse serum in PBS 1% BSA) for 30 minutes to prevent 
background staining. Primary antibodies against FoxP3 (IgG1, 1:50), CD3 (IgG2a, 1:100) and 
CD4 (IgG2b, 1:50) were applied to slides in the staining buffer containing human serum and 
incubate for an hour. FoxP3 primary antibodies were amplified with goat-anti mouse IgG1 FITC 
(1:100), followed by rabbit-anti-FITC (1:200) and finally with goat-anti-Rabbit FITC (1:100). All 
incubation steps were 30 minutes each and all washes in between were done for 10 minutes each 
in phosphate buffer saline. CD4 antibody was incubated with anti-IgG2b-biotin-conjugated 
secondary antibody (1:100) in staining buffer containing human serum for 30 min at 37ºC and 
strepavidin 647(1:400) was applied for amplification. CD3 primary antibody was detected with 
anti-IgG2a CY-3. All washed were done in a tin foiled covered humidified chamber to protect 
from light. Then slides were dipped into DAPI (excite at 360 and emit at 460) for 20 seconds 
followed by 3 wash in PBS and mounted. The edges of slides were cleaned and nail varnish was 
applied to the edges to secure the cover slip on the slide and dried for 1 hour in light protected 
box and image taken with confocal microscope. 
 
2.6.3.2 IL-17 secreting lymphocytes detection in human liver tissue 
Staining on paraffin embedded human liver tissue sections were used for these 
experiments. Slides were deparaffinise in Xylene for 5minutes and then rehydrated in Methanol in 
5 minutes twice and then washed in distilled water for 3minutes followed by washing in 
TBS/Tween. Antigen retrieval was done in EDTA buffer for 20 minutes as described above. 
Slides were then incubated in horse serum for 30 minutes. Without washing, goat polyclonal IL17 
(1:100; 1 µg/ml) in staining buffer was incubated for an hour followed by 10 minutes PBS wash 
twice was done. Then slides were incubated in donkey-anti-goat FITC (1:100) in staining buffer 
for 30 minutes followed by another wash. Then slides were incubated in rabbit-anti-FITC (1:200) 
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in staining buffer for 30 minutes and washed twice. Finally slides were incubated in quaternary 
antibody goat anti-rabbit FITC (1:100) for half an hour followed by two more wash in PBS. Then 
slides were dipped into DAPI (excite at 360 and emit at 460) for 20 seconds followed by 3 wash 
in PBS and mounted. The edges of slides were cleaned and nail varnish was applied to keep then 
in place and dried for 1 hour in light protected box as described above and images were taken 
with confocal microscope. 
 
2.6.3.3  Detection of Treg, CD4 and CD8 & dendritic cells; Th17 and Tc17; IL-17 cells 
and Treg in inflamed human liver 
Staining protocol was similar to described above. FoxP3 (IgG1) was visualized with anti-
IgG1 biotin (1:100) and strepavidin alexa fluor 555(1:1000). Dendritic cells, CD11c (rabbit 
monoclonal) was visualized with anti-IgG1FITC (1:100) followed by rabbit anti-FITC (1:200) and 
finally with goat anti rabbit FITC (1:100). Directly conjugated alexa 647 was used for CD8 cells 
staining. 
Staining for Th17/Tc17 was done as follows; IL-17 goat polyclonal antibody was 
detected by donkey anti-goat FITC (1:100), then with rabbit antiFITC (1:200) and finally with 
goat anti-rabbit FITC (1:100). CD4 IgG2b antibody was detected with anti-IgG2b biotin-
conjugated secondary antibody(1:100) in staining buffer containing human serum for 30 min at 
37ºC and strepavidin 555(1:1000) was applied for amplification. IgG1 CD8 alexa 647 was used 
for CD8 staining. 
Staining for IL17 and FoxP3 was done as follow; IL-17 goat polyclonal antibody was 
detected by donkey anti-goat FITC (1:100), then with rabbit antiFITC (1:200) and finally with 
goat anti-rabbit FITC (1:100). FoxP3 were visualized with anti-IgG1 biotin (1:100) and 
strepavidin alexa fluor 555 (1:1000).  
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Clone Antigen 
Concentration/ 
working dilution 
Source 
F 7.2.38 Mouse anti-human CD3 IgG1 (F,P,C) 270 µg /ml Dako
PS1 Mouse mAb to CD3 1:100 dilution Abcam
X 0931 Mouse IgG1 100 µg/ml Dako
N1698 Universal mouse negative control 200 µl Dako
AF 317-NA Goat polyclonal IL-17 0.75 µg/ml R&D
236A/E7 Mouse anti-human Foxp3 IgG1 (F,P,C) 10 µg/ml(P,F), 20 µg/ml(C) Abcam
4B12 Mouse anti-human CD4(P) IgG1 0.75 µg/ml Dako
OKT4 Mouse anti-human CD4 IgG 2b (C) 50 µg/ml eBioscence
555391 Mouse mAb to CD11c 1:50 dilution BD
Ab45977 Rabbit monoclonal to MPO 1:50 dilution Abcam
EP1347Y Rabbit-antihuman CD11c (F,C) 1:100 dilution Abcam
9359 Rabbit mAb to Stat5 1:50 dilution Cell signalling
E208 Rabbit mAb to PhosphoStat5 (Y694)(P) 1:50 dilution Abcam
144B Mouse mAb to CD8(P,C) 1:100 dilution Abcam
OKT3 Mouse anti-human CD3 IgG2a (P,C) 1:50 dilution eBioscence
MAB 336 Mouse anti-human MDC 1:50 dilution R&D
SC-12285 Goat polyclonal IgG MDC  (C-18) 1:50 dilution Santa-Cruz
Ab53002 Rabbit polyclonal to MDC 1:50 dilution Abcam
 
Table 2-2 Primary Antibodies used for immunohistochemistry  
Frozen (F), Paraffin (P), and confocal microscopy(C) 
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Table 2-3 Antibodies used for immunofluorescence and confocal microscopy. 
  
 
Secondary, Tertiary & 
Quaternary  
Working dilution Source 
Goat anti-mouse IgG1 
FITC 
1:100 dilution 
Southern 
Biotech (SB) 
Rabbit-anti FITC 1:200 dilution Sigma 
Goat-anti Rabbit FITC 1:100 dilution SB 
Anit-IgG2b biotinylated 1:100 dilution SB 
Strepavidin 647 1:400 dilution Invitrogen 
Strepavidin 555 1:1000 dilution Invitrogen 
Anti –IgG2a Cy-3/TRITC 1:50 dilution SB 
Donkey anti-goat FITC 1:100 dilution SB 
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The following staining reagents were used for detection in immunohistochemistry; 
Vector Secondary ABC (Avidin-Biotin) & ImmPRESS (Peroxidase) 
Vector stain Elite ABC, PK-6102, Vector Laboratories 
Avidin/biotin blocking (Vector Laboratories, SP-2001) 
ImmPRESS Reagent, Universal Anti-mouse/rabbit Ig, MP – 7500 
ImmPRESS Reagent, Anti Goat IgG; MP7405 
ImmPRESS Reagent, Anti-Mouse IgG; MP7402 
 
Control: 
Dakocytomation; N-Universal; Negative Control; Mouse; Ref: N1698 
Goat IgG, Vector Labs 
Rabbit IgG, Dako 
 
Substrate 
ImmPACT DAB; SK 4105; Vector Labs 
VIP; SK-4600; Vector Labs 
Nova Red; SK4800; Vector Labs 
NICKEL DAB; SK-4100; Vector Labs 
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2.7 Multi-colour flow cytometry 
Flow cytometry provides a mechanism to detect either cell surface or intracellular (cytokine 
or transcription factors) antigen in individual cells.  The flow cytometer passes single cells in 
suspension through a chamber where they are subjected to a laser light source, the scattering of 
which is dependent upon the size and granularity of the cells that pass through. Use of 
fluorochrome-conjugated antibodies result in the laser light being absorbed then emitted at a 
longer wavelength allowing cells to be identified. 
Due to the necessity for staining multiple surface receptors and intra cellular transcription 
factors to identify Regulatory T cells and Th17 cells, I used the DAKO Cyan 9 colour cytometer 
for immunophenotyping experiments. The cytometer uses three argon lasers with an emission 
wavelength of, 405 nm (pacific blue and pacific orange), 488 nm (FITC, PE, PE TxRed, PE Cy5, 
and PE Cy7) and 635 nm (APC/Alexa fluor 647 and APC Cy7).  The use of multi colour 
cytometer requires careful selection of flurochromes with variable emission spectra, such that 
interference does not occur.  However, some flurochrome overlap is unavoidable and this is 
compensated for during the cytometer set up.  By using Summit software 4.3 any regions of 
emission spectra that can be superimposed on one another are subtracted from the signal 
collected by the cytometer by identifying a sub-population of cells labelled with each of the 
fluorochromes used. I chose to use CD4 antibodies (coupled to different flurochromes) for 
compensation. Manual compensation was applied using median channel fluorescence intensity of 
both positive and negative populations to compensate for fluorochrome spill over into other 
channels. (Figure.2.2) 
For the analysis of the percentage of regulatory T cells in freshly isolated LIL and when 
possible matched PBL, phenotypic markers (CD4, CD25, CD127, FoxP3), chemokine receptors, 
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integrins, and selectin expression were determined and data were analysed using Summit v4.3 
software (Dako Cytomation). The complexity of receptor expression on Regulatory T 
lymphocytes required the use of four different fluorochromes (three for surface receptors and an 
intracellular transcription factor) to accurately dissect the phenotype. Antibodies against 
chemokine receptors were used to detect the receptors expressed by Regulatory T cells, Th17 and 
Tc17 populations.   
Antibodies conjugated to different flurochromes raised against relevant cell surface 
receptors, chemokine receptors, integrins, intracellular cytokines and transcription factors were 
used at optimal dilutions. The lymphocyte population was gated using forward and side scatter 
parameters and then then cells were regated  according to expression of CD3 (PE-Cy7)to exclude 
debris. 
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Figure 2-2 Example of a typical compensation for flow cytometry. 
Compensation for different flurochromes spillover was performed manually by adjusting 
the median channel fluorescence intensity in both positive and negative population. 
Uncompensated samples are shown in A&C and compensated samples are shown in B&D. 
 
 
 
Antibodies and chemokine receptors used fot phenotyping of both liver derived and 
peripheral blood Regulatory T cells an IL-17 secreting cells experiments are described in the 
Table 2.4, 2.5 and 2.6. 
  
C
A B
D
102 
 
 
Clone/Name Antigen/Conjugate Concentration Source 
RPA-T4 CD4- Pacific Blue 10µg ml-1 BD Pharmingen 
MOPC-21 Mouse IgG1 Pacific Blue 10µg ml
-1 BD Pharmingen 
IM 2646 CD25 PE Cy-5 1:5 dilution Beckman Coulter 
A 09148 Mouse IgG2a PE-Cy5 1:5 dilution Beckman Coulter 
UCHT1  CD3 PE-Cy7 1:5 dilution eBioscience 
P3 PECy7 IgG1 1:20 dilution eBioscience 
UCHL1 CD45 RO PE-Cy5 1:5 dilution BD Pharmingen 
FAB14001A IL-23R 1:10 dilution R&D systems 
HCD127 CD127-Alexa 488 1:20 dilution Biolegend 
MOPC-21 Mouse IgG1 Alexa 488 1:20 dilution Biolegend 
O323 APC/Cy7- CD27 1:5 dilution Biolegend 
MOPC-21 Mouse IgG1 APC/Cy7 1:5 dilution Biolegend 
BNI3 CD152 PE-Cy5 1:5 dilution BD Pharmingen 
G155-178 Mouse IgG2a  PE-Cy5 1:5 dilution BD Pharmingen 
PCH101 FoxP3-PE 1:5 dilution eBioscience 
Ebr2A Rat IgG 2a PE 1:5 dilution eBioscience 
AFKJS-9 ROR -γt 1:100 dilution eBioscience 
eBio4B10 Alexa Fluor 647 T-bet 10µl/ml eBioscience 
51-4714 Alexa Fluor 647 IgG1 10µl/ml eBioscience 
A07748 CD3 PE TexRed 1:500 Beckman Coulter 
SK3/ 55852 CD4 PE-Cy7 1:500 BD Pharmingen 
PN  IM3450 CD161 APC 1:20 Beckman Coulter 
130-092-678 CD161 APC 1:500 Miltenyi 
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Clone/Name Antigen/Conjugate Concentration Source 
IC0041A APC IgG control 1:50 R&D systems 
O323 APCCy7 CD27 1:5 Biolegend 
MOPC-21 APCCy7 MouseIgG1 1:5 Biolegend 
eBioA1 PE conjugated CD39 1:20 eBioscience 
559562 CCR6 PE 1:100 BD system 
EBioJ105 PE conjugated CD279 1:5 eBiosceicne 
556577 FITC conjugated Perforin 1:5  BD 
558132 FITC conjugated GranzymeB 1:5 BD 
A07795 Mouse IgG1 FITC 1:10 Beckman& Coulter 
FAB14001A IL-23R APC 1:10 R&D  
OKT4 Alexa Fluor 647 CD4 1:5 eBioscience 
P3 Alexa Fluor 647 IgG1 0.2mg/ml eBioscience 
555347 CD4 PE 1:5 BD 
555345 CD4 FITC 1:5 BD 
MHCD0818 CD8 PECy5.5 1:400 Invitrogen 
MH9D1 IL-9 PE 1:5 eBioscience 
550259 CD103 FITC 1:5 BD 
550260 CD103PE 1:5 BD 
34058 CD56 FITC 1:5 BD 
 
Table 2-4 Antibodies used for phenotyping of Treg and IL-17 secreting cells. 
  
104 
 
 
Clone/Catalog# Antigen/Conjugate Dilution factors Source 
IC002P Mouse anti-human IgG1 PE 1:10 dilution R&D systems 
IC003P Mouse anti-human IgG2a PE 1:10 dilution R&D systems 
IC004P Mouse anti-human IgG2b PE 1:10 dilution R&D systems 
53504/FAB145P CCR1 1:10 dilution R&D systems 
48607 /FAB151P CCR2 1:10 dilution R&D systems 
61828 /FAB 155P CCR3 1:10 dilution R&D systems 
205410 /FAB1567P CCR4 1:10 dilution R&D systems 
CTC5 /FAB1802P CCR5 1:10 dilution R&D systems 
53103 /FAB 195P CCR6 1:10 dilution R&D systems 
150503 /FAB197P CCR7 1:10 dilution R&D systems 
191704 /FAB1429P CCR8 1:10 dilution R&D systems 
112509 /FAB179P CCR9 1:10 dilution R&D systems 
FAB3478P CCR10 1:10 dilution R&D systems 
42705 /FAB330P CXCR1 1:10 dilution R&D systems 
48311 /FAB 331P CXCR2 1:10 dilution R&D systems 
49801 /FAB160P CXCR3 1:10 dilution R&D systems 
12G5 /FAB170P CXCR4 1:10 dilution R&D systems 
51505 /FAB190P CXCR5 1:10 dilution R&D systems 
56811 /FAB699P CXCR6 1:10 dilution R&D systems 
 
Table 2-5 PE conjugated chemokine receptor antibodies used for flow cytometry. 
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Clone/Catalog# Antigen/Conjugate Dilution factors Source 
IC002F Mouse anti-human  IgG1 FITC 1:10 dilution
 R&D systems 
IC003F Mouse anti-human IgG2a FITC 1:10 dilution R&D systems 
IC004F Mouse anti-human IgG2b FITC 1:10 dilution R&D systems 
FAB155F CCR3 1:10 dilution R&D systems 
FAB1567F CCR4 1:10 dilution R&D systems 
FAB1802F CCR5 1:10 dilution R&D systems 
FAB195F CCR6 1:10 dilution R&D systems 
FAB197F CCR7 1:10 dilution R&D systems 
FAB1429F CCR8 1:10 dilution R&D systems 
FAB179F CCR9 1:10 dilution R&D systems 
FAB330P CXCR1 1:10 dilution R&D systems 
FAB 331F CXCR2 1:10 dilution R&D systems 
FAB160F CXCR3 1:10 dilution R&D systems 
FAB170F CXCR4 1:10 dilution R&D systems 
FAB190F CXCR5 1:10 dilution R&D systems 
 
Table 2-6 FITC conjugated chemokine receptor antibodies used for flow cytometry. 
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2.7.1 Staining for cell surface markers  
Staining for Treg surface markers such as CD4, CD25, CD127, homing receptors such as 
chemokine receptors, integrins and selectin and isotype control antibodies were done as normal 
surface staining protocol. Briefly, cells were resuspended to a count of 1 x 10 6/ml in staining 
buffer (500ml PBS-0.1% BSA (v/v), 0.5 mM MgCl2, 1mM CaCl2) and divided into 100 µl 
aliquots. Antibodies conjugated to FITC (fluorescein-isothiocyante), PE (R-pyhcoerythrin), PE-
Cy5 (R-phycoerythrin: Cyanine-5), PE-Cy7 (phycoerythrin: Cyanine-7), PB (pacific blue), APC 
(allophycocyanin), APC-Cy7 (Allophycocyanin Cyanine-7) raised against relevant cell surface 
receptors were used at optimal dilutions (Table 2.4). Cells were incubated for 30 minutes with 
individual conjugated primary mouse anti-human antibodies at 4ºC in the dark  before being 
washed twice with flow cytometry staining buffer (PBS + 5% FCS). Supernatant was discarded 
and stained cells pellet was vortexed gently and these cells are ready for phenotypic analysis or to 
proceed to intra-cellular cytokine or transcription factor staining. 
 
2.7.2 Staining for intracellular cytokine and transcription factor for 
cytometric analysis 
Following surface staining, in order to stain intra-cellular cytokines like TNF-α or IL-17 
or transcription factors such as FoxP3 and T-bet, cells were treated using fixation/ 
permeablization buffer (eBioscience Cat.00-5523). Briefly, 1ml of 1% paraformaldehyde 
(eBioscience 1:4 ratio of fixation concentrate and diluents from the kit) was added to each FACS 
tube and cells were incubated at room temperature for 20 minutes followed by centrifugation at 
400Xg for 5 minutes. Cells were then permeabilized with freshly prepared 0.1% saponin in 
permeabilization buffer (10X permeablization buffer from the kit) and incubated for 20 min 
followed by centrifugation. Cells were then blocked with 2% rat or mouse serum (dependant on 
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antibody used) for 10 minute before application of flurochrome conjugated antibodies or isotype 
controls. 
Prior to detection of intra-cellular cytokines such as IFN-γ, TNF-α, IL-22 and IL-17 in 
cultured lymphocytes and liver infiltrating lymphocytes, cells were re-stimulated with Ionomycin 
(500ng/ml) and PdBu (phorbol-12-13-dibutyrate; Sigma-Aldrich, 50nM) or PMA (Phorbol 12-
Myristate 13-Acetate, 50ng/ml) for 5 hours at 37ºC. Intracellular cytokine secretion from the 
Golgi complex was blocked by using a “Golgi block” such as Monensin or Brefeldin (Brefeldin 
A, 1000ng/ml or Monensin 1- 3 µM) for the last 2 hours of cell stimulation. Cells were washed, 
incubated with appropriate intracellular cytokine antibodies or control antibodies. Then 
permeablization buffer was added and cells were incubated in 4ºC for 20 min in the dark before a 
final wash. Table 2.7 showed the intra-cellular cytokines used for the experiments. 
Clone Antigen/Conjugate Concentration Source 
340449 IFN-  FITC 1:10 BD 
MHCIFG05 IFN-  APC 1:5 Caltag 
64CAP/DEC IL-17 PE 1:5 eBioscience 
51-7229-42 IL-22 Alexa Fluor 647 1:5 eBioscience 
IC 7821 P IL-22 PE 1:5 R&D 
554512 TNF-α FITC 1:50 BD 
 
Table 2-7 Intracellular cytokine antibodies used for flow cytometry. 
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2.8 Western blotting 
Fresh normal and disease liver tissue samples were mechanically homogenized in lysis 
RIPA buffer containing protease inhibitor cocktail (Sigma). The protein concentration of tissue 
lysates was determined using Biuret reaction. Dilution of BSA (sigma) was used as protein 
standard. The cell lysates were agitated at 4ºC for 2 to 3 hours and stored at - 20ºC for future use. 
The lysates were diluted with PBS and SDS-PAGE buffer to protein concentrations prior to 
loading onto the gels and signals were normalized using beta actin expression. The composition 
of the stacking and resolving gels are shown in the Table 2.8. 
 
 
Percent Gel 
 
 
dd H2O 
 
30% Degassed 
Acrylamide/Bis 
 
Gel buffer 
 
10% SDS
 
5% 
 
5.7ml 
 
1.7ml 
2.5ml 
(Stacking) 
 
0.1ml 
 
15% 
 
2.4ml 
 
5ml 
2.5ml  
(Resolving) 
 
0.1ml 
 
Table 2-8 Reagents used to generate SDS-PAGE gels. 
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2.8.1 SDS-PAGE (SDS Poly Acrylamide Gel Electrophoresis) 
Proteins samples from diseased and normal livers were separated by electrophoresis in 
acrylamide gels made up of a 5% loading gel/ stacking gel over a 15% resolving gel cast in the 
BioRad Mini Trans Blot cell system. Lysates were diluted in buffer with β-mercaptoethanol, 
boiled at 100ºC for 10 minutes and centrifuged before loading into wells The lysates were loaded 
at (20µl/lane) and a pre-stained rainbow molecular weight ladder (Amersham, GE Healthcare) 
was used as a molecular weight marker (CCL17=8kDa). Protein electrophoresis was performed 
at 200 V for 30 minutes in 1 x electrophoresis buffer to separate the proteins in the lysates. 
2.8.2 Western Blot Transfer 
Protein products in the gel were then transferred onto Hybond-ECL nitrocellulose 
membranes (Amersham) in 1x transfer buffer running at 100 V for 60min with constant stirring.  
Appearance of the rainbows markers on the membrane confirmed that protein transfer was 
complete and then the membrane was stained with Ponceau S solution (Sigma) for 5 min 
followed by rinsing in water to visualise the transfer.   
2.8.3 Western Blot Development 
Once the transfer was complete, the nitrocellulose membrane were blocked with 5% 
skimmed milk in PBS + 0.02% Tween-20 for an hour at room temperature and subsequently 
incubated with goat anti-human CCL17 antibody (R&D systems, Table 2.9) for 1 hour. The blots 
were then washed in PBS Tween solution for an hour and incubated with a rabbit anti-goat HRP-
conjugated secondary antibody (1 in 2500, Dako) for an hour at RT to detect the primary 
antibody.  The membranes were then repeatedly washed in 1 x PBS Tween and immunoreactive 
bands were detected using the ECL detection system (Amersham) for a minute followed by 
exposure to a chemosensitive film (Amersham Biosciences) and development using a Kodak X-
Omat 1000 processor. 
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Buffer Concentration&Volume Composition 
Lysis Buffer in dH2O  
Glycerol 
1M TrisHCL pH 6.8 
Sodium dodecyl sulphate (SDS) 
Bromophenol Blue 
β-mercaptoethanol 
Resolving gel buffer (pH8.8) 1.5M 
 
Tris based 
Stacking gel buffer  (pH 6.8) 0.5M 
 
Tris based 
10x Electrophoresis Buffer (per 1L)  Glycine (144g); Tris (30.3g) 
Sodium dodecyl sulphate (SDS) 10g 
 
Transfer Buffer 
(per 2 Litre) 
 Glycine (28.8g); Tris(6.0g) 
Sodium dodecyl sulphate (SDS)1g 
400ml MeOH 
Blocking buffer 
(25 ml  per membrane) 
 5% non-fat milk (Marvel) 
PBS +0.02%Tween-20 (PBS-T) 
 
 
5X SDS-PAGE sample buffer 
 
 
200 mM 
Tris pH 6.8 
20% Glycerol 
10% SDS 
0.05% bromophenol blue 
10 mM β-ME 
 
15 % SDS PAGE Resolving/ Separating gel 
2.4ml 
2.5ml 
5.0ml 
100µl 
ddH2O 
Resolving gel buffer 
Acrylamide/bis-acrylamide 30% solution 
10% w/v SDS 
 
5%  SDS PAGE Stacking/ 
Loading gel 
5.7ml 
2.5ml 
1.7ml 
100µl 
ddH2O 
Stacking gel buffer 
Acrylamide/bis-acrylamide 30% solution 
10% w/v SDS 
Human CCL17/TARC Polyclonal Ab, Goat IgG 
(R&D systems; AF364)  (MW 8kDa) 
 
0.2 µg/ml 
 
 
Table 2-9 Buffers, components of SDS-PAGE gels and antibodies used for Western 
blotting.  
 (All chemicals from Sigma-Aldrich)  
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2.9 RT-PCR 
Gene expression of the chemokines CCL17, CCL22, CCL20 and IL17RA gene expression 
was analysed by RT-PCR.  
2.9.1 RNA Extraction 
Total RNA was extracted from cells using RNeasy kit (Qiagen) according to 
manufacturer’s instructions.  
For CCL17 and CCL22 detection, amplification of RNA was carried out from 
lipopolysaccharide stimulated and unstimulated liver infiltrating dendritic cells from diseased liver 
tissue, monocyte derived dendritic cells from peripheral blood and TNF-α and IFN-γ stimulated 
and unstimulated hepatic sinusoidal endothelial cells. For detection of CCL20 and IL-17RA gene 
expression, RNA was extracted from biliary epithelial cells stimulated with IL1β, IL-17, TNF-α, 
IFN-γ and TNF-α+IFN-γ. RNA concentration was determined by measuring optical density of a 
dilution of the sample in the plate reader at 260nm and 280nm. 
2.9.2 RT protocol 
Individual PCR tubes for each sample were loaded with 1µg RNA and heated at 65º C for 
5 min and then placed on ice. A master mix for 1st strand cDNA synthesis was made up as 
described in Table 2.10. Master mix was added to the RNA samples which were left at 25ºC for 
10min then incubated at 42ºC for 1 hour. After a final incubation at 95ºC for 5min, cDNA were 
stored at -20ºC or -80º C until use. Each reaction was performed with a non-template control, 
RT-control were included in each PCR detection assays to exclude non-specific detection. 
Reverse transcription was carried out for the chemokines, IL-17RA and GAPDH was used as an 
endogenous control.  
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Master mix for 1st strand cDNA was synthesized as follow 
Reagents Amount Final concentration Source 
5 X PCR First Strand 
Buffer(Green GoTaq) 
6 µl X1 Promega,UK 
DNTPs 2.5 µl 10Mm Roche 
MgCl2 6 µl 25 Mm Promega,UK 
Random Hexamers 1 µl   Promega,UK 
Superscript ΙΙ reverse 
Transcriptase 
0.5 µl  Invitrogen 
PCR water 14 µl  Sigma 
Total volume of master mix for each sample is 30µl. 
Table 2-10 Reagents in 1st strand cDNA synthesis  
 
2.9.3 PCR Protocol 
The PCR reaction was conducted using 1µg/ml of cDNA per reaction (6µl of volume).  The 
reagents used in the PCR protocol are shown in the table below. 
Reagents Amount Final concentration Source 
5 X Flixi Taq PCR buffer 10 µl X1 Promega,UK 
DNTPs  1µl 10Mm Roche 
MgCl2  3 µl 25 mM Promega,UK 
Reverse Primer  2 µl  0.4µM(stock 10µM) Alta bioscience 
Forward Primer  2 µl 0.4µM(stock 10µM) Alta bioscience 
Flexi Taq polymerse 0.25 µl  Invitrogen 
PCR water 25.75 µl  Sigma 
Total volume 44µl + 6µl of cDNA = 50 µl per reaction 
Table 2-11 Components of PCR reaction 
The reaction conditions for CCL17 and CCL22 PCR were hot start at 95°C for 5 min, denaturing 
at 95°C for 1 min, annealing at 66°C for 1 min and, extension at 72°C  for 1 min. 35 cycles were 
performed for CCL17 &CCL22 chemokines and 27 cycles for GAPDH. A final extension at 
72°C for 5 min was performed and samples were stored at 4°C until analysis. For CCL20 and 1L-
17RA, initial denaturing was at 94ºC for 3 minutes followed by 35 cycles of 30s of denaturing at 
94ºC, 30s of annealing of primers at 55ºC and 60s of extension at 72ºC and final extension at 
72°C for 5 min.    
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All primers were designed based upon GenBank sequences and are detailed in the table below. 
Primers Sequence Source 
CCL17 forward 5’-ACT GCT CCA GGG ATG CCA TCG TTT TT-3’ Alta Bioscience 
CCL17 reverse 5’-ACA AGG GGA TGG GAT CTC CCT CAC TG-3’  
CCL22 forward 5’-AGG ACA GAG CAT GGA TCG CCT ACA GA-3’  
CCL22 reverse 5’-TAA TGG CAG GGA GGT AGG GCT CCT GA-3’  
CCL20 forward 5’-GCG CAA ATC CAA AAC AGA CT-3’  
CCL20 reverse 5’- CAA GTC CAG TGA GGC ACA AA-3’  
IL-17RA forward 5’-CCA GAT CCC AGC TTT GAG AG-3’  
IL-17RA reverse 5’-AAA TGC CCG CCA CAT AGT AG-3’  
GAPDH forward 5’-GGC CTC CAA GGA GTA AGA CC-3’  
GAPDH reverse 5’-AGG GGT CTA CAT GGC AAC TG-3’  
 
Table 2-12 Primers used for RT-PCR 
Product sizes for each set of primers were: CCL17, 270 bp; CCL22, 363 bp; CCL20, 200 bp; IL-
17RA, 285 bp. Each PCR experiments included negative controls in which RNA was omitted 
from the RT mixture and cDNA was omitted from the PCR reactions. RNA from human 
peripheral blood monocyte-derived dendritic cells was used as positive control for CCL17 and 
CCL22 chemokines. 
After the PCR, 15µl of amplified products was run on a 2% agarose gel containing 
ethidium bromide (Sigma) using 1 x TAE buffer. 
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2.10 Sandwich ELISA for CCL17, CCL22 and CCL20 
The concentration of CCL17 and CCL22 in stimulated liver derived dendritic cells 
supernatant samples or CCL20 in cytokines stimulated biliary epithelial cells supernatant samples 
were determined by sandwich ELISA. Human liver derived dendritic cells from different diseased 
livers were stimulated with LPS (1µg/ml) for 24 hours and supernatant were collected. Similarly 
biliary epithelial cells were stimulated with TNF-α, IFNγ, IL-1β, IL-17 or combination of these 
cytokines for 24 hours. Quantikine sandwich ELISA kits for CCL17 (DDN00), CCL22 
(DMD00) and CCL20 (DM3A00) were purchased from R&D Systems and used according to 
manufacturer’s instructions. Monoclonal antibodies specific for CCL17, CCL22, and CCL20 were 
pre-coated in microplates. All the reagents and samples were kept at room temperature before 
use and wash buffer and protein standards of known concentration was prepared in serial 
dilutions. Test supernatant samples (from different diseased livers and normal liver) or protein 
standards were then added to relevant wells and incubated at RT for two hours before washing 
the plates 4 times with wash buffer. Horseradish peroxidise conjugated antibody directed against 
the corresponding chemokines were then added to each well, incubated for two more hours and 
the wells were washed again 4 times. The ELISA was developed by adding tetramethylbenzidine 
substrate (TMB) in hydrogen peroxide and the enzymatic reaction was stopped by using 2 N 
sulphuric acid. Colorimetric analysis was performed by measuring absorbance values at 450nm 
using a Dynatech Laboratories MRX plate reader. All the measurements were performed in 
triplicates for each experiment. 
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2.11 Transwell chemotatic migration assay 
The migratory properties of Treg or Th17 cells isolated from inflamed livers and peripheral 
blood were assessed using fibronectin-coated (Sigma-Aldrich) 6.5-mm diameter, 5-µm pore 24 
well plate Transwell inserts (Costar Corning). The lower Transwell chambers were filled with 
600µL of assay media (RPMI medium with 0.1% BSA; Sigma-Aldrich), BEC media or media 
supplemented with different chemokines (100 ng/ml recombinant human CCL22, CCL17, 
CCL20 or BEC supernatant stimulated with different cytokines. LITreg or peripheral blood Th17 
resuspended in RPMI was added to the upper chambers (some after 30 minuntes of Pertussis or 
CXCR3 block). Anti CXCL9-11 block or Anti CCL-20 block was applied to BEC supernatant for 
Th17 chemotaxis assay. Then cells were collected from the top and bottom chambers after 4 
hours incubation at 37°C. Transmigrated cells were collected from the lower chamber and 
measured by fixed volume counting (using Caltag counting beads: PCB-100) and also phenotyped 
for Treg and Th17 markers and chemokine receptors expression by Cyan flow cytometry. 
Migration assays were conducted in duplicate and migration in test wells was compared with 
control wells contained medium with 0.1% BSA or BEC media alone. On occasion to inhibit 
chemokine-mediated signalling, Treg and Th17 were incubated with pertussis toxin (100 ng/ml; 
Sigma Aldrich Ltd., Aldrich) or CXCR3 blocking antibody or blocking antibody to CCL20 or 
CXCL9-11 was applied in the BEC supernatant prior to chemotaxis.  
To calculate the specific migration, the number of cells in each subpopulation which 
migrated in the absence of chemokine was subtracted from the number of the corresponding cell 
subpopulation which migrated in the presence of chemokine. Basal and chemokine directed 
migration were also evaluated by determining a chemotatic index. 
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Clone Antigen Concentration 
 
Source 
          300-30 CCL 17 100 ng/ml R & D Systems
300-36A CCL22 100 ng/ml R & D Systems
Clone 87328        
MAB 672 
Anti I-TAC 5µg/ml R & D Systems  
Clone 33036 Anti-CXCL10 5µg/ml R & D Systems
Clone 49106 
MAB392 
Anti-CXCL9 50µg/ml R & D Systems 
MAB 160/49801 Anti-CXCR3 10µg/ml R & D Systems
Recombinant CCL20 
300-29A 
CCL-20 100ng/ml Peprotec 
Clone 67310       
MAB 360 
mAb anti-human 
CCL20Ab 
100ng/ml R & D Systems 
Pertussis Toxin Anti-GCPR 100ng/ml Sigma-Aldrich Ltd
 
Table 2-13 Recombinant chemokines, blocking antibodies and Pertussis toxin used for 
chemotaxis assay. 
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2.12 Flow based adhesion assay 
Recruitment of Treg to the liver during inflammation is mediated by specific homing 
receptors. The flow based adhesion assay allows one to study adhesive interactions between Treg 
and cultured endothelium under inflammatory conditions and physiological fluid flow. This has 
allowed us to characterise the functional significance of Regulatory T cell homing receptors 
(chemokine receptors and integrins) and their interaction with cell surface and secreted ligands 
expressed by hepatic sinusoidal endothelium. 
2.12.1 Preparation of microslides for flow based   adhesion assay 
Glass microslides (Camlab Ltd, Cambridge, UK) were initially acid-washed overnight 
(70% v/v nitric acid; Sigma Aldrich Ltd.) before being rinsed in an excess of tap water with a 
final wash in distilled water. They were then blotted dry and dehydrated in anhydrous acetone to 
remove all traces of water. Microslides were then coated for 10 minutes at room temperature 
with a 4% (v/v) solution of 3-aminopropyltriethoxysilane (APES; Sigma Aldrich Ltd.) prepared 
in anhydrous acetone. They were then washed in anhydrous acetone 3 times, and rinsed in 
distilled water to remove any residual acetone before being blotted and dried in a glass oven 
overnight at 60ºC. To facilitate connection of microslides to a custom designed multi-port culture 
dish (Glassblower, School of Chemistry, and University of Birmingham, UK) silicone tubing 
adaptors (Portex Ltd., Kent, UK) were attached at one end of the slides which were then 
autoclaved prior to use. 
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Figure 2-3 Schematic diagram of flow chamber and flow based adhesion assay 
Capillary tube glass microslides are attached to silicone adaptor tubing. Hepatic sinusoidal 
endothelial cells were grown in microslides and stimulated with TNF-α and IFN-γ for 24 hours. 
One end of microslide was attached to syringe pump and the other end to electronic valve which 
can switch between cells and wash buffer. Freshly isolated peripheral blood regulatory T cells 
were perfused over the microslides at a constant shear stress of 0.05Pa which is equivalent to 
hepatic sinusoidal blood flow. Adhesion cascades were recorded with video monitor and 
experiments were analysed offline for rolling adhesion and transmigration. 
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2.12.2 Culture of hepatic sinusoidal endothelial cells in microslides 
Sterile microslides were coated with RTC (in house preparation) for 1 hour at 37ºC and 
washed thoroughly with PBS.  Cultured HSEC were trypsinized, washed in PBS and resuspended 
to a count of 2 x 10 6 /ml in complete medium for seeding of six microslides.  Microslides were 
then attached to a 1 ml pipette and 50 µl of the cell suspension was aspirated into each slide 
before being incubated at 37ºC for 2 hours to allow cells to settle and adhere.  Individual 
microslides were then attached to one of the six ports within the culture dish via the silicone 
tubing and the culture dish was filled with 40 ml of complete medium.  The culture dish was 
placed in a humidified incubator at 37ºC and attached via silicone tubing to an external pump, 
timed to change media within the microslides at 2 hourly intervals.  HSEC cultured within 
microslides were stimulated with TNF-α and IFN-γ, both 10 ng/ml for 24 hours before the flow 
assay. 
The microslides containing stimulated confluent HSEC monolayers were then fixed to a 
glass slides using cyanoacrylate glue and the two ends of the microslide were coated in double-
sided adhesive tape to allow an airtight seal. One end of the microslide was then attached via 
silicone tubing to a Harvard syringe pump (Harvard Apparatus, South Natic,  USA) and the other 
to an electronic valve (Lee Products Ltd., Gerrards Cross, UK) which permitted alternation 
between a cell free wash buffer (BEM/0.1% BSA) and Treg cell suspension (1 x 10 6/ml in 
BEM/0.1% BSA). The withdrawal rate of the syringe pump was altered such that the flow rate 
within the microslide was at a pre-determined value. Regulatory T cells were perfused over 
cultured endothelial sinusoidal cells at a constant wall shear stress of 0.05Pa, which approximates 
the flow rate within the post-capillary venules/sinusoids in vivo. On occasion, HSEC monolayers 
were pre-treated with blocking antibodies against ICAM-1, and VCAM-1 (or control) to 
selectively inhibit these adhesion molecules. Alternatively, Treg were incubated with a blocking 
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antibody against CXCR3 or pertussis toxin (PTX) to selectively inhibit Gi protein linked receptor 
signalling. Antibodies and blocking agents were prepared in flow assay media which is made up 
of BEM/0.1% BSA and 50 µl was aspirated into relevant microslides or applied to Treg 
suspensions for 30 minutes prior to assay. All blocking incubations were at 37oC and details of 
the blocking antibodies used are described in Table 2.14. In experiments to block individual 
CXCR3 ligands, CXCL9, CXCL10 and CXCL11 were individually applied to stimulated HSEC in 
each microslide for 30 minutes before the flow experiments. 
Treg captured from flow were visualised (X100 magnification) by phase-contrast 
microscopy using an Olympus IX50 inverted microscope (Olympus, Southall, Middlesex, UK) 
and video-microscopic recordings were made along the length of the microslide against the flow 
to prevent double counting of cells. Both the inflow and wash out phases of the adhesion 
experiment were recorded on video. Offline analysis allowed the pattern of adhesion and 
transmigration to be assessed. Treg adherent to the upper surface of the HSEC monolayer 
appeared phase-bright whilst those that had migrated through the monolayer appeared phase-
dark. Adherent cells were classified as exhibiting static adhesion (non-migrated), or migrated and 
individual categories were expressed as a percentage of total adhesion.  Total adhesion was also 
normalised for adhesive surface area and number of Treg perfused i.e. adherent cells/mm 2/106 
Treg perfused. Total migrated cells were expressed as migrated cells / mm 2/106 Treg perfused or as 
percentage of adherent cells which had transmigrated. 
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Clone 
 
Antigen 
 
Concentration 
 
Company 
DAK-G01 Mouse IgG 20 µg/ml Dako 
MAB160/49801 CXCR3 10 µg/ml R&D Systems 
11C81 ICAM-1 10 µg/ml R&D Systems 
4B2 VCAM-1 10 µg/ml R&D Systems 
Pertussis Toxin - 100 ng/ml Sigma Aldrich Ltd 
49106 Anti- CXCL9 50µg/ml R&D Systems 
33036 Anti-CXCL10 5µg/ml R&D Systems 
87328 Anti-CXCL11 5µg/ml R&D Systems 
 
Table 2-14 Blocking antibodies used in flow based studies 
 
2.13 Statistical analysis 
Data normally distributed were analysed using Student’s T-Tests (paired or independent) 
whilst non-normally distributed data were compared using Wilcoxon signed ranks test (for related 
samples) or Mann-Whitney U tests (for unrelated samples comparing normal and diseased livers). 
A value of p ≤ 0.05 was considered statistically significant. 
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CHAPTER 3 PHENOTYPE AND 
FUNCTION OF REGULATORY T CELLS 
IN HUMAN LIVER 
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3.1 INTRODUCTION 
The liver maintains tolerance to harmless food antigens load from the gastrointestinal tract 
whilst maintaining the capacity to sustain effective immune response against pathogens. It has 
been suggested that the fate of an immune response against intrahepatic antigens depends on the 
dominant site of antigen presentation. Where antigen is overwhelmingly presented within the 
liver, CD8+ T-cell tolerance is likely to ensue; however, if there is significant early antigen 
presentation within the lymph nodes, an effective immune response is generated that can clear 
pathogens from the liver but which may also generate hepatocellular injury (Bowen et al., 2005). 
The level of antigen expression is also crucial as the presence of high-level antigen within the 
liver will lead to deletion of CD8+ T cell (Mehal, 2003).  
Major players actively involved in maintaining hepatic tolerance include antigen presenting 
cells (APC) such as tolerogenic dendritic cells (Hadeiba et al., 2008;Thomson, 2010) and 
regulatory T cells (Eksteen et al., 2007;Lan, 2006). Hepatic antigen presenting cells also include 
diverse non-professional antigen presenting cells including kupffer cells, hepatocytes, and 
endothelial cells all of which can present antigen under particular condition. The unique 
architecture of the liver allows lymphocytes flowing through the low flow sinusoids to interact 
with resident liver APC, allowing them to direct immune response towards immunity or tolerance 
(Adams et al., 1989;Goddard et al., 2004a). The normal liver contains a large population of 
resident lymphocytes that differ from peripheral blood (Crispe, 2003). CD8+ T cells usually 
outnumber CD4+T cells in the liver (Winnock et al., 1995) in a reversal of the usual ratio in 
blood.   
In chronic hepatitis, both effector subsets and regulatory lymphocytes are found at the site 
of inflammation and the balance of the cells recruited will determine the nature of the hepatitis 
and liver disease. The naive CD4 T cell is a multipotential precursor with defined antigen 
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specificity but substantial plasticity for development of downstream distinct effector or regulatory 
lineages, contingent upon signals from cells of the innate immune system. The most important 
lineages are Th1, Th2, Th17 and Th9 effector cells and anti-inflammatory regulatory Tcells.  
The maintenance of tolerance to self-antigens and the resolution of inflammation involve 
central and peripheral mechanism (Walker & Abbas, 2002). Regulatory T cells (Treg) are a subset 
of CD4 T lymphocytes that play a crucial role in maintaining peripheral tolerance by suppressing 
self-reactive T cells which escape from central thymic deletion. Thus, Treg prevent collateral 
autoimmune damage as a consequence of immune responses to infections and inflammation 
(Sakaguchi and Powrie, 2007). Surviving an infection requires the generation of an effective 
immune response against the invading pathogen whilst limiting collateral damage to self tissues 
that may result from an over exuberant immune response. Treg limit excessive inflammation 
towards the microorganism which could otherwise lead to persistent injury and inflammation 
(Belkaid & Rouse, 2005)  
Treg are crucial in the tolerogenic properties of the liver and help to suppress responses to 
harmless food antigens and bacterial components (Crispe et al., 2006). Naturally occurring, 
thymic derived Treg are defined by expression of CD4, CD25high, and FoxP3+ (Sakaguchi, 2004), 
and low expression of the IL-7 receptor/CD127low (Liu et al., 2006;Sakaguchi, 2005;Seddiki et al., 
2006). FoxP3 is the master regulator of Treg development and function (Fontenot et al., 
2003a;Hori et al., 2003;Khattri et al., 2003). The FoxP3 gene was first identified as the defective 
gene in the mouse strain Scurfy which is an X-linked recessive mutant  lethal in hemizygous 
males exhibiting hyperactivation of CD4+ T cells and overproduction of proinflammatory 
cytokines(Brunkow et al., 2001). Mutations of the human gene FOXP3 are the cause of the 
genetic disease IPEX (immune dysregulation, polyendocrinopathy, enteropathy, X-linked 
syndrome), which is the human counterpart of Scurfy.  
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Natural Treg suppress effector cell proliferation and cytokine production in vitro in a cell-
contact dependent manner and protect against autoimmunity following adoptive transfer in vivo 
(Sakaguchi et al., 1995). They can also suppress effector activities of differentiated CD4+ and 
CD8+ T cells and the function of natural killer cells, natural killer T cells, B cells, macrophages, 
and dendritic cells (Miyara and Sakaguchi, 2007b;Shevach, 2006;Tang and Bluestone, 2008;von, 
2005). Multiple mechanisms of Treg mediated suppression function in a synergistic or sequential 
manner to suppress inflammation. Antigen-activated Treg are recruited to antigen-presenting 
dendritic cells as a consequence of their high expression of LFA-1 and out-compete antigen-
specific naive T cells (Onishi et al., 2008). Treg then modulate dendritic cell function by 
downregulation of dendritic cell CD80 and CD86 by a CTLA-4-dependent mechanism (Wing et 
al., 2008). They also act to absorb IL-2 thereby inducing apoptosis in responder T cells(Pandiyan 
et al., 2007). Some Treg secrete perforin and actively kill effector cells whereas other secretes 
immunosuppressive cytokines including IL-10 or IL-35 (Collison et al., 2007). Other mechanisms 
of suppression involve enzyme activity. Thus, Treg can stimulate dendritic cells to express the 
enzyme indoleamine 2, 3-dioxygenase, which catabolizes the essential amino acid tryptophan to 
kynurenines that are toxic to T cells (Munn et al., 2002). Treg also generate pericellular adenosine 
catalyzed by their cell surface expression of CD39, ectonucleoside triphosphate 
diphosphohydrolase 1 (Borsellino et al., 2007)and CD73, ecto-5′-nucleotidase (Deaglio et al., 
2007). 
 Interleukin 2 (IL-2) is critical for the function of Treg(Itoh et al., 1999). CD25, a 
component of the high-affinity IL-2 heterotrimeric receptor complex (IL-2R) is expressed in high 
levels on Treg and is functionally essential for Treg development. Treg are refractory to TCR-
induced proliferation (Itoh et al., 1999;Takahashi et al., 1998) and they depend on IL-2 for their 
survival (de la Rosa et al., 2004;Furtado et al., 2002). Signalling via the IL-2R complex, in 
combination with TCR engagement is essential for their proliferation and suppressive function. 
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The number of FoxP3+ Treg is reduced in mice lacking either CD25 or IL-2(Antony et al., 2006), 
and autoimmunity in CD25-deficient mice can be prevented by adoptive transfer with wild-type 
CD25+CD4+ T cells (Malek et al., 1984). Stimulation of Treg with IL-2 leads to phosphorylation 
and activation of STAT5 with consequent binding to the FoxP3 promotor and enhance FoxP3 
expression. T cell-specific deficiency of STAT5a and b, which mediate signalling from the IL-2R 
β chain to the nucleus, abrogates the development of Foxp3+ Treg, producing 
autoimmune/inflammatory diseases (Burchill et al., 2007;Yao et al., 2007).  
The high levels of CD25 on Treg may absorb IL-2 from other effector cells, the main 
source of IL-2 in inflamed environment. IL-2 produced by activated non-regulatory T cells 
contributes to the maintenance, expansion, and activation of natural Treg, which in turn limits the 
expansion of non-regulatory T cells providing negative feedback control of the immune 
response. Disruption of this feedback loop promotes the development of 
autoimmune/inflammatory disease (Sakaguchi, 2008). The poor expansion and impaired function 
of intrahepatic Treg despite accumulation at sites of chronic viral hepatitis has been attributed to 
downregulation of STAT5 phosphorylation and upregulation of programmed death-1 expression 
(Franceschini et al., 2009). 
Hepatic inflammation occurs in response to a variety of injuries including hepatitis B and 
hepatitis C viruses, responses to altered-self antigens in autoimmune diseases. An increased 
frequency of Treg has been reported in chronic viral hepatitis (Xu et al., 2006) where a failed 
immune response leads to viral persistence (Belkaid & Rouse, 2005) and also in hepatocellular 
carcinoma where protective anti-tumour CD8 T cell responses may be suppressed by their 
presence in the peri-tumor region (Rushbrook et al., 2007;Unitt et al., 2005) promoting tumour 
progression and poor survival (Fu et al., 2007). Decreased Treg number and impairment in 
function has been implicated in autoimmune hepatitis (Longhi et al., 2004;Longhi et al., 2005b), 
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transplant rejection (Demirkiran et al., 2006;Demirkiran et al., 2007). Recently, monocyte 
overactivation and inability of Treg to restrain them has been reported to contribute the 
perpetuation of the autoimmune attack (Longhi et al., 2009).  
Previous studies indicate that antigen-specific Treg migrate to and become activated in 
regional lymph nodes where tissue-specific self-antigens or microbial antigens are presented.  The 
concentration of peptide required to activate the peptide-specific Treg to exert suppression in vitro 
has been estimated to be 10- to 100-fold lower than the concentration needed for activating naive 
T cells with the same antigen specificity (Takahashi et al., 1998). They also migrate into inflamed 
tissues, infectious sites, and tumours (Belkaid & Rouse, 2005) . In peripheral lymph nodes, the 
majority of FoxP3+ Treg express high levels of CCR7 (Huehn et al., 2005) and expression of 
chemokine receptors and adhesion molecules will control their trafficking and positioning in 
response to inflammation. Very little is known about Treg recruitment into tissues and thus I 
undertook a project to investigate the presence of Treg and their positioning in relation to effector 
and dendritic cells in both liver inflammation and lymph node. 
The frequency, distribution, surface phenotype, transcription factor expression and 
functional capacity of liver infiltrating regulatory T cells were analysed using 
immunohistochemistry and analysis of fresh human liver infiltrating lymphocytes. I paid 
particular attention to the proximity of Treg, effector cells and dendritic cells in inflamed liver.   
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3.2 RESULTS 
3.2.1 Presence of FoxP3 regulatory T cells in human liver 
Presence of FoxP3+ regulatory T cells in hepatic inflammation was investigated by 
immunohistochemistry on paraffin embedded liver tissue sections. Few Tregs were detected in 
normal liver tissue by immunohistochemistry (Fig.3.1) although they could be readily detected in 
the chronically inflamed livers (Figure 3.1 and Figure.3.2).  
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Figure 3-1 Expression of FoxP3+ Regulatory T cells in human liver samples.  
Immunohistochemical staining of paraffin embedded liver sections demonstrating expression of 
FoxP3+ Treg cells (shown with arrows) in (A) Normal Liver (B) Primary Biliary Cirrhosis (C) 
Autoimmune Hepatitis (D) Hepatitis C. (Positive staining cells are shown as brown stain). Fields 
were captured using 20x objectives.  
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Figure 3-2 Expression of FoxP3+ Regulatory T cells in human liver samples. 
Immunohistochemical staining of paraffin embedded liver tissue sections demonstrating the 
presence of FoxP3+ Tregcells (shown with arrows) in (A) Chronic Hepatitis B (B) Seronegative 
hepatitis (C) Alcoholic liver disease. (Positive staining FoxP3 cells are shown as brown stain with 
arrows). Control antibody staining (D) was negative.  Fields were captured using 20x objectives.  
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To confirm the FoxP3+ cells were Treg I carried out costaining with Treg surface markers. 
Using confocal microscopy I was able to detect cells that were CD4+, CD3+, FoxP3+ in the 
different diseased liver tissue (Figure 3.3).  
 
Figure 3-3 Confocal microscopy of FoxP3+ regulatory T cells in inflamed human liver. 
Confocal microscopy using CD3, CD4, FoxP3 demonstrating the distribution and presence of 
liver infiltrating regulatory T cells in inflamed human livers (A&B=AIH; autoimmune hepatitis, 
C&D=HCV; chronic hepatitis C). FoxP3+ regulatory T cells are shown in portal tract of inflamed 
livers. Areas of CD3+, CD4+, FoxP3+ costaining were shown with arrows. Pictures were taken at 
x25 and x40 magnification. CD3=Red; CD4=Blue; FoxP3=Green; Nuclear staining 
DAPI=Grey. (N=6)  
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3.2.2 FoxP3+ cells in normal and chronically inflamed livers 
I then calculated the proportion of the CD3 infiltrate that was FoxP3+ in a variety of liver 
diseases. All diseased livers contained a significantly higher proportion of Treg compared with 
non-diseased livers (Fig 3.4). Paraffin embedded serial liver sections from different liver diseases 
were stained for CD3 antibody, FoxP3 antibody and control antibody. Numbers of CD3 and 
FoxP3 cells are counted in same area in five high power fields for each diseased liver. Average 
values were calculated and the ratio of CD3 lymphocytes which are positive for FoxP3 cells was 
calculated for each liver diseases. Table 3.1 showed the frequency of CD3 and FoxP3 cells and 
percentage in each disease livers. 
Interestingly greater numbers of FoxP3+ Treg were seen in the patients (explanted liver 
tissue samples) with the most severe inflammation with the highest frequencies are detected in 
patients who had undergone emergency liver transplantation for fulminant liver failure as a 
consequence of severe seronegative (nonA nonB) hepatitis (Fig.3.4). 
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Disease state 
 
CD3 Portal 
Tract 
Mean±SD 
 
CD3 
Parenchyma
Mean±SD 
 
FoxP3 
Portal 
Tract 
Mean±SD
 
FoxP3 
Parenchyma 
Mean±SD 
Total  % 
of CD3 
which are 
FoxP3+ 
Mean±SD
Normal Liver 51 ± 28 11.6 ± 3.8 2.2 ± 1.2 0.21 ± 0.1 3.04±0.76 
Chronic hepatitis C 239.5 ± 84.6  40.1 ± 16.6 25.7 ± 5.7 2.5 ± 1.2 8.85±3.6 
Chronic hepatitis B 327 ± 118 39 ± 10 28 ± 4.5 2.6 ± 1 8.2±2.8 
Seronegative hepatitis 343.8 ± 121.7  60.1 ± 25.7 38.3 ± 8.4 10.1 ± 4.6 15.6±6.9 
Autoimmune hepatitis 280 ± 119 53.8 ± 30.6 27.6 ± 5.8 6.7 ± 4.3 11.6±3.5 
Primary biliary cirrhosis 226 ± 94  35.5 ± 13  28.6 ± 6.9 2.7 ± 1.2 11.4±5.4 
Alcoholic liver disease 258.8 ± 116 24.7 ± 8.5 20 ± 7.4 1.6 ± 1 7.4±3.4 
 
Table 3-1 Total cells number of CD3 and FoxP3 in different liver diseases. 
Table shows the total numbers of CD3 and FoxP3 in portal tract and parenchyma of different 
liver diseases. Immunohistochemistry were done on liver sections with CD3 and FoxP3. CD3 
and FoxP3 from five areas of portal tract and parenchyma were counted at high power fields and 
average was calculated. 7-8 cases of normal and diseased livers were studied. Seronegative 
hepatitis= non A non B hepatitis. 
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Figure 3-4 Percentage of CD3 T cells which are FoxP3+ in normal and different human 
liver diseases.  
The ratio of FoxP3+ cells to CD3 staining T cells was quantified by immunohistochemistry in 
normal livers (NL) and different chronic liver diseases. Compared to normal liver, diseased livers 
has significantly higher infiltration of FoxP3+ cells (p <0.05 comparing normal to different 
diseased livers, Mann Witney U tests; n= 7-8 for normal and diseased livers) (NL=normal liver, 
HCV=chronic hepatitis C, HBV=chronic hepatitis B, NANB= nonA nonB or seronegative 
hepatitis, AIH= autoimmune hepatitis, PBC=primary biliary cirrhosis, ALD=alcoholic liver 
disease)  
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Multi-colour flow cytometry was used to phenotype Treg isolated from normal and 
inflamed liver tissue. Liver infiltrating lymphocytes were isolated from both normal and inflamed 
liver tissues using mechanical digestion and density gradient centrifugation. Cells were stained for 
Treg surface markers CD4, CD25, CD127 and transcription factor FoxP3. The total percentage of 
CD4+CD25highCD127low FoxP3+  Treg was greater in diseased than normal liver. In normal liver Treg 
frequency varied from 0.5-2 % whereas in diseased livers it ranged from 3-7 %.( Figure 3.5). 
 
 
Figure 3-5. Liver infiltrating regulatory T cells in normal liver and inflamed liver.  
Flow cytometry dot plot comparing the frequency of liver infiltrating Treg in inflamed diseased 
liver (one representative plots shown from 8 diseased livers studied and 7 normal livers). Liver 
infiltrating Treg (LITreg) were identified by gating on liver infiltrating lymphocytes CD3high CD4high 
followed by CD25high (Y axis) and CD127low (X axis). 
 
 
 
 
 
 
 
136 
 
 Percentage of CD4+CD25highCD127low  Treg  in different liver diseases was shown in Table 
3.2. The frequency was much greater in all diseased livers compared to normal liver. Majority, 
>90% of these CD4+CD25highCD127low cells are FoxP3 positive by intracellular transcription 
factor staining. 
 
Disease state 
 
% of CD25high  CD127low 
Normal Liver 1.24± 0.3 
Chronic hepatitis C 4.3±1.62 
Non alcoholic steatohepatitis 4.3±1.17 
NonA nonB/ Seronegative hepatitis 6.1±1.98 
Autoimmune hepatitis 5.2±1.2 
Primary Biliary cirrhosis 4.8±1.6 
Alcoholic liver disease 3.4±1.72 
 
Table 3-2 Percentage expression of CD4+CD25highCD127lowcells in normal liver and 
different diseased livers.  
Percentage expression of  liver infiltrating regulatory T cells in normal and different diseased 
livers was shown. Data were analysed from flow cytometry on freshly isolated liver infiltrating 
lymphocytes using CD4, CD25high and CD127low  population. Mean ± SD (N=2 for NonA NonB 
hepatitis; N=2-4 for each diseased livers and N= 5 for normal livers)  
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3.2.3 Distribution of FoxP3+ cells in different liver diseases 
Immunohistochemical staining suggested that Treg are present in both septal and 
parenchyma areas. In order to assess the distribution of FoxP3+ Treg in hepatic inflammation, the 
staining of cells on different liver diseases was quantified in the portal tract and the hepatic 
parenchyma separately. Numbers of CD3 and FoxP3 cells are counted in same area of portal 
tract and parenchymal in five high power fields for normal and each diseased livers. Average 
values were calculated and the ratio of CD3 lymphocytes which are positive for FoxP3 cells was 
calculated for portal tract and parenchyma.  
Percentage of FoxP+ cells in relation to CD3 suggested that FoxP3+ Treg were found at 
higher frequencies in the parenchyma compared with portal tracts in patients with seronegative 
hepatitis and autoimmune hepatitis whereas in the other liver diseases and in normal liver, 
FoxP3+ Treg  were detected at higher frequencies in portal tracts (Fig. 3.6) 
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Figure 3-6 FoxP3+ Treg in parenchyma and portal tract of different diseased livers and 
normal liver. 
Percentage of FoxP3+ cells in relation to CD3 in portal tract and parenchyma are shown for 
normal liver and different chronic liver diseases (autoimmune hepatitis, seronegative hepatitis, 
primary biliary cirrhosis, alcoholic liver disease, chronic hepatitis C, normal liver). Autoimmune 
hepatitis, seronegative hepatitis cases have higher preponderance of FoxP3+ cells in parenchyma 
compared to portal tract. (N=7 for normal liver and diseased livers) 
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3.2.4 T effector cells in chronically inflamed human livers 
Chronic hepatic inflammation is characterised by infiltration by both CD4 and CD8 
lymphocytes. Thus, I went on to study the presence of these T effector lymphocytes in the liver. 
Immunohistochemical and confocal staining suggested that both CD4 and CD8 subsets are 
present in inflamed liver (Figure 3.7 and Figure 3.8).  
 
 
Figure 3-7 CD4 and CD8 effector T lymphocytes in inflamed liver.  
Immunohistochemistry of inflamed diseased liver tissue sections illustrating CD8+ Tcells (A) and 
CD4+ T cells (B) in inflamed liver tissues. Cells were shown with arrows. Image of a patient with 
HCV was shown. Images were captured with x20 lens (HCV=chronic hepatitis C). 
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Figure 3-8 Confocal images of CD4 and CD8 T cells in inflamed human liver. 
Presence of CD8 (Panel A, red colour) or CD4 (Panel B, blue colour) T lymphocytes in inflamed 
parenchyma, septal area and portal tract is shown in this three colour confocal images. CD8 and 
CD4 together (Panel C&D, both red and blue colour) was noted in septal area, portal tract, 
parenchyma. Nuclear staining was done with DAPI=Grey. (Confocal images of a patient who 
was transplanted for autoimmune hepatitis was shown) 
  
A B
C D
Parenchyma
Portal Tract 
Portal Tract
Parenchyma 
Portal Tract 
Parenchyma 
Septal area
Portal Tract 
Septal area
Cirrhotic nodules 
CD8 T cells 
CD4 T cells 
CD4 and CD8
 T cells 
141 
 
 T effector cells involved in inflammation also include Th1 cells and also the 
recently described Th17 subset. I detected Th1 CD4 and Th1 CD8 cells defined by their 
expression of IFN-γ and TNF-α by intracellular cytokine (Fig.3.9). Presence of IFN-γ and TNF-α 
in Th1 cells in diseased livers were analysed by stimulating freshly isolated liver infiltrating 
lymphocytes with PMA and ionomycin and then secretion of the cytokines were blocked with 
BrefeldinA. Figure 3.9 demonstrate the Th1 cytokine expression of liver infiltrating CD4 and 
CD8 T cells and Table.3.3 showed percentage expression from each donor.  
  
Figure 3-9 Th1 cells in inflamed human liver.  
Flow cytometry dot plot analysis of Th1 lymphocytes isolated from a diseased liver (primary 
biliary cirrhosis).  Th1CD8 cells (top panel) and Th1CD4 cells (lower panel) expressing IFN-γ 
and TNF-α are shown. Cells were gated on freshly isolated liver infiltrating lymphocytes and 
regated on CD3 lymphocytes. Intracellular cytokine staining was done after stimulating liver 
infiltrating lymphocytes with PMA and ionomycin for 5 hours. (N=4, diseased livers and N=3, 
normal livers)  
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Disease state 
CD8 
 IFN-γ 
CD8  
TNF-α 
CD4 
IFN-γ 
CD4 
TNF-α 
Alcoholic liver disease  34%  24%  18%  18% 
Autoimmune hepatitis  31%  31%  19%  19% 
NonA nonB/ Seronegative hepatitis 51%  44%  19%  20% 
Primary Biliary Cirrhosis  35%  27%  26%  22% 
 
Table 3-3 Percentage expression of CD8 IFN-γ, CD8 TNF-α, CD4 IFN-γ and CD4TNF-α 
in inflamed livers.  
Liver infiltrating lymphocytes were freshly isolated and stimulated with PMA and inomycin for 5 
hours and then cells were stained for surface markers, CD3, CD4, CD8 and intra cellular 
cytokines IFN-γ and TNF-α and analysed on flow cytometry for Th1 cytokine expression. 
Experiments were done on one donor from each different explanted diseased liver. 
 
 
 
 In addition to Th1 cells, I investigated interleukin-17 expressing CD4 T cells (Th17) 
(Figure 3.10) and interleukin-17 expressing CD8 T cells (Tc17) cells (Figure 3.11) in chronic liver 
diseases studied. Intracellular cytokines staining for IL-17 were performed after stimulating the 
cells with PMA and Ionomycin for 5 hours. Percentage expression of Th17 and Tc17 from 
normal and diseased livers is shown in Table 3.4. 
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Figure 3-10 Th17 cells in normal and diseased livers 
Flow cytometry dot plot showing the presence of Th17 lymphocytes isolated from normal liver 
and diseased liver (primary biliary cirrhosis as example). Cells were gated on freshly isolated liver 
infiltrating lymphocytes and then re-gated on CD3 lymphocytes (one representative example of 6 
experiments). These cells were stimulated with PMA and ionomycin for 5 hours before labelling. 
 
Figure 3-11 Tc17 cells in inflamed liver 
Presence of Tc17 in diseased liver is analysed by flow cytometry. Cells were gated on liver 
infiltrating lymphocytes and re-gated on CD3 lymphocytes. Explanted liver from a patient with 
autoimmune hepatitis is shown. Cells were stimulated for 5 hours before labelling. 
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Disease state CD4 Th17 CD8 Tc17 
Normal Liver 1 0.37% 0.1% 
Normal Liver 2 0.4% 0.12% 
Normal Liver 3 0.52% 0.14% 
 
Autoimmune hepatitis 2.2% 0.6% 
Primary Biliary Cirrhosis 1.6% 0.4% 
Alcoholic liver disease 1.7% 0.5% 
NonA nonB/ Seronegative hepatitis 2.3% 0.6% 
Chronic Hepatitis C 1.5% 0.6% 
 
Table 3-4 Percentage expression of Th17 and Tc17 in normal and different diseased 
livers. 
Liver infiltrating lymphocytes from normal liver and diseased livers are freshly isolated from 
explanted donors. Then cells were stimulated with PMA and ionomycin for 5 hours and 
intracellular cytokines staining with IL-17 was performed along with surface staining for CD3, 
CD4 and CD8. Percentage expression of both Th17 and Tc17 was shown for normal and 
diseased livers. 
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3.2.5 Defining Regulatory T cells 
Both liver and blood-derived Treg were defined by the characteristic phenotype 
CD4+CD25high CD127lowFoxP3+ (Liu et al., 2006;Sakaguchi, 2004;Seddiki et al., 2006). Liver-
infiltrating lymphocytes are freshly isolated from explanted human liver tissue by mechanical 
digestion and density gradient centrifugation for each experiment before being stained with 
antibodies against CD3, CD4, CD25, CD127 and the intracellular transcription factor FoxP3. 
More than 95% of CD4+CD25high CD127low liver-infiltrating lymphocytes expressed FoxP3 
(Fig.3.12).  
 
Figure 3-12 Phenotyping of liver infiltrating regulatory T cells by flow cytometry. 
Human liver infiltrating lymphocytes were stained for cell surface expression of CD4, CD25, and 
CD127. The stained cells were fixed, permeabilized and stained intracellularly for FoxP3. For 
analysis, liver infiltrating lymphocytes were gated on forward scatter and side scatter and liver 
infiltrating Treg (LITreg) identified by gating on liver infiltrating CD3high CD4high lymphocytes 
followed by CD25high (Y axis) and CD127low (X axis). The oval box represents the population of 
liver infiltrating Treg cells. Histogram shows the expression of transcription factor, FoxP3 which 
was analysed on liver infiltrating Treg (CD3high CD4high CD25high CD127low) by flow cytometry. 
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3.2.6 Phenotypic characteristic of liver infiltrating regulatory T cells 
The vast majority of liver-infiltrating Treg expressed CD45RO and more than 80% 
expressed high levels of CD27 (Fig.3.13) consistent with a tissue-infiltrating phenotype (Ruprecht 
et al., 2005a). Furthermore, there is high expression of ectoenzyme CD39 on liver infiltrating Treg. 
They also express OX-40.  
 
 
Figure 3-13 Flow cytometry analysis of LITreg phenotypic markers  
Flow cytometry overlay histogram shows the percentage positivity of liver-infiltrating Treg for 
CD27, CD45RO, CD39, and OX-40. The numbers in the histograms indicate the percentage 
expression of relevant markers. Cells were gated on liver infiltrating CD3high CD4high CD25high 
CD127low lymphocytes for phenotypic markers analysis. N=6 
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3.2.7 Positioning of regulatory T cells, dendritic cells and CD8 T cells in the 
human liver 
Multicolour confocal analysis was performed to detect the positioning of liver infiltrating 
regulatory T cells (LITreg) with resident CD11c dendritic cells (Figure 3.14); dendritic cells and 
CD4 and CD8 cells (Figure 3.15). I then went on to perform four colour confocal microscopy to 
investigate the positioning of these three cell types.  LITreg, dendritic cells and CD8 T cells are in 
close proximity at sites of inflammation in both inflamed portal tract and parenchyma (Figure 
3.16). Quantification of each cell types in relation to anatomical distribution of each diseased liver 
studied was shown in Table 3.5. 
  
148 
 
 
 
Figure 3-14 Liver infiltrating Treg and liver resident dendritc cells in inflamed human liver 
portal tract and parenchyma.  
Confocal images of the hepatic parenchyma infiltrate, interface hepatitis (A&B) and portal tract 
(C&D) demonstrating FoxP3 Treg (Red/TRITC) and CD11c dendritic cells (Green/FITC) in 
close proximity in both the inflamed lobule (B) and portal tract (D). Cell nuclei stained with 
DAPI (Grey). Staining from a patient explanted liver tissue who had liver transplantation for 
autoimmune liver disease was shown. P=parenchyma; PT=portal tract.  
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Figure 3-15 Liver infiltrating CD4 and CD8 T cells resides close to resident dendritic 
cells.  
Four colour confocal microscopy of liver infiltrating dendritic cells (Green/FITC), 
CD4(Red/TRITC), and CD8 (Blue/Cy3) T cells in inflamed portal tract (PT) and parenchyma 
(P) in a patient with autoimmune liver disease (A&C) and normal liver (B&D). CD8 and CD4 T 
cells are detected in close proximity with CD11c dendritic cells. P=parenchyma; PT=portal tract. 
Top panel magnificationx25; lower panel magnification=x40 
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Figure 3-16 CD11c dendritic cells, CD8 T cells and FoxP3 Treg in human liver.  
Four colour confocal images of inflamed liver portal tract (PT) and lobular hepatitis in 
parenchymal area (P) showing LITreg, CD11c dendritic cells and CD8 T cells (Figure A). 
Explanted liver tissue from autoimmune hepatitis liver was shown. Figure B is the higher 
magnification of lobular hepatitis in parenchyma (P) and Figure C is the higher magnification of 
portal tract (PT). Figure A was captured with x25 and Figure B&C were captured with x40 
magnification. 
Treg (FoxP3; TRITC, Red), (CD8, Blue, Cy5), (CD11c, Green, FITC); (cell nuclei, DAPI, Grey)
B
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Types of cells Portal Tract Parenchyma Septal area 
CD8 
HCV1 
HCV2 
PBC 
AIH1 
AIH2 
31±7 
26 
35 
34 
38 
22 
18±5 
12 
16 
19 
25 
20 
27±5 
28 
32 
28 
30 
19 
FoxP3 
HCV1 
HCV2 
PBC 
AIH1 
AIH2 
21±4 
19 
23 
18 
28 
18 
5±1 
4 
6 
4 
5 
4 
16±4 
14 
18 
12 
23 
14 
Dendritic cells 
HCV1 
HCV2 
PBC 
AIH1 
AIH2 
23±8 
14 
22 
19 
35 
26 
17±6 
9 
12 
20 
24 
19 
21±8 
8 
21 
24 
30 
23 
 
Table 3-5 Localization and frequency of different cell types in inflamed human liver 
Total numbers of individual cells were counted in high power field of confocal image of liver 
tissues from patients transplanted for chronic hepatitis C, N=2; primary biliary cirrhosis, N=1 
and autoimmune hepatitis, N=2.  
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3.2.8 Liver infiltrating regulatory T cells are functional 
3.2.8.1 Liver infiltrating regulatory T cells suppress proliferation of allogenic T 
responder cells in vitro 
To investigate whether liver infiltrating regulatory T cells are functional, allogeneic 
stimulation/suppression assays were used with 3H thymidine incorporation. These confirmed the 
ability of liver infiltrating Treg to suppress T responder cell proliferation in vitro at ratios of 1 to 4 
(Fig 3.17 and Table 3.6). 
 
Figure 3-17 LITreg are suppressor to autologous T responder cells  
The suppressive function of freshly isolated human liver-infiltrating Treg was assessed by 3H 
thymidine incorporation assay. Liver infiltrating Tregs from diseased livers were freshly isolated 
using the Dynal magnetic Treg isolation kit. Suppression of proliferation was done ratios of 1:16 to 
1:1 freshly isolated liver infiltrating Treg suppress proliferation of autologous CD4 CD25- 
lymphocytes activated by allogenic liver-derived DC (p by Student’s t test * p <0.05, **p<0.005). 
Data represent mean± SEM of 3 independent experiments. 
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Liver 
Treg 
 
T 
responder 
Treg: 
Tresponder
CCPM 
Exp 1 
CCPM 
Exp 2 
CCPM 
Exp 3 
Mean   
 
SEM 
 
100000 100000 1:1 1902 2345 2146 2131 130 
50000 100000 1:2 4078 4354 5420 4617 416 
25000 100000 1:4 4996 5363 6520 5626 467 
12500 100000 1:8 9102 9643 10206 9650 324 
6250 100000 1:16 11102 10904 13120 11708 721 
 
Table 3-6 Suppression of proliferation assay using liver infiltrating regulatory T cells and 
autologous responder cells. 
Freshly isolated liver infiltrating regulatory T cells were used to assess the suppressive function. 
Suppression of proliferation was done ratios of 1:16 to 1:1 freshly isolated liver infiltrating Treg vs. 
autologous T responder cells which were activated by allogenic liver-derived DC. 3H thymidine 
incorporation was used. Data from three diseased livers was shown. Exp= experiment. 
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3.2.8.2 STAT5 signalling in liver infiltrating regulatory T cells 
IL-2 is critical for the differentiation and survival of Treg. Binding of IL-2 to its receptor, 
CD25 on Treg leads to STAT5 phosphorylation which is a critical factor in Treg differentiation and 
expression of FoxP3. Thus, to determine whether Treg within liver tissue are functional, we 
stained for phosphoSTAT5 on serial liver tissue sections and quantified the percentage of FoxP3 
cells which contained phosphoSTAT5. Only 5-15% of the liver infiltrating FoxP3+ cells 
expressed phosphoSTAT5 (Fig. 3.18). 
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Figure 3-18 Presence of phosphoSTAT5 in inflamed human liver 
A-D) Single immunohistochemical staining of formalin-fixed, paraffin-embedded liver sections 
showed phophoSTAT5 staining using monoclonal antibody (shown with arrows, detected as a 
brown pigment) in patients with autoimmune hepatitis (A &C) liver and alcoholic liver disease 
(B). Pictures were taken at x 20 magnification. Control sections are staining was negative (D).  
Percentage of FoxP3 cells which are phosphoSTAT5 positive in normal and inflamed liver is 
shown (E). Serial liver sections were stained with FoxP3 & phosphoSTAT5 antibodies. Numbers 
of positive staining were counted from the same areas and % positivity of phosphoSTAT5 in 
relation to FoxP3 was calculated (n=6 for each diseased livers and normal liver). 
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3.3 DISCUSSION 
The liver is one of the most tolerogenic organs in the body despite being constantly 
exposed to antigens from the gut (Adams & Eksteen, 2006;Adams and HUTCHINSON, 
1997;Knolle and Gerken, 2000). The intrahepatic immune environment exhibits dichotomy as it 
is not only associated with the induction of tolerance but can also mount effective immune 
responses against invading organisms. 
It has been described  that both resident tolerogenic dendritic cells (Knolle & Gerken, 
2000;Munn et al., 2002;Munn, 2002;Thomson & Lu, 1999a) and regulatory T cells play an 
important role in maintaining this tolerance (Sakaguchi, 2005). In addition to passive mechanisms 
of unresponsiveness such as ignorance and anergy, naturally occurring, thymic derived, CD4+ 
CD25high CD127low FoxP3+ Treg are essential in maintaining peripheral tolerance by actively 
suppressing the cytokine production and proliferation of T effector cells (Sakaguchi et al., 
1995;Sakaguchi, 2004). Hence, a thorough examination of the presence, distribution, phenotype, 
function of these liver infiltrating Treg is necessary to determine whether these cells are involved 
in intrahepatic tolerance under homeostatic conditions and in the context of established chronic 
inflammation.  
In an attempt to identify and characterize intrahepatic regulatory T cells, I have utilized 
normal liver tissues from organ donors, normal margins of hepatic resections, and explanted liver 
tissues from individuals who underwent liver transplantation for end-stage liver cirrhosis. I have 
confirmed that Tregs are present within both normal and inflamed human liver tissue characterised 
by three surface markers CD4, CD25high, CD127low as described (Liu et al., 2006;Sakaguchi et al., 
1995;Seddiki et al., 2006). Moreover, > 95% of liver infiltrating CD4, CD25high, CD127low express 
the Treg signature transcription factor FoxP3+, which controls the development and function of 
these cells, as previously reported (Hori et al, 2003). 
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By immunohistochemistry, the infiltrate contained a 4 fold greater proportion of FoxP3+ 
Treg to CD3 cells in chronically inflamed livers compared with non-diseased livers. Indeed, only 
3% of CD3 cells co-expressed FoxP3+ in the normal liver, but up to 15% of CD3 cells in the 
inflamed liver co-expressed FoxP3+. A similar difference in Treg (CD4+CD25+FoxP3+CD127low) 
frequency was noted by FACS analysis of total liver tissues (1.5% vs. 6% of LIL in normal and 
disease livers, respectively). However, fewer Treg were detected by FACS compared with 
immunohistochemistry. One explanation would be that FoxP3+ immuno-reactive cells include 
peripherally induced Treg in TGF-β rich hepatic microenvironment, but this is unlikely as the 
majority of FoxP3+ liver-derived lymphocytes were CD4+CD25+CD127low. More likely, the 
protocol used to isolate liver infiltrating lymphocytes which used a mechanical rather than 
enzymatic digestion to preserve cell surface receptors may not completely retrieve all liver-
infiltrating Treg.  Although the proportions of Treg varied between the two methods, the overall 
results were similar with the highest frequencies detected in patients with fulminant seronegative 
hepatitis, the most florid and destructive form of hepatitis which leads to liver failure. These 
findings suggest that T cell-mediated hepatitis and liver destruction is not a consequence of a 
failure of Treg to infiltrate the liver but rather an inability of the recruited cells to control the 
effector arm of the response.  
FoxP3+ Treg  contribute to viral persistence by suppressing immune response in chronic 
hepatitis B and chronic hepatitis C (Franzese et al., 2005;Stoop et al., 2005) and also inhibit anti-
tumour immune responses mediated by effector CD8 T cells in hepatocellular carcinoma (Fu et 
al., 2007;Unitt et al., 2005). Previous studies have suggested there is an increased frequency of Treg 
in chronic HCV and HBV. However, I did not see higher frequencies compared with 
autoimmune diseases in which it has been described that Treg are reduced in frequency and 
function (Longhi et al., 2004;Longhi et al., 2005b). In fact, I detected higher frequencies of 
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FoxP3+ Treg in autoimmune disease compared with chronic viral infection. A possible explanation 
is that the increased numbers of liver infiltrating Treg are part of a failed regulatory arm in the face 
of mounting effector T cells recruitment and activation but they suggest Treg numbers are not the 
cause of the differential immune responses in autoimmune versus chronic viral infection. 
A higher proportion of the T cells infiltrate in the hepatic parenchyma or inflamed lobules 
were FoxP3+ Treg in autoimmune hepatitis and seronegative hepatitis. On the other hand, other 
chronic liver diseases such as alcoholic liver disease, hepatitis C and primary biliary cirrhosis there 
was high preponderance of  FoxP3+ Treg in portal tracts. This likely reflects the more severe 
lobular inflammation and interface hepatitis in autoimmune hepatitis and seronegative liver 
diseases will require more suppression by regulatory T cells. 
The outcome of hepatic inflammation will be determined by the balance of effectors, and 
regulatory cells activated and recruited to the liver. Chronically inflamed liver is infiltrated by 
effector T lymphocytes including CD4 Th1 and CD8 Th1 cells which play a major role in acute 
and chronic hepatitis (Adams and Hubscher, 2006;Heydtmann et al., 2006;Shields et al., 1999). 
The recently described Th17 has been implicated in autoimmune and chronic inflammatory 
diseases (Annunziato et al., 2007;Harada et al., 2009;Veldhoen et al., 2006). Polarised Th1 cells in 
inflamed liver express distinct chemokine receptors CCR5, CXCR3, CXCR6 (Curbishley et al., 
2005;Heydtmann et al., 2005;Shields et al., 1999). I found that effector T cells and regulatory T 
cells were both recruited at site of hepatic inflammation. CD8 Th1 and CD4 Th1 cells were 
capable of expressing both TNF-α and IFN-γ in hepatic inflammation. However, this potential 
was found after stimulation with PMA and ionomycin ex-vivo and it may not represent the actual 
state of inflamed environment. I also detected both CD4 IL-17 secreting cells (Th17) and CD8 
IL-17 secreting cells (Tc17) after stimulation in different inflammatory liver diseases. 
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Immunophenotyping demonstrated that majority of LITreg are CD45RO memory cells 
consistent with previous studies of other subsets (Heydtmann et al., 2006;Volpes et al., 1991).  
These LITreg cells are CD27high and CD27 expression has been reported as a characteristic of 
tissue-infiltrating Treg in inflamed synovial tissue (Mack et al., 2009;Ruprecht et al., 2005a). 
Moreover, CD39, one of the ectonucleotidases which generate pericellular adenosine from 
extracellular nucleotides is also highly expressed on LITreg.  Binding of adenosine to the adenosine 
A2A receptors on activated T cells will increase the intracellular cyclic AMP in the responder cells 
leading to inhibition of T cell proliferation and IL-2 production (Deaglio et al., 2007;Novak & 
Rothenberg, 1990).  
Analysis of the distribution of Treg in diseased and normal liver tissue demonstrated that 
they are closely associated with CD11c+ DCs and CD8 T cells at sites of inflammation both in 
portal tracts and in the hepatic lobules. Thus, Treg are ideally situated to mediate suppression of 
intrahepatic immune responses. High levels of CD39 expression on FoxP3+ Treg suggest that they 
may need to be in contact with effector cells to maintain full suppression. We have previously 
described that liver dendritic cells preferentially express immunosuppressive IL-10 (Goddard et 
al., 2004b) which may play an important role in Treg mediated suppression. Liver derived dendritic 
cells (Thomson, 2010) and kupffer cells also express indoleamine 2,3-dioxygenase (Munn et al., 
2002;Munn, 2002) which is implicated in Treg mediated suppression. 
Tissue infiltrating Treg have been shown to suppress effectors T cells in other tissues 
(Ruprecht et al., 2005b) and could thus contribute to the local control of ongoing inflammation. 
To confirm the cells I detected in liver tissue were functional, I showed that 
CD4+CD25+FoxP3+CD127low cells from liver tissue suppressed allogeneic responder cells in vitro. 
However, this does not address whether Tregs in tissue are functional.  Thus, although these cells 
are functional in vitro it is possible that their function is suppressed within the liver 
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microenvironment in vivo. In order to investigate this possibility I stained the intrahepatic Treg in 
situ for phosphorylated STAT5.  STAT5 phosphorylation is a consequence of IL-2 binding of its 
receptor, CD25 and thus provides an indication of whether the intrahepatic Treg are activated 
(O'Gorman et al., 2009). STAT 5 has been described as a critical mediator of Treg biological 
activity and STAT5 activation promotes Treg differentiation and function while constraining Th17 
generation. We quantified the numbers of pSTAT5 positive cells in the liver and found that only 
5-15% of the liver infiltrating FoxP3+ cells expressed pSTAT5. Thus it is possible that these 
LITreg are suppressed in situ, possibly by PD-1 dependent mechanisms, as has been proposed for 
chronic HCV infection (Franceschini et al., 2009), allowing the effector arm to drive persistent 
inflammation. However, it is also possible that low proportion of cells staining with 
phosphoSTAT5 may be a reflection of the transient nature of phosphorylation and may not be 
an ideal to investigate the functional property of regulatory T cells. This is the limitation of 
human study and in-vivo study in future may explain these functional aspects of tissue infiltrating 
Treg. 
 Taken it all together, I have shown the presence of functional immunoregulatory Treg cells 
in human hepatic inflammation which express characteristic receptors associated with Treg. The 
frequency and distribution in the hepatic lobules compared with portal tract varies depending on 
the nature of inflammatory liver disease. Surprisingly, I did not find low levels of Treg in 
aggressive autoimmune hepatitis nor did I detect higher frequencies in chronic hepatitis B and C 
infection. Intrahepatic Treg may limit liver injury by controlling inflammation in diseases such as 
autoimmune hepatitis leading to stable chronic inflammation. The most aggressive immune-
mediated disease I studies fulminant hepatitis had the highest frequency of both IFN-γ and TNF-
α expressing T effectors along with FoxP3+ Treg cells at the site of inflammation suggesting both 
subsets are recruited. The question remains whether the regulatory arm of intrahepatic 
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lymphocytes is functioning properly or more dominating effector arms plays a role still needs 
further investigations.  
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CHAPTER 4 RECRUITMENT AND 
POSITIONING OF REGULATORY T 
CELLS IN INFLAMED HUMAN LIVER 
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4.1 INTRODUCTION 
The hepatic tolerogenic environment is required to suppress immune activation as a 
consequence of constant antigen exposure from the gut. Several mechanisms maintain this 
tolerogenic environment including tolerogenic hepatic dendritic cells and the tolerogenic 
consequences of antigen presentation by other liver cell types including sinusoidal endothelium 
and stellate cells.  It has recently become apparent that regulatory T cells also play an important 
role in controlling intrahepatic immune responses (Crispe, 2009). Naturally occurring, thymic 
derived CD4, CD25high FoxP3+ (Sakaguchi, 2004), CD127low (Liu et al., 2006;Sakaguchi, 
2005;Seddiki et al., 2006) Treg are present in the inflamed liver and suppress effector cell 
proliferation and cytokine production at sites of intrahepatic inflammation. As mentioned in the 
previous chapter, Treg are crucial in maintaining peripheral immune tolerance to self antigen and 
in the context of the liver this includes food antigens from the gut and antigens generated by 
metabolism by hepatocytes.  They also limit immune responses to infection to prevent persistent 
inflammation and autoimmunity and in this context a defect in Treg function has been associated 
with autoimmune hepatitis and over active Treg has been implicated in the failed immune 
response and persistent infection in chronic hepatitis B and C infection. 
In the healthy organism Treg suppress effector T cell activation in secondary lymphoid 
tissues to maintain steady-state self-tolerance. However in chronic inflammatory states such as 
autoimmune hepatitis, effector T cells are activated in local secondary lymphoid tissues by 
dendritic cells which take up, process and transport antigen from the site of infection or 
inflammation. Thus, when steady-state self-tolerance is breached as a consequence of infection or 
chronic inflammation Treg become further activated to allow their migration into peripheral tissue 
where they limit local bystander and collateral damage.  
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Treg are detected at sites of inflammation where they suppress immune responses locally 
(Belkaid, 2008;Cao et al., 2003;Ruprecht et al., 2005b;Strauss et al., 2007;Tang & Bluestone, 
2008;van Amelsfort et al., 2004). As naturally occurring regulatory T cells are generated in the 
thymus, their presence in the liver implies they are recruited from the blood to the site of hepatic 
inflammation to limit immune damage.  
Lymphocyte subsets including Treg display distinct migratory behaviour which is 
determined by their ability to respond to chemokine and adhesion molecule which provide a 
tissue “post code” and this in turn depends on the presence of specific combinations of adhesion 
receptors and chemokine receptors on the Treg.  The ability of activated lymphocytes to enter 
peripheral tissues such as the liver requires the downregulation of the chemokine receptor CCR7 
and adhesion molecule L-selectin that promotes entry to secondary lymphoid tissues and the 
expression of receptors such as CXCR3 and CCR5 and the integrins LFA-1 and VLA-4 which 
allow the cell to respond to signals at sites of inflammation. Chemokines secreted by the damaged 
tissues or local innate immune cells such as dendritic cells at the sites of inflammation are crucial 
in directing the recruitment and positioning of effector cells and regulatory lymphocytes.   
Our group has previously shown that CCR10 expressing Treg home to inflamed bile ducts 
in response to the chemokine CCL28 in the human liver (Eksteen et al., 2006). Moreover, our 
previous work demonstrated that CXCR3 and CCR5 are highly expressed on liver infiltrating 
lymphocytes (Shields et al., 1999;Shields and Adams, 2002) and can promote transendothelial 
migration through liver sinusoids. In other tissues the CCR4 chemokine receptor has been 
implicated in directing Treg recruitment in inflamed tissue particularly skin (Cavassani et al., 
2006;Iellem et al., 2001a;Iellem et al., 2003) but also the joint, mouth (Cardoso et al., 2008a), 
breast,  inflamed gut(Enarsson et al., 2006;Gobert et al., 2009;Yuan et al., 2007), and cardiac 
allograft tolerance(Lee et al., 2005b). 
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Chemokines are critical for directing the recruitment of both innate and adaptive immune 
cells including Treg to the site of inflammation. They are involved in homeostatic and 
inflammatory trafficking so that Treg are recruited appropriately to lymphoid tissues and to sites of 
inflammation. Chemokines modulate migration by activating integrins to allow them to bind their 
ligands and mediate lymphocyte adhesion, arrest under flow and subsequent transmigration. They 
also activate small GTPases resulting in cytoskeletal reorganization and the induction of a motile 
migratory phenotype. Different combinations of chemokines, chemokine receptors, integrins and 
their ligands provide an address/post code to which Treg expressing the appropriate receptors can 
respond. In the context of hepatic inflammation we have reported that CXCR3 ligands are 
expressed and presented on activated human hepatic sinusoidal endothelium at sites of 
inflammation where they can operate to recruit effector cells expressing the CXCR3 receptor 
(Curbishley et al., 2005). In support of the importance of this pathway the CXCR3 chemokine 
receptor is highly expressed on liver infiltrating T cells including the CCR10+ Treg population 
(Eksteen et al., 2006). 
Dendritic cells are professional antigen presenting cells with the ability to fully activate 
naive T cells and thereby to shape the outcome of immune activation. They are involved in 
immune homeostasis, helping to maintain surveillance without triggering inappropriate activation 
by self-antigens and also implicated in immunopathology. They take up, process and present 
sampled antigen from peripheral tissue and present the antigen to both effector and regulatory 
lymphocyte in draining lymph nodes. Dendritic cells are also targets of Treg mediated suppression. 
CTLA-4 (CD152) and lymphocyte activation gene 3 (LAG3) which are expressed by Treg allow 
the Treg to interact with CD80 and CD86 costimulatory molecules expressed by dendritic cells. 
These interactions result in contact dependent suppression of immune responses (Huang et al., 
2004;Sakaguchi, 2005) partly by downregulating CD80 and CD86 on DC (Wing et al., 2008) and 
hampering activation of other T cells by DC. Antigen-activated Treg also exert suppression by the 
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formation of  LFA-1-dependent aggregates which can prevent the activation of immature DCs 
thus preventing antigen-reactive naïve T cells from being activated resulting in specific immune 
suppression (Onishi et al., 2008). 
Although the phenotype of blood Treg has been described, little is known about the 
chemokine receptors involved in recruitment and positioning of Treg in chronically inflamed 
human tissues. I hypothesised that chemokine receptors regulate regulatory T cells recruitment 
and positioning in inflamed liver. 
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4.2 RESULTS 
4.2.1 Chemokine receptor expression on liver infiltrating Treg  
Chemokine receptor expression on liver infiltrating lymphocytes was investigated by 
using multi-colour flow cytometry. Liver infiltrating regulatory T cells were defined by surface 
markers CD4, CD25high, CD127low. More than 95% of the cells in this population expressed 
transcription factor FoxP3. Fresh liver infiltrating lymphocytes from explanted liver were isolated 
using mechanical digestion instead of collagenase to preserve cell surface chemokine receptors 
(Shields et al., 1999;Shields & Adams, 2002). This is followed by density gradient separation over 
lympholyte to obtain the liver infiltrating lymphocytes. A panel of antibodies against chemokine 
receptors (CCR1-CCR10; CXCR1-CXCR6) along with Treg surface markers and FoxP3 were used 
to stain fresh liver infiltrating lymphocytes. The results for chemokine receptors expression on 
freshly isolated liver-derived Treg are shown (Figure 4.1).  
4.2.2 Higher expression of CCR4 & CXCR3 in inflamed liver infiltrating Treg 
Approximately 20% (20±5% STD) of liver-infiltrating Treg expressed CCR7. The majority 
of LITreg expressed CCR4 (74±7% SD) and CXCR3 (67±9%SD) (Fig, 4.1). Furthermore, the 
levels of these receptors were higher on liver-infiltrating Treg isolated from inflamed liver 
compared with normal liver tissue; (74±7%SD) % vs (32±7SD) % for CCR4 and (67±9% SD) vs 
(21± 6%SD) for CXCR3 (both p≤ 0.05).  
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Figure 4-1 Chemokine receptors expression on liver infiltrating regulatory T cells.  
Freshly isolated disease liver infiltrating lymphocytes were stained with regulatory T cells marker 
CD4, CD25, CD127 and FoxP3. CD4+CD25highCD127lowFoxP3+ Treg were gated for the analysis 
and this gating was applied to chemokine receptor staining and compared with control. As shown 
in the figure, the percentage of LITreg expressing CCR4 and CXCR3 were much higher compared 
to other chemokine receptors. CCR7 expression was also detected and there is also moderate 
level expression of CCR5, CCR6, CCR9, CCR10, CXCR4 and CXCR6.  Data represents 
mean±SEM for 6 experiments from patients transplanted for primary biliary cirrhosis, 
autoimmune hepatitis, alcoholic liver disease, cryptogenic cirrhosis. 
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4.2.3 CCR4 and CXCR3 expression in human liver 
Similar proportion of liver infiltrating Treg or liver-infiltrating CD4+CD25low effector cells 
expressed CXCR3 (Figure 4.2) but more liver infiltrating Treg expressed CCR4 (74%) compared 
with liver-infiltrating CD4+CD25low cells from diseased livers (40%) suggesting that CCR4 is 
preferentially expressed on liver-infiltrating Treg (Figure 4.2). 
 
Figure 4-2 High expression of CCR4 and CXCR3 on liver infiltrating regulatory T cells.  
CXCR3 expression on LITreg was analysed with flow cytometry. The expression of CXCR3 on 
LITreg was compared with liver infiltrating CD4+ CD25low  in diseased livers and there was no 
difference in expression between LITreg  67% (±4SEM)  and CD4+ CD25low  68% (±3SEM). 
However, significantly higher expression of CXCR3 was observed on diseased LITreg compared 
to normal liver (67% vs. 21%). Data represent mean ±SEM of 4 experiments.  
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4.2.4  CXCR3 and CCR4 expression in matched samples. 
Circulating and liver-derived Treg of patients from matched blood and liver samples were 
compared to detect whether CCR4 and CXCR3 have higher expression in inflamed liver (Fig 
4.3). 82±7 % of liver-infiltrating Treg stained for CCR4 vs. 67±6 % in matched blood Treg and 
66±6% of liver-infiltrating Treg stained for CXCR3 compared with 43±7% of matched blood Treg  
(P<0.05).  
 
Figure 4-3 Expression of CCR4 and CXCR3 in matched patients.  
CCR4 expression overlay histogram in peripheral blood Treg and liver Treg in matched patient who 
underwent liver transplantations (A) and percentage expression of CCR4 in matched samples (B). 
Figure (C) showed CXCR3 expression overlay histogram in matched patient and and CXCR3 
frequency on peripheral blood Treg and LITreg from explanted livers in same patients. Cells were 
gated on CD4high, CD25high CD127low FoxP3+. 5 matched donors were studied. 
*
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4.2.5 Co-expression of CXCR3 and CCR4 chemokine receptor on liver 
infiltrating regulatory T cells. 
Once I have shown that CCR4 and CXCR3 are expressed at higher levels on a high 
proportion of liver-infiltrating Treg, I then investigated whether they are co-expressed on the same 
cells or whether there were two sub-populations of liver-infiltrating Treg each expressing 
individual receptor.  More than 75% of liver-infiltrating Treg co-express CCR4 and CXCR3 
(Fig.4.4).  
 
 
Figure 4-4 Co-expression of CCR4 and CXCR3 in liver infiltrating regulatory T cells.  
Flow cytometry dot plot showing co-expression of CXCR3 and CCR4 on liver infiltrating 
regulatory T cells. Freshly isolated liver infiltrating lymphocytes are labelled with CD4, CD25, 
CD127, FoxP3 and chemokine receptors CCR4 and CXCR3. Liver-infiltrating lymphocytes were 
gated on CD3+CD4+CD127lowCD25high (left panel) and this gating was applied to CCR4 PE(Y 
axis) and CXCR3 APC (X axis) confirming co-expression of two chemokine receptors on the 
same cell in approximately 75% of the liver infiltrating Treg (right panel). One representative 
experiment of 5 is shown. Control antibody staining is shown in middle panel. 
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4.2.6 CXCR3 expression on LITreg does not correlate with the proportion of 
liver infiltrating Th1 cells. 
Because CXCR3 ligands are IFN-γ dependent we looked for a correlation between the 
expression of CXCR3 on liver infiltrating Treg and infiltrating IFN-γ secreting CD4 and CD8 cells 
(Figure 4.5). I used intracellular cytokine staining and flow cytometry to analyse TNF-α and IFN-
γ expression by CD4 and CD8 cells after PMA and ionomycin stimulation and correlated the 
frequency of these cells with levels of CXCR3 on LITreg from the same liver sample. Inflamed 
liver contained a similar proportion of IFN-γ and TNF-α secreting CD4 and CD8 cells compared 
with normal liver although as the total infiltrate is far greater in diseased livers (Figure 4.6). 
CXCR3 expression on Treg from normal liver ranged from 15-28% and from diseased liver 
between 60-80 % (Figure 4.6). The highest levels of CXCR3 were detected on Treg from severe 
seronegative hepatitis where CD8 IFN-γ and CD8 TNF-α secretion were highest as well (Figure 
4.6). However, there was no overall correlation between CXCR3 expression on Treg and CD4 and 
CD8 Th1 cytokine secretion (Figure 4.6) 
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Figure 4-5 CD8Th1 and CD4Th1 cytokine expression in chronically inflamed liver.  
Flow cytometry from a diseased liver (seronegative hepatitis) is shown to demonstrate IFN-γ 
expressing CD4 and CD8  (A&B) and TNF-α expressing CD4 and CD8 (C&D). Cells were gated 
on liver infiltrating CD3 lymphocytes. (Representative example from a patient with seronegative 
hepatitis was shown). 
  
A 
C D
B
174 
 
 
Figure 4-6 No correlation between LITreg CXCR3 expression and TNF-α and IFN-γ 
expression on liver infiltrating CD4 and CD8 cells.  
Flow cytometry analysis of matched cells from the same liver samples on both diseased and 
normal liver was performed to determine the correlation between the levels of CXCR3 
expression by liver-infiltrating Treg and TNF-α and IFN-γ expression by liver-infiltrating CD4 and 
CD8 effector cells. The percentage of liver-infiltrating CD8 and CD4 T cells expressing TNF-α 
and IFN-γ is shown on the x axis and the frequency of CXCR3% Treg (CD4+CD25highCD127low) 
isolated from the same donor liver and analysed without expansion is shown on the y axis. Data 
from 4 normal livers and 4 diseased livers (autoimmune hepatitis, primary biliary cirrhosis, 
alcoholic liver disease and nonAnonB hepatitis) are shown. There was no clear correlation 
between CXCR3 frequencies in the Treg population and cytokine secretion by T effectors. Treg 
were gated on CD4,CD25highCD127low. Intracellular cytokine, TNF-α and IFN-γ staining was 
performed by incubating liver infiltrating lymphocytes with PMA and ionomycin for 5 hours with 
Brefeldin A Golgi block in the last 2 hours followed by intracellular cytokines staining. 
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4.2.7 Recruitment of Treg is dependent on VLA-4 and CXCR3 
The immunophenotyping revealed that CXCR3 is expressed at high levels on most liver 
infiltrating Treg (67%±9 SD). We have previously shown that liver infiltrating lymphocytes also 
expressed high levels of CXCR3 in the inflamed livers and CXCR3 ligands, CXCL9, CXCL10 
and CXCL11 are expressed at high levels on hepatic sinusoids in vivo and on TNF-α and IFN-γ 
stimulated human sinusoidal endothelial cells in vitro (Curbishley et al., 2005). The integrin ligands 
ICAM-1 and VCAM-1 are also expressed on HSEC in response to TNF-α and IFN-γ stimulation 
(Lalor et al., 2002b). In the following studies I used the flow-based adhesion assays to determine 
the function of CXCR3 and integrins in peripheral blood derived Treg interactions with 
endothelium.  
I have previously phenotyped both peripheral blood and liver derived regulatory T cells in 
patients who underwent for liver transplantation and observed that chemokine receptors CXCR3 
and CCR4 are highly expressed on the both peripheral blood Treg and liver infiltrating Treg but 
liver Treg has higher expression of these chemokine receptors. Peripheral blood derived Treg were 
used for flow based adhesion assay to study the recruitment cascade. PBTreg were the closest to 
represent hepatic sinusoidal Treg for the recruitment process as lymphocytes including regulatory 
T cells flow across hepatic sinusoid, adhere and transmigrate across the human sinusoidal 
endothelium to the site of liver inflammation. Thus, peripheral blood regulatory T cells were 
freshly isolated with CD4 CD25 magnetic beads for flow based adhesion experiments and kept in 
IL-2 (50U/ml) before the experiments and resuspended in basal endothelial flow assay media just 
before the experiment.   
The basal levels of Treg adhesion on TNF-α and IFN-γ stimulated HSEC was 157±15 SD 
cells//mm2/106 perfused and this was reduced by about 60% following pre incubation of Treg 
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with anti CXCR3 mAb for 30minutes (p≤0.001) (Figure 4.7). A similar level of inhibition was 
seen when Treg were pre-treated with pertussis toxin (p≤ 0.004). This suggests that CXCR3 is the 
dominant receptor involved in the adhesion of Treg to stimulated HSEC. Adhesion was also 
significantly reduced to 30% by blocking antibodies to VCAM-1 (the ligand for VLA-4). In 
contrast, antibody to ICAM-1 on HSEC did not significantly reduce adhesion and blocking both 
these integrin ligands together did not increase blockade over the use of anti-VCAM-1 alone 
suggesting that VCAM-1 is the dominant integrin ligand mediating adhesion (Figure 4.7 and 
Figure 4.8). 
  I then calculate the proportion of adherent Treg which subsequently underwent 
transendothelial migration across HSEC under condition of flow. On average, 37% of adherent 
Treg transmigrated across HSEC within 5 minutes of initial adhesion. This was reduced 
significantly by incubation with anti-CXCR3 mAb or pertussis toxin applied to Treg for 30 
minutes (p<0.05 for both). Addition of anti-VCAM-1 mAb to HSEC for 30 minutes also 
reduced the transmigration of adherent Treg but this did not reach statistical significance (average 
31%) and no significant effect was noticed with anti-ICAM-1 blockage (Figure 4.9).  
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Figure 4-7 The effect of antibodies raised against CXCR3, integrin ligands and pertussis 
toxin on the adhesion of regulatory T cells.  
CXCR3 inhibition with a function blocking antibody or PTX (Gi protein block) significantly 
reduces the total adhesion of regulatory T cells to 24 hours TNF-α and IFN-γ stimulated HSEC. 
Adhesion was further reduced by the addition of blocking antibodies against ICAM-1/VCAM-1. 
Data represent number of adherent Treg/mm2/106 perfused and are the mean ±SEM of five 
experiments. All experiments are performed at a flow rate of 0.182ml/min (0.05Pa), which is 
equivalent to sheer stress at hepatic sinusoid. Statistical significance was calculated using paired 
T-tests, comparing treatment with control. (* =p≤0.05; **=p ≤0.005) 
 
Figure 4-8 Adhesion of Treg on stimulated primary hepatic sinusoidal endothelium 
Adherent Treg on control HSEC (A) and reduction of adherent Treg with Pertussis block (B), anti-
CXCR3 block (C) and anti-VCAM block (D). 
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Figure 4-9 The effect of antibodies raised against CXCR3, integrin ligands and Pertussis 
toxin on the transmigration of regulatory T cells.  
CXCR3 inhibition with a function blocking antibody or PTX (Gi protein block) significantly 
reduces the transmigration of regulatory T cells to 24 hours TNF-α and IFN-γ stimulated HSEC. 
Transmigration was also reduced by the addition of blocking antibodies against ICAM-1/VCAM-
1. Data represent number of adherent Treg/mm2/106 perfused and are the mean ±SEM of five 
experiments. All experiments are performed at a flow rate of 0.182ml/min (0.05Pa), which is 
equivalent to sheer stress at hepatic sinusoid. Statistical significance was calculated using paired 
T-tests, comparing treatment with control.(*=p≤0.05) 
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4.2.8 Effect of individual CXCR3 chemokines on Treg recruitment 
The activation of CXCR3 on Treg could be mediated by the three CXCR3 ligands, namely 
CXCL9, CXCL10 and CXCL11 all of which are found on sinusoidal endothelium. I therefore 
studied the effect of blocking antibodies to the individual ligands. Peipheral blood derived 
regulatory T cells were used for these experiments to mimic the normal physiological process as 
described before. HSEC are stimulated for 24 hours with TNF-α and IFN-γ and incubated with 
individual CXCR3 receptor chemokines block, anti-CXCL9, anti-CXCL10 and anti-CXCL11 for 
30 minutes before the flow based adhesion assay. The basal adhesion of peripheral Treg was 
around 150 adherent Treg/mm2/106 perfused similar to the previous assay and this was taken as 
100%. Inhibiting the individual chemokines reduced both adhesion (Figure 4.10) and 
transmigration (Figure 4.11) however it did not reached to statistical significance. However, 
significant inhibition was only achieved when CXCR3 was blocked (Figure 4.7 & 4.9) suggesting 
there is redundancy in the system and all CXCR3 chemokines contribute in combination or in a 
serial cascade for Treg recruitment. 
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Figure 4-10. Effect of Individual CXCR3 chemokines block on total adhesion of Treg.  
To investigate the individual effect of CXCR3 ligands, anti-CXCL9-11 were blocked individually 
on 24 hours stimulated HSEC. Adhesion was calculated using frame by frame analysis of 
experiment videos to count the percentage of cells which are adhered to HSEC. Individual 
chemokine blockade reduce the adhesion of Treg to stimulated endothelium. Data represent 
mean± SEM of four experiments. All experiments were performed at 0.05Pa. 
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Figure 4-11 Effect of Individual CXCR3 chemokines block on transmigration of Treg.  
To investigate the effect of individual CXCR3 ligands on transmigration, anti-CXCL9-11were 
blocked individually on stimulated HSEC. Transmigration was calculated using frame by frame 
analysis of experiment videos to count the percentage of adherent cells which transmigrated 
across the HSEC. Individual chemokine blockade reduce the transmigration of Treg to stimulated 
endothelium. Data represent mean± SEM of four experiments. 
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4.2.9  Expression of CCR4 ligands on liver infiltrating dendritic cells 
CCR4 is the other chemokine receptor which is highly expressed on liver infiltrating Treg 
and it is co-expressed with CXCR3 on more than 75% of LITreg. CCR4 has two ligands, CCL17 
and CCL22.  Immunohistochemistry was used initially to localise the source of the CCR4 ligands 
in human liver tissue. Expression of CCL22 could be detected in inflammatory liver diseases 
although it was not abundant (Figure 4.12) and staining was restricted to dendritic like cells at 
areas of active inflammation including portal infiltrates, interface hepatitis and lobular hepatitis 
within the parenchyma. There was very little detectable staining on normal liver tissue and 
staining with control antibody was negative. I was unable to detect CCL17 and CCL22 in normal 
liver tissue but CCL17 chemokine were detected in chronically inflamed liver tissue by western 
blotting (Figure 4.12).  
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Figure 4-12 Protein expression of CCL22 and CCL17.  
(A) Expression of CCL22 in human liver tissue samples by immunohistochemistry. Staining 
pattern of CCL22 is on liver infiltrating dendritic cells (LIDC) within inflammatory infiltrates 
(positive staining cells shown with arrows) in a patient with autoimmune hepatitis. Image was 
taken at x40 magnification.                                                                                                                     
(B) Detection the presence of CCL17 was observed in whole liver lysates not on HSEC lysates. 
Western blot analysis of CCL17 in liver tissue lysate from different chronic liver diseases and 
either unstimulated (Unstim) or TNF-α/IFN-γ stimulated HSEC (Stim) cell lysate.  CCL17 is 
present in chronically inflamed diseased livers but could not be detected in normal liver tissue 
lysates or in lysates of HSEC. NASH = non-alcoholic steatohepatitis; AIH = autoimmune 
hepatitis; NANB = nonAnonB seronegative hepatitis; PSC = primary sclerosing cholangitis; PBC 
= primary biliary cirrhosis; NL = normal liver. HSEC Unstim = HSEC unstimulated and HSEC 
Stim = HSEC stimulated with TNF-α and IFN-γ.   
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Co-localisation of CD11c+ dendritic cells and CCL22 chemokine in inflamed liver tissue 
was confirmed by dual immunofluorescence (Figure 4.13). Moreover, CCL22 staining are present 
in the same areas with CD11c+ dendritic cells in immunohistochemistry staining in serial liver 
tissue sections (Figure 4.14). 
 
Figure 4-13 Co-expression of CD11c and CCL22 in diseased liver tissues. 
Liver infiltrating CD11c+ dendritic cells expression of CCL22 chemokine was confirmed by co-
localisation of TexRed-labelled CD11c dendritic cells (A) with FITC labelled CCL22 (B). Areas 
of co-expression appeared as yellow (C). DAPI=Blue. Staining with control antibody was 
negative. Pictures were taken at X20 lens. The results are representative of the pattern of 
immunofluorescence staining seen in tissue sections from donors with PBC, ALD, AIH. 
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Figure 4-14. Co-localisation of dendritic cells and CCL22 in inflamed liver tissue. 
Serial liver sections are stained with CD11c (Figures A&B, B is the higher magnification of A) 
and CCL22 (Figures C&D, D is the higher magnification of C). CCL22 staining was detected in 
the same areas as CD11c (B&D). Images were taken at x10 lens (A&C) and x20 lens (B&D). 
Images were taken from a patient with primary biliary cirrhosis. 
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4.2.10 De novo synthesis and secretion of CCR4 ligands by liver infiltrating 
dendritic cells. 
To confirm the immunohistochemistry finding of CCR4 ligands expression by dendritic 
cells. I initially used RT-PCR to detect mRNA from stimulated and unstimulated liver infiltrating 
myeloid dendritic cells isolated from diseased livers. Neither stimulated (TNF-α + IFN-γ) nor 
unstimulated HSEC low passage (passage1-2) or high passage (passage4-6) showed any detectable 
staining or mRNA suggesting that CCL17 and CCL22 are absent from HSEC. However, de novo 
synthesis of CCL17 and CCL22 was detected by disease liver infiltrating dendritic cells (LIDC) 
both unstimulated and stimulated with lipopolysaccharide (Figure 4.15). 
To detect the secretion of CCR4 ligands by liver infiltrating dendritic cells, ELISA was 
performed on supernatants collected from liver infiltrating dendritic cells which were stimulated 
with LPS 1µg/ml for 24 hours. Compared with normal liver, DC from diseased livers secreted 
more of both chemokines stimulated and unstimulated (P≤0.05) (Figure 4.16). 
  
187 
 
 
Figure 4-15  Measurement of CCR4 ligand transcript in HSEC and liver infiltrating 
dendritic cells. 
De novo synthesis of CCR4 ligands, CCL17 and CCL22 by liver-derived DC was confirmed by 
RT-PCR.  Liver infiltrating myeloid DCs (LIDC) were isolated from liver tissue from patients 
with autoimmune hepatitis (AIH) and primary biliary cirrhosis (PBC) and analysed either 
unstimulated (U) or after stimulation (S) with lipopolysaccharides (LPS). Monocyte-derived TNF-
α activated DCs (MoDC) are shown as a positive control. CCL17 and CCL22 mRNA was 
detected in diseased liver-infiltrating DCs (LIDC) but not on HSEC. Representative data from 
one of three experiments is shown (HSEC= Hepatic sinusoidal endothelial cells low passage; 
HSEC= Hepatic sinusoidal endothelial cells high passage; LIDC= Liver infiltrating dendritic 
cells) CCL17=270bp; CCL22 363bp. 
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Figure 4-16 Measurement of CCR4 ligands CCL17 & CCL22 production by liver 
infiltrating dendritic cells following stimulation with LPS. 
In order to determine the CCL17 & CCL22 production, primary liver infiltrating dendritic cells 
are cultured and stimulated them with LPS (1µg/ml) for 24 hours. CCL17 (TARC) and CCL22 
(MDC) proteins levels were measured in cultured supernatant by sandwich ELISA. Experiments 
reflect liver infiltrating dendritic cells isolated from 3 donors (2X AIH; 1PBC) and assays 
conducted in triplicates. Results were expressed as mean± SEM. * P< 0.05, ** P< 0.005. Statistical 
significance was determined using Student’s t test comparing normal and diseased livers. 
Stim=stimulated with LPS, Unstim=unstimulated. 
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4.2.11 CCR4 receptor on liver infiltrating Treg  is functional 
To confirm that CCR4 on freshly isolated liver-infiltrating Treg is functional, I used a 
chemotaxis assay to study responses to CCL17 and CCL22 using fresh LITreg (Fig 4.17). The 
chemotactic indices for CCL17 and CCL22 were around 3 times compared to control and this 
increase was inhibited by pertussis toxin. Liver-infiltrating Treg were phenotyped before the 
chemotaxis assays and confirmed that more than 75% expressed CCR4. 
 
Figure 4-17 Chemotaxis of LITreg to CCL17 and CCL22 demonstrating CCR4 is 
functional.  
Liver-infiltrating Treg migrate towards CCR4 ligands in vitro. Migration of liver-infiltrating Treg to 
CCR4 ligands, CCL22 and CCL17 was assessed using fibronectin-coated 5µm pore transwell 
migration chambers. The lower chambers were filled with 600µl assay media (RPMI medium with 
0.1% BSA; Sigma-Aldrich) alone or supplemented with chemokines (100 ng/ml recombinant 
human CCL22 and CCL17 from R&D Systems). 0.1%BSA was used as control. A total of 5x105 
Treg isolated from inflamed livers (n=4) were loaded per well in the upper chamber; experiments 
were done in duplicates. Treg were collected from the top and bottom chambers after 5 hours 
incubation at 37°C in 5% CO2. The proportion of transmigrated cells was calculated by fixed 
volume counting and phenotyped for Treg markers and chemokine receptor expression by flow 
cytometry. To inhibit chemokine-mediated signalling LITreg were incubated with pertussis toxin 
(100 ng/ml; Sigma Aldrich Ltd) prior to the assay. Results are expressed as mean ± SEM.  LITreg 
showed significant migration to CCL22 and CCL17 which was inhibited by pertussis toxin 
compared with migration to BSA (*= p<0.05). Phenotyping of the migrated LITreg in the lower 
chamber revealed they were CCR4+.  
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4.2.12 Close proximity of liver infiltrating dendritic cells, T effector cells & 
regulatory T cells. 
Regulatory T cells exert their suppressive function on T effectors cells via many 
mechanisms, contact dependent and also operate through effects on antigen presenting cells such 
as dendritic cells. Therefore, Treg need to be close to T effector cells and dendritic cells to 
function efficiently. Confocal analysis in inflamed human liver tissue suggested that liver 
infiltrating Treg are in close vicinity to effectors and dendritic cells (Figure 4.18). Table 3.5 in 
Chapter 3 showed the quantitative analysis of these cells types in different liver diseases. 
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Figure 4-18 CD11c dendritic cells, CD8 T cells and FoxP3 Treg in human liver.  
Confocal image of inflamed liver portal tract and parenchyma autoimmune hepatitis liver. Treg 
(FoxP3; TRITC, Red), (CD8, Blue, Cy5), (CD11c, Green, FITC); (cell nuclei, DAPI, Grey). 
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4.3 DISCUSSION 
Regulatory T cells operate at sites of inflammation in peripheral organs as well as in 
secondary lymphoid tissues (Tang & Bluestone, 2008;Walker et al., 2003). At inflammatory sites 
they mediate bystander and antigen-specific suppression of local immune responses to prevent 
collateral tissue damage in response to injury and infection (Holmen et al., 2006;Ni et al., 
2006;O'Connor et al., 2007). The outcome of chronic inflammation is the result of a balance 
between pro and anti-inflammatory responses in which Treg maintain stable chronic inflammation 
whilst preventing fulminant destructive inflammation (Westendorf et al., 2005). This is 
particularly important in liver disease where intrahepatic Treg are detected in chronic hepatitis 
from a variety of causes (Lan, 2006;Longhi et al., 2005a;Rushbrook et al., 2005). The frequency 
and function of intrahepatic Treg has been reported to affect the outcome of chronic infection 
with hepatitis B and C viruses and to be associated with suppression of anti-tumour immune 
response in hepatocellular carcinoma (Rushbrook et al., 2005;Unitt et al., 2005). 
The migration and positioning of leukocytes in tissues during homeostasis and in response 
to inflammation is controlled by the coordinated expression of adhesion molecules and 
chemokine receptors that determine a) where and when cells will be recruited via endothelium b) 
their subsequent migration and positioning in tissue. Little is known about the molecular control 
of Treg recruitment to inflamed tissues although this will be critical in defining their role in disease 
and in developing strategies for their therapeutic use. In order to determine the receptors 
responsible for the recruitment of Treg to human liver we compared chemokine receptor 
expression on liver-derived Treg (analysed straight from liver tissue without expansion) with 
blood-derived Treg isolated from the same patient at the time of liver transplantation. Two 
receptors in particular were over-expressed on liver-infiltrating cells, CXCR3 and CCR4 with the 
majority of liver-infiltrating Treg in chronic inflammatory liver diseases expressing both receptors. 
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CXCR3 has been reported on circulating human Treg (Lim et al., 2006;Lim et al., 2008) where its 
expression is presumed to favour homing to inflamed tissue sites. Our data confirmed that this is 
the case because the majority of Treg in inflamed human liver expressed high levels of functional 
CXCR3 which promoted their transmigration across liver endothelium under flow. We found 
only 15-20% of Treg in normal liver expressed CXCR3 which further supports its particular role in 
the recruitment of Treg to sites of inflammation. Levels of the CXCR3 ligands are low to 
undetectable in normal liver but markedly increased in inflammatory liver diseases (Curbishley et 
al., 2005;Harvey et al., 2003). 
In chronic inflammatory liver disease the CXCR3 ligands CXCL9, CXCL10 and CXCL11 
are increased as a consequence of secretion by hepatocytes, stroma cells and endothelium.  They 
can be readily detected on the glycocalyx of sinusoidal vessels (Narumi et al., 1997;Shields et al., 
1999;Tamaru et al., 2000) where they promote the transendothelial migration of effector T cells 
(Curbishley et al., 2005). We have developed an in vitro flow-based adhesion assay in which 
primary cultures of human sinusoidal endothelial cells (HSEC) are grown in microslides under 
physiological levels of shear stress to model the hepatic sinusoid (Curbishley et al., 2005). 
Treatment of the HSEC with TNF-α and IFN-γ induces expression of CXCL9, CXCL10 and 
CXCL11 as well as the adhesion molecules ICAM-1 and VCAM-1 thereby recapitulating the 
phenotype of chronically inflamed sinusoids in vivo (Curbishley et al., 2005). In the present study 
we used this assay to determine the role of CXCR3 on liver-infiltrating Treg. We found that 
signalling through CXCR3 not only activated integrin-mediated arrest from flow but also 
promoted the transendothelial migration of Treg across inflamed hepatic sinusoidal endothelium. 
The fact that a similar degree of inhibition to both processes was seen when either a blocking 
CXCR3 antibody or the Gα protein inhibitor pertussis toxin used suggests that CXCR3 is the 
dominant chemokine receptor involved. In the in vitro flow assays all three CXCR3 ligands were 
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involved because blocking individual chemokines had a lesser effect than blocking the common 
receptor CXCR3. These findings are consistent with studies in murine models of inflammatory 
disease that report the requirement for CXCR3 expression to allow Treg to be recruited to 
inflamed tissues in GVHD (Hasegawa et al., 2008) and to the brain in EAE (Muller et al., 2007). 
Recently CXCR3 has been implicated in the recruitment of Treg into the murine liver in response 
to inflammation and IFN-γ production from NKT cells (Santodomingo-Garzon, 2008). Thus 
interferon-inducible chemokines CXCL9 and CXCL10 expressed on inflamed hepatic sinusoidal 
endothelium promote the recruitment of both effector cells and CXCR3 expressing Treg under 
shear stress. A difference between the behaviour of effector cells and Treg was the involvement of 
VCAM-1 but not ICAM-1 in adhesion of Treg to HSEC whereas effector cells used ICAM-1. 
The other chemokine receptor that was strongly over-expressed on liver-infiltrating Treg 
was CCR4 which was co-expressed with CXCR3 in nearly 80% of Treg from chronically inflamed 
livers. Liver-derived Treg migrated to the CCR4 ligands CCL17 and CCL22 in vitro demonstrating 
that the receptor is functional. CCR4 expression has been associated with Treg and shown to 
control migration and immune suppression in the skin (Iellem et al., 2001b;Sather et al., 2007) 
and also in immunologically tolerant cardiac allograft (Lee et al., 2005a).  Until this report CCR4 
was not believed to play a role in recruitment of T cells to the liver. Only few effector cells in the 
liver express CCR4 (Shields et al., 1999).  CCR4 is the receptor for two chemokines, CCL17 and 
CCL22 both of which are secreted by DCs on maturation and which serve to recruit and retain 
Treg in contact with DCs in lymph nodes (Cardoso et al., 2008b;Curiel et al., 2004;Iellem et al., 
2001b;Katou et al., 2001;Tang and Cyster, 1999;Vulcano et al., 2001). The interaction between 
Treg and DC inhibits DC maturation and the expression of co-stimulatory molecules required for 
effector T cell activation (Bayry et al., 2007;Houot et al., 2006;Sansom, 2006;Wing et al., 2008).  
We were unable to detect either chemokine in normal human liver tissue by western blotting of 
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whole liver tissue or immunohistochemistry. However both chemokines were detected in 
inflamed liver tissue and immunohistochemistry showed staining restricted to CD11c+ DCs 
within inflammatory infiltrates in septal areas and lobules. In order to confirm that liver-
infiltrating DCs secrete CCR4 ligands we isolated myeloid DCs from liver tissue and showed they 
expressed and secreted both CCL17 and CCL22. 
Confocal microscopy of liver tissue revealed that in chronic hepatitis liver-infiltrating Treg 
were closely associated with both DCs and CD8 T cells suggesting that they are ideally positioned 
to maintain intrahepatic immune suppression. We propose that localisation to these infiltrates 
occurs in response to sequential chemokine signals. Local proinflammatory cytokines including 
IFN-γ lead to the secretion of CXCL9 and CXCL10 by sinusoidal and parenchyma cells; these 
chemokines are presented on the glycocalyx of sinusoidal endothelium where they recruit 
CXCR3high circulating Treg into the liver. Subsequent migration within the inflamed liver is guided 
by CCR4 which allows tissue-infiltrating Treg to respond to CCL17 and CCL22 secreted by 
activated intrahepatic DCs thereby resulting in their accumulation within DC-rich inflammatory 
infiltrates in liver tissue. 
Therefore, our experimental data suggested that in chronic inflammatory human liver 
disease there is a high frequency of liver-infiltrating CD4+CD25+CD127lowFoxP3+ Treg which are 
detected in close association with intrahepatic DCs at sites of inflammation. Moreover, liver-
infiltrating Treg use CXCR3 to undergo transendothelial migration across hepatic sinusoidal 
endothelium and CCR4 to respond to CCL17 and CCL22 secreted by intrahepatic DCs. Thus 
different chemokine receptors play distinct roles in the recruitment and positioning of Treg at sites 
of hepatitis in chronic liver disease.   
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5.1 INTRODUCTION 
CD4+ T helper (Th) lymphocytes and CD8+ T effector lymphocytes are essential mediators 
of successful hepatic immune responses and are also implicated in inflammatory diseases (Adams 
& Eksteen, 2006;Adams and Lloyd, 1997;Adams & Shaw, 1994). The Th1/Th2 paradigm, first 
introduced by Mosmann & Coffman (Mosmann et al., 1986) explained many phenomena in 
adaptive immunity but proved to be an over-simplification.  Recently a subset of IL-17 secreting 
lymphocytes has been described which includes both CD4+ T helper (Th) lymphocytes (Th17) 
(Harrington et al., 2005;Park et al., 2005) and CD8+ cytotoxic T effector lymphocytes (Tc17) 
(Kondo et al., 2009). Th17 has been shown to play a role in human chronic inflammatory and 
autoimmune related diseases such as rheumatoid arthritis (Sato et al., 2006), multiple sclerosis, 
psoriasis, acanthosis, and inflammatory bowel diseases (Duerr et al., 2006;Lock et al., 2002;Pene 
et al., 2008;Zheng et al., 2007). 
IL-17 secreting cells have been implicated in a variety of human liver diseases. An increased 
frequency of intrahepatic IL-17 lymphocytes was observed in primary biliary cirrhosis liver 
compared to healthy liver (Lan et al., 2009) and high concentration of Th17 cells were also 
reported around inflamed peri-ductal regions in chronic biliary inflammation (Harada et al., 
2009). Th17 cells have also been detected in human alcoholic hepatitis and alcoholic liver disease 
where the ability of IL-17 to recruit neutrophils may link the adaptive and innate immune 
responses and explain some of the features of alcoholic hepatitis (Lemmers, 2009). Regarding the 
role of IL-17 cells in viral hepatitis, I collaborated with Paul Klenerman group in Oxford, to 
define a novel subset of Tc17 cells (IL-17 secreting CD8) cells in the inflamed chronic hepatitis C 
infected human liver. More recent studies report increased frequencies of Th17 cells in the blood 
of patients with chronic hepatitis B compared with normal healthy individual.  In this study Th17 
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cells were inversely correlated with Th1 cells and showed a positive correlation with serum 
transaminases (Ge et al., 2009). 
The presence of IL-17 secreting lymphocytes in the liver during chronic hepatic 
inflammation suggests that Th17 and Tc17 cells are either recruited into the liver from blood or 
they differentiate locally within the liver from memory T lymphocytes under a polarising cytokine 
microenvironment.  It is perhaps more likely that both processes are involved with recruitment 
of Th17 cells being mediated by specific chemokines and local conditions maintaining their 
polarisation and survival in tissue.  The recruitment and positioning of lymphocyte subsets in 
inflamed microenvironments in critically dependent on chemokines (Rot, 2004). Our laboratory 
previously reported that biliary epithelial cells are the source of inflammatory chemokines such as 
CXCL9, CXCL10, CXCL11 (Curbishley et al., 2005), CXCL16 (Heydtmann et al., 2005) that can 
attract liver infiltrating effector lymphocytes expressing CXCR3 and CXCR6 and CXCL8 
(Morland et al., 1996;Morland et al., 1997a) which can attract neutrophils thereby linking innate 
and adaptive responses in hepatitis.  
CCR6 is the chemokine receptor which best defines IL-17 secreting cells suggesting that 
together with its ligand CCl20 it might be a critical recruitment signal for Th17 cell recruitment to 
tissue. CCL20, which is the only CCR6 ligand was originally named as LARC (liver and 
activation-regulated chemokine) as it was detected in liver cell lines (Hieshima et al., 1997). 
CCL20 is also alternatively named as macrophage inflammatory protein-3α (MIP-3α) or Exodus-
1. CCL20 messenger RNA expression has been reported on human biliary epithelial cells (Harada 
et al., 2009) and it has been shown to be involved in the local necroinflammatory response in the 
human liver (Shimizu et al., 2001). Epithelial cells such as human bronchial epithelial cells also 
secrete CCL20 in response to pro-inflammatory cytokines.  
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CCR6 is expressed on memory T cells and immature dendritic cells (Liao et al., 1999;Yang 
et al., 1999). The ligand-receptor pair CCL20-CCR6 has been described to be responsible for the 
chemoattraction of immature dendritic cells, effector/memory T cells and B cells and reported to 
play a role at skin and mucosal surfaces under homeostatic and inflammatory condition, as well as 
in pathology (Schutyser et al., 2000;Schutyser et al., 2003). 
I was interested in determining the chemokine receptors that might be responsible for 
recruiting Th17 and Tc17 cells to the liver. The potential candidates include CXCR3 and its 
ligands, CXCL9 CXCL10 CXCl11 and CCR6 and its ligand CCL20. Our group have shown that 
these ligands are expressed by inflamed bile ducts. Importantly, Th17/Th1 cells expressing both 
CCR6 and CXCR3 have been reported previously (costa-Rodriguez et al., 2007b).  
Although Th17 have been described in human liver diseases, little is known about their 
phenotype, homing receptors and how they are positioned in inflamed liver.  Even less is known 
about Tc17. This lead me to investigate the phenotype of liver infiltrating Th17and Tc17cells, 
their frequency and distribution and also to address the questions of which chemokine 
receptor/chemokine pair might be involved in their recruitment to the liver and positioning 
around bile ducts. 
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5.2 RESULTS 
5.2.1 IL-17 secreting lymphocytes in human liver 
IL-17 staining lymphocytes were detected in both normal and diseased human liver tissue.  
Very few cells were seen in normal liver but in chronically inflamed tissue cells could be detected 
in inflamed portal tracts, septa and within the lobules in the parenchyma. There was no 
detectable staining on hepatocytes, epithelial cells or mesenchymal tissue. IL-17 staining in 
human liver tissues was shown in Figure 5.1.   
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Figure 5-1 Hepatic IL-17 expression in different inflamed diseased livers.  
Immunohistochemical staining of IL-17 lymphocytes (shown with arrows) in inflamed human 
non-alcoholic steatohepatitis liver (A), alcoholic liver disease (B) and primary biliary cirrhosis (C) 
using goat polyclonal antibody against IL-17. IL-17 cells were noted mainly in portal tract but 
they are also present in parenchyma.  No detectable staining was seen in control tissue (D). 
Images were taken at magnification X200.  
A 
C 
B
D
Bile duct 
Bile duct
IL-17 cells
IL-17 cells 
IL-17 cells
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Having identified the presence of IL-17 cells in inflamed liver by immunohistochemistry, 
I used flow cytometry to analyse freshly isolated liver infiltrating lymphocytes.  Il-17 secreted cells 
were defined by expression of Il-17 after PMA ionomycin treatment.  In chronic inflammatory 
liver diseases the frequency of Il-17+ cells defined in this way was 1-2% of the total lymphocyte 
population whereas Il-22+ cells represented 0.3% (Figure 5.2) 
 
Figure 5-2 IL-17 & IL-22 secreting CD3 and CD4 lymphocytes (Th17) in human liver 
Freshly isolated liver infiltrating lymphocytes were stimulated with PMA and ionomycin for 5 
hours and Brefeldin A was used to block Golgi apparatus for intracellular cytokines. Then the 
cells were stained with lymphocyte markers CD3, and CD4. These cells were then fixed with 
paraformaldehyde and permeabilized with saponin and stained for intracellular IL17 and IL22. 
Flow cytometry analysis of isolated liver infiltrating lymphocytes showed the presence of IL-17 
and IL-22 in total CD4+ liver infiltrating lymphocytes compared with isotype control. Cells are 
gated on total liver derived lymphocytes and the presence of IL-17 and IL-22 in these 
lymphocytes was shown. Control sample did not have any staining for intracellular cytokines. 
(Analysisi of explanted liver tissue from autoimmne hepatitis was shown) 
.   
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5.2.2 IL-17 expressing cells frequency in normal and diseased liver 
Immunohistochemical analysis was performed to investigate the frequency of IL-17 
secreting cells and their distribution in inflamed liver tissue and control sections. Histological 
sections of undiseased liver and end stage explanted primary biliary cirrhosis, autoimmune 
hepatitis, chronic hepatitis C, nonAnonB/seronegative hepatitis, alcoholic liver disease and non-
alcoholic steatohepatitis patients were stained with IL-17 antibody. Diseased livers contained 
significantly higher numbers of IL-17 positive cells per examined area (portal tract/parenchyma) 
compared with normal/resection liver tissues. The highest numbers of IL-17 expressing cells 
were seen in steatohepatitis (alcoholic and non-alcoholic) but they were also seen in other chronic 
liver diseases including chronic HCV infection, primary biliary cirrhosis and autoimmune 
hepatitis. Interestingly, patients with fulminant seronegative hepatitis had the highest frequencies 
of IL-17 secreting cells. 
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Figure 5-3 IL-17 lymphocytes frequency in different chronic liver diseases and normal 
liver.  
Frequency of IL-17 expressing cells were accessed in normal liver and different types of 
chronically inflamed liver diseases (normal liver; n=5, diseased livers n=5-7). Five areas were 
examined and average was taken for each cases. Compared to normal liver, diseased livers have 
significantly higher percentage of IL-17 expressing cells (p≤0.05). Y axis showed the percentage 
of IL-17+ cells in relation to CD3 and X axis showed the different types of liver diseases (p≤ 0.05 
comparing normal with different diseased liver diseases using Mann Whitney U test). 
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5.2.3 Presence of Th17 cells in inflamed human liver 
To further define the IL17+ cells in tissue I used confocal microscopy staining CD4 
intracellular IL-17 and DAPI as a nuclear stain in paraffin embedded liver tissue after antigen 
retrieval. The staining detected both CD4+ IL-17+ dual positive cells in inflamed liver tissues 
(Figure 5.4A). Th17 staining in hepatic inflammation was confirmed by analysing the profile 
through a cell from confocal microscopy (Figure 5.4B).  
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Figure 5-4 Th17 cells in chronic liver disease.  
(A) Confocal staining of a patient with autoimmune hepatitis showing CD4+ IL-17+ dual positive 
Th17 cells. Middle and right panel showed the magnified image. Original magnification x 25.  
(B) Cross section of a Th17 cells shows three different plane of staining in Th17 cell (CD7+IL-
17+). Red line represents CD4 staining. Green line represents intracellular cytoplasmic IL-17 
staining and Gray line represents DAPI nuclear staining at different wavelength. In this cross 
section of the Th-17 cell, CD4 surface staining was detected in the periphery (red line/Cy5) and 
IL-17 staining was in the cytoplasm (green line/FITC) and nuclear staining (grey line/DAPI). 
  
A  
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5.2.4 IL-17 secreting lymphocytes are not restricted to CD4 subset. 
When confocal images were analysed closely, not all IL-17+ cell costained with CD4 
(Th17 cells), and some IL-17 staining cells are not at CD4 T cells areas. This finding leads me to 
investigate whether there are subsets of lymphocytes such as CD8 cells which express IL-17. 
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5.2.5 IL-17 secreting CD4 (Th17) and IL-17 secreting CD8 (Tc17) are 
present in inflamed human liver 
In order to analyse the subsets of IL-17 secreting cells in inflamed liver, I stained for CD4 
and CD8 along with intracellular cytokines in flow cytometry analysis. The freshly isolated liver 
infiltrating lymphocytes were gated using forward and side scatter, then gated again on CD3 to 
exclude other cell types. These cells were then further analysed for CD4/CD8 against IL-17 and 
IL-22. This clearly demonstrated that IL-17 and IL-22 secreting cells are both detected in the 
CD4 Th17 (Figure 5.6A) and CD8 Tc17 (Figure 5.7A). The percentage of Th17 cells was much 
higher compared with Tc17 cells. Confocal analysis using CD4 and CD8 lymphocyte surface 
markers and IL-17 also suggested that both Th17 and Tc17 cells are present in the inflamed 
human livers (Figure 5.6B and Figure 5.7B) 
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Figure 5-6 (A) Flow cytometry and (B) confocal microscopy showing Th17 in inflamed 
human liver. 
(A) Liver derived lymphocytes were stained with surface marker CD3 and CD4. Then cells were 
stimulated for 5 hours with PMA + ionomycin and followed by intra-cellular IL-17 & IL-22 
cytokine staining. Cells were gated on liver infiltrating CD3 showing that presence of IL-17 
secreting CD4 cells (Th17) and IL-22 secreting CD4 cells. Flow cytometry dot plot from a patient 
with non-alcoholic steatohepatitis was shown.  
(B) Staining of non-alcoholic steatohepatitis cirrhosis liver section showing presence of IL-17 
secreting CD4 lymphocytes (Th17). CD4 lymphocyte = red; IL-17 = green; Nuclei were stained 
with DAPI = Grey. Infiltration of Th17 is mainly observed in portal tract area (X40) 
A  
 B
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Figure 5-7 (A) Flow cytometry and (B) confocal microscopy demonstrating Tc17 in 
inflamed human liver. 
(A) Liver derived lymphocytes were stained with surface marker CD3, and CD8. Then cells were 
stimulated for 5 hours with PMA + ionomycin followed by intra-cellular IL-17 & IL-22 cytokine 
staining. Cells were gated on liver infiltrating CD3 demonstrating the presence of IL-17 secreting 
CD8 subsets Tc17 in a patient with primary biliary cirrhosis. IL-22 expressing CD8 cells were 
also noted. 
(B) Staining of Primary biliary cirrhosis liver section showing the presence of IL-17 secreting 
CD8 lymphocytes (Tc17). CD8 lymphocyte = red; IL-17 = green; Nuclei were stained with 
DAPI = Grey. Infiltration of Tc17 are mainly observed in portal tract area (X40) 
A  
 B
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5.2.6 Th17 and Tc17 in normal and diseased liver 
The frequency of Th17 and Tc17 in normal and diseased liver tissue was investigated by 
flow cytometry. In order to get the actual frequency, all the experiments were done on freshly 
isolated explanted human liver and stimulation and staining was done on the same day. In 
general, Th17 cell were more frequent than Tc17 in diseased livers (Table 5.1). 
Th17 percentage was higher in diseased liver compared to normal liver (Figure 5.8A).  IL-
22 expression on Th17 cells are also much more frequent in diseased liver compared with normal 
liver (Figure 5.8B). 
Diseased aetiology Th17 positive cells% Tc17 positive cells% 
Hepatitis C 1.5% 0.6% 
Primary Biliary Cirrhosis 1.6% 0.4% 
Alcoholic liver disease 1.7% 0.5% 
Autoimmune Hepatitis 2.2% 0.6% 
Non alcoholic steatohepatitis 1.8% 0.5% 
Normal Liver 0.3% 0.1% 
Mean±SD 1.5±0.64 0.45±0.18 
 
Table 5-1 Frequency of Th17 and Tc17 in normal liver and different diseased livers.  
Liver infiltrating lymphocytes were freshly isolated, PMA and ionomycin stimulated for 5 hours 
and then cytokines secretion were blocked with BrefeldinA and stained for both surface and 
intracellular IL-17 cytokines. 
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Figure 5-8 Th17 cells in diseased and normal liver 
Expression of IL-17 (A) and IL-22 (B) in CD4 subset of lymphocytes analysed by flow 
cytometry. Frequency of expression was compared between normal and diseased liver. Freshly 
isolated liver infiltrating lymphocytes were stimulated with PMA and Ionomycin for 5 hours and 
then stained with CD3, CD4 surface markers. Then cells were fixed with paraformaldehyde and 
permeabilized with saponin. Intracellular cytokines staining was done with IL-17, IL-22. (N=4 
normal; N=5 diseased liver, ALD, PBC, HCV, AIH, NANB). 
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 Tc17 cells and IL-22 expressing CD8 T cells are present in diseased liver tissue (Figure 
5.9) however, there is very minimal expression in normal liver to detect by flow cytometry. 
 
 
 
Figure 5-9  Flow cytometry analysis of Tc17 in diseased liver.  
Expression of IL-17 and IL-22 in CD8 subset of lymphocytes. Freshly isolated liver infiltrating 
lymphocytes were stained as described above and analysed on flow cytometry. (N=5 diseased 
liver, ALD, PBC, HCV, AIH, NANB).  
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5.2.7 Immunophenotype of human liver infiltrating Th17 and Tc17 in 
chronic liver diseases 
5.2.7.1 Th17 and Tc17 are restricted to CD161high population 
It has been reported that human Th17 cells originate from CD161+ naive CD4+ T cells 
precursor (Cosmi et al., 2008). Moreover, IL-17-producing cells are contained in the CD161+ 
fraction of CD4+ T cells present in the circulation or in inflamed tissues, although they are not 
CD1-restricted natural killer T cells (Cosmi et al., 2008).  In collaboration with Paul Klenerman 
group in Oxford, I have noted that both liver-infiltrating Th17 and Tc17 cells are mainly 
restricted to CD161high population as shown in Figure 5.10. 
 
Figure 5-10  Th17 and Tc17 in inflamed human liver are mainly CD161high.  
Liver infiltrating lymphocytes are gated on CD4 or CD8 population and this gating was applied 
to either control or IL-17 vs CD161. The result suggested that both Th17 (A) and Tc17 (B) were 
restricted to CD161high population. One representative patient (HCV) of six experiments was 
shown. (HCV, ALD, PBC, NANB, NL).   
A  
 B
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5.2.7.2 Th17 and Tc17 cells express IL-23 receptor. 
IL-23 is a heterodimeric cytokine of the IL-12 family composed of p19 subunits and the 
p40 subunit which is also shared by IL-12 (Oppmann et al.). Initial Th17 lineage commitment of 
CD4 cells requires IL-1β, IL-6 and TGF-β and once they are differentiated, IL-23 has been 
shown to be crucial for survival and stabilization of Th17 cells. IL-23 p19-deficient mice are 
resistant to the development of EAE, a Th17 driven disease in mice, compared to p-35 deficient 
mice (Cua et al., 2003). IL-6 and IL-21 induce expression of the IL-23 receptor in a STAT3 
dependent manner (Zhou et al., 2007) which also depends on RORγt because RORγt deficient 
mice have reduced expression of IL-23R (Nurieva et al., 2007). The presence of IL-23 receptor 
on Th17 cells is thus essential for IL-23 responsiveness. Flow cytometry analysis on fresh liver 
infiltrating lymphocytes has shown high IL-23 receptor expression on Th17 and Tc17 cells 
(Figure 5.11) 
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Figure 5-11 IL-23 Receptor expression on liver infiltrating Th17 and Tc17 cells.  
Flow cytometry analysis showed the IL-23R expression on LITh17 (B) and LITc17 (C). Liver 
infiltrating lymphocytes were gated on liver infiltrating CD4 or CD8 cells. (A) dot plot showing 
the co-expression of IL-17 and IL23R. (B&C) Overlay histogram of percentage IL-23 receptor 
expression in liver infiltrating Th17 and Tc17 lymphocytes. Representative overlay histogram is 
of a patient with alcoholic liver disease.  N=3.  
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5.2.7.3 Th17 cells in the liver secrete other cytokines 
Th17 cells also secrete other cytokines including IL-22 (Wilson et al., 2007). Thus, freshly 
isolated liver infiltrating CD4 lymphocytes were gated as above and cytokines expression on 
Th17 cells analysed.  Th17 cells not only expressed IL-17 but also other cytokines including IFN-
γ, TNF-α and IL-22. Co-expression with TNF-α was more prominent compared to other 
cytokines. Thus, Th17 cells are polyfunctional, polysecretor effector cells (Figure 5.12 and Table 
5.2) 
 
Figure 5-12 Liver infiltrating Th17 cells are polysecretor.  
Flow cytometry analysis of liver infiltrating CD4 lymphocytes from a patient with autoimmune 
hepatitis. There is co- expression of intracellular IL-17 with IFN-γ, TNF-α and IL-22. Cells were 
gated on CD3+ CD4+ liver infiltrating lymphocytes. (N=4) 
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Disesese state 
 
 
IL-17+IFN-γ 
 
IL-17+TNF-α 
 
IL-17+IL-22 
 
 
Autoimmune hepatitis 
 
 
1% 
 
3% 
 
0.8% 
 
Primary biliary cirrhosis 
 
 
1.2% 
 
1.4% 
 
0.7% 
 
Alcoholic liver disease 
 
 
1.1% 
 
1.2% 
 
0.7% 
 
Autoimmune hepatitis 
 
 
1.2% 
 
1.3% 
 
1% 
 
Table 5-2 Percentage coexpression of different cytokines on liver infiltrating Th17 cells.  
Table showing the percentage coexpression of different cytokines on Th17 cells in diseased 
livers. Four diseased livers were studied and they all showed co-expression of intracellular 
cytokines.  
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5.2.7.4 Expression of transcription factor RORC in Th17 and Tc17 cells.  
Retinoid nuclear receptor RORC is the human homologue of murine RORγt and RORα 
the signature Th17 transcription factor. RORγt is selectively expressed in vitro differentiated Th17 
cells (Ivanov et al., 2006). RORα is another member of the retinoid receptor family and plays a 
similar role in the differentiation of Th17 cells (Yang et al., 2008c). The induction of RORγt is 
dependent on STAT3 (Yang et al., 2008c;Zhou et al., 2007) and IL-23 R expression is dependent 
on RORγt (Nurieva et al., 2007). My analysis on liver infiltrating Th17 and Tc17 cells suggested 
that both highly express the signature transcription factor RORC (Figure 5.13) 
 
Figure 5-13 Expression of transcription factor RORC in liver infiltrating Th17 and Tc17 
cells 
Freshly isolated liver infiltrating lymphocytes were stimulated with PMA and ionmycin. Then 
cells were fixed, permeablized and stained with intracellular cytokine for IL-17 and transcription 
factor RORC. Liver infiltrating Th17 (A) and Tc17 (B) both has high expression of transcription 
factor RORC.  
A 
 
B 
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5.2.7.5 Chemokine receptors  expression  on LITh17 & LITc17 cells 
The expression of potential homing receptors on liver infiltrating Th17 and Tc17 
lymphocytes was assessed by using flow cytometry (Figure 5.14). LITh17 cells express CCR4, 
CCR6 and CXCR3 (Figure 5.14A). LITc17 cells express CCR6 and CXCR3 (Figure 5.14B). 
Importantly, CCR6 and CXCR3 were highly expressed in both subsets.  Percentage expression of 
chemokine receptors on both subsets in liver were described in Figure 5.14 and Table 5.3. 
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Figure 5-14 Chemokine receptors expression on liver infiltrating Th17 and Tc17 cells. 
Liver infiltrating lymphocytes were freshly isolated and stained for surface receptor CD3, CD4 
and CD8. Then cells were stimulated with PMA and inomycin for 5 hours with final golgi block 
for last 2 hours. These cells were then stained for intra-cellular cytokine IL-17 and chemokine 
receptors and analysed on flow cytometry. Data is from diseased livers (2x autoimmune hepatitis, 
primary biliary cirrhosis, alcoholic hepatitis) N=4 
 
 CCR4 CCR6 CXCR3 
Th17 % (Mean±SD) 44±13.7 67±9.8 48±11.8 
 
 CCR6 CXCR3 
Tc17 % (Mean±SD) 65±10.8 38±8.5 
Table 5-3 Chemokine receptors expression on liver infiltrating Th17 and Tc17 cells. 
Liver infiltrating Th17 and Tc17 chemokine receptors expression percentage is shown in Table 
5.3.  
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5.2.7.6 Integrins expression on LITh17 and LITc17 
Both β1 and β2 integrins were present at high levels on most LITh17 and LITc17 cells as 
seen in other lymphocytes subsets. Integrins which are important for lymphocyte recruitment via 
endothelium include αLβ2 (LFA-1, CD11a/CD18) which binds ICAM-1 & ICAM-2 on 
endothelium, and α4β1 (VLA-4, CD49d/CD29), α4β7 (LPAM-1, CD49d/cd104) via its ligands 
VCAM-1 and MadCAM-1 (Butcher & Picker, 1996). Flow cytometry analysis suggested that αLβ2  
is highly expressed on both subsets and there was also high expression of β1 integrins (Figure 
5.15). 
 
 
Figure 5-15 Expression of integrins on LITh17 and LITc17 cells. 
Flow cytometry analysis on liver infiltrating Th17 and Tc17 stained for surface markers for CD3, 
CD4, CD8 and intra-cellular cytokines IL-17. Then these Th17 and Tc17 cells were gated on 
CD11a, CD18, CD29 and CD49d. Both Th17 and Tc17 in inflamed liver express high levels of 
LFA-1 and VLA-4. Sample from a patient transplated for autoimmune hepatitis was shown. 
N=4. 
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5.2.8  IL-17 secreting lymphocytes were located around human biliary 
epithelial cells 
Immunohistochemistry demonstrate many of the IL-17 cells in portal tracts were closely 
associated with bile ducts (Figure 5.16). Dual staining with the biliary epithelial cells marker 
(HEA125) and IL-17 also suggest that IL-17 cells are in close proximity to bile ducts (Figure 
5.1A&C). This finding was similar to previous studies suggesting that IL-17 cells were observed 
in peri-ductal region and increase frequency was noted in biliary disease (Harada et al., 2009;Lan 
et al., 2009). 
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Figure 5-16 Presence of IL-17 cells in close proximity to bile ducts.  
Immunohistochemical staining of IL-17 demonstrate that IL-17 cells (arrow) are located around 
bile ducts (arrow head). IL-17 staining was shown as brown pigment. Picture was taken at x20 
lens. Patient with primary biliary cirrhosis sample was shown. 
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5.2.9 Biliary Epithelial cells express IL-17RA receptor 
As IL-17 secreting cells were detected around the bile ducts, I proceed to investigate 
whether biliary epithelial cells (BEC) express the IL-17 receptor. IL-17 receptor family includes 
IL-17RA to IL-17RE. In humans, IL-17RA can form a heterodimer with IL-17RC that binds to 
human IL17A and IL-17F (Toy et al., 2006), two major cytokines secreted from Th17 cells. IL-
17RC is the cognate receptor for IL-17F (Kuestner et al., 2007). IL-17 receptor has been shown 
to be expressed widely on epithelial cells, endothelial cells, haemopoietic cells and fibroblasts. 
Human biliary epithelial cells (BEC) from diseased livers were isolated and flow 
cytometry analysis was performed to detect IL-17 receptor (IL-17RA). Intracellular staining of 
CK19 marker (normally >97% of gated population) was used after to confirm that the cells were 
biliary epithelial cells. BEC were stimulated with TNF-α (10ng/ml) and IFN-γ (50ng/ml each) 
for 24 hours. Biliary epithelial cells express the IL-17RA receptor (Figure 5.17). More than 90% 
of early low passage cells (P1, P2) express IL-17RA receptor and its expression regress with 
higher passage (P4- P6). 
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Figure 5-17 Expression of IL-17 Receptor (IL-17RA) on the biliary epithelial cells.  
Biliary epithelial cells (BEC) were stimulated with TNF-α (10ng/ml) and IFN-γ (50ng/ml) for 24 
hours and expression of IL-17RA receptor was accessed by flow cytometry. Cells were gated on 
forward and side scatter. CK19 was used as biliary cell marker and stained after fixation and 
permeabilization of cell. Expression of IL-17RA receptor was higher on stimulated BEC (93%) 
compared to unstimulated BEC (68%). One representative example of 4 experiments was shown. 
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5.2.10 Expression of CCL20 on human biliary epithelial cells. 
5.2.10.1 Immunohistochemistry for CCL20 
Detection of Th17 cells around bile ducts associated with expression of the IL-17 
receptor on biliary epithelium led me to investigate whether biliary epithelial cells secrete the 
chemokine CCL20 (the ligand for CCR6) which could recruit CCR6+ IL-17 cells to the bile ducts.   
First, I determined the expression and distribution of CCL20 in normal and inflamed liver tissue 
using immunohistochemistry on paraffin embedded liver tissue sections. The expression of 
CCL20 was largely restricted to bile ducts and bile ductules in inflammatory liver disease (Figure 
5.18A). There were no detectable staining on hepatocytes and staining with the control antibody 
was negative (Figure 5.18B).  
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Figure 5-18 Expression of CCL20 on human biliary epithelial cells 
Liver tissue sections were stained with CCL20 antibody. CCL20 staining was shown in Figure A 
(red pigment shown with arrow). Staining was particularly intense on bile ducts (arrow head) 
around the portal tract area. There was no detectable staining of hepatocytes, or vascular 
endothelium. Staining of control antibody (B) was negative. Staining on primary biliary cirrhosis 
and primary sclerosing cholangitis was shown. N=4; Original magnification X 20. 
 
  
A 
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5.2.10.2 ELISA for CCL20 
To confirm the immunohistochemical CCL20 staining on bile ducts and to determine 
whether CCL20 protein is secreted by biliary epithelial cells. I measured CCL20 secretion using a 
sandwich ELISA in biliary epithelial cells conditioned supernatant. Biliary epithelial cells were 
stimulated with IL-1β, IL-17, TNF-α, IFN-γ or combination of TNF-α and IFN-γ (10 ng/ml) for 
24 hours and the supernatants were collected for Quantikine sandwich ELISA analysis was 
performed (Figure 5.19). 
 
Figure 5-19 CCL20 secretion by biliary epithelial cells.  
Sandwich ELISA was used to measure CCL20 in culture supernatants from unstimulated biliary 
epithelial cells (BEC) and those stimulated with different cytokines. This confirmed the 
immunohistochemical findings of detection of CCL20 on bile ducts. BEC were stimulated with 
different cytokines including TNF-α, IFN-γ, combination of both, IL-1β and IL-17(all 10ng/ml) 
for 24 hours before supernatants were collected for ELISA. Data represent the mean ±SEM of 
four diseased livers (PBC, ALD, PSC, and NASH). Statistical significance was calculated using 
student’s t test (*p ≤0.05) and compares the unstimulated and different cytokines stimulated 
biliary epithelial cells. 
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5.2.10.3 Transcription of  CCL20 and IL17RA by biliary epithelial cells 
To investigate whether biliary epithelial cells has messenger RNA for CCL20 and IL-
17RA receptor, I carried out PCR reaction on isolated human BEC cells. PCR was done on both 
unstimulated and biliary epithelial cells stimulated with different cytokines (Figure 5.20). In all 
reactions, a negative PCR control was included.  The message for CCL20 and IL-17 RA receptor 
was observed on both unstimulated and different cytokines stimulated biliary epithelial cells. 
Each reaction was performed  with a non-template control and RT-control included in the same 
run. 
 
Figure 5-20 Expression of CCL20 and IL-17 receptor transcripts (mRNA) in human 
biliary epithelial cells. 
De novo synthesis of CCL20 and IL-17RA receptor messenger RNA by both cytokine stimulated 
and unstimulated biliary epithelial cells were shown. RT-PCR was performed and product was 
developed on 2% Agarose gel. Data from one of 3 replicate experiments was shown. 
(US=unstimulated); IL-1=interleukin 1β; IL17=interleukin17; TNF=tumour necrosis factor-α; 
IFN=interferon-γ. Negative PCR control without cDNA was used in each reaction. 
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5.2.11 CCR6 on Th17 is functional 
The chemokine receptor CCR6 and its ligand CCL20 has been reported to mediate Th17 
cell migration (Hirota et al., 2007;Singh et al., 2008) and I investigated whether CCR6 Th17 cells 
was functionally active. Chemotaxis assays was used to detect whether CCR6 chemokine receptor 
expressing Th17/Tc17 cells migrate towards biliary epithelial cells which express and secrete 
CCL20. CD4 cells were isolated using a Dynal CD4 isolation from which highly purified Th17 
cells were isolated again using Miltenyi IL-17 secretion and capture. These cells were cultured in 
Th17 polarizing cytokines with IL-1β, IL-6, TGF-β and IL-2 previously described (Bettelli et al., 
2006;costa-Rodriguez et al., 2007a;Cua et al., 2003;Korn et al., 2007;Langrish et al., 2005;Mangan 
et al., 2006;Nurieva et al., 2007;Veldhoen et al., 2006;Zhou et al., 1998).  
Th17 cells were cultured in Iscove’s modified Dulbecco’s medium which is rich in 
aromatic amino acids and AhR agonists which has been shown to be essential for expansion of 
both mice and human Th17 cells (Veldhoen et al., 2008a;Veldhoen et al., 2009). These cultured 
Th17 cells were then used for migration assay. Biliary epithelial cells were stimulated with 
different cytokines including IL-17 and supernatants were collected. Purely isolated Th17 cells 
migrate towards the IL-17 stimulated BEC supernatant (chemotactic index was 2.5 times 
compared to control) and this migration could be blocked significantly by blocking antibodies 
against CCL20 in the supernatant or blocking the G protein coupled chemokine receptors with 
PTX. These findings demonstrate that Th17 cells use chemokine receptors which may include 
CCR6 to migrate towards CCL20 ligand secreted by biliary epithelial cells (Figure 5.21).  
However, subsequent investigation following this thesis suggested that chemokines CXCL9-11 
also contributed to Th17 migration.  
233 
 
 
 
 
Figure 5-21 Chemotasis of  Th17 cells towards BEC supernatant.  
Pure Th17 cells were freshly isolated and kept overnight in Th17 polarizing media. BEC culture 
media was used as negative control. Biliary epithelial cells were stimulated with IL-17 and 
supernatant were collected after 24 hours. 5µ pore gelatin coated Conning chemotactic migration 
chambers were used for the assay. The lower chamber was filled with 600µl of BEC media 
(negative control) or IL-17 stimulated BEC supernatant ± anti CCL20 block. Isolated Th17 cells 
resuspended in 1ml of RPMI are loaded per well in upper chambers. Assay was done in 
duplicates. For the chemokine receptors blockade, Th17 cells were incubated with PTX for 30 
minutes before the assay and recombinant CCL20 in BEC media was used in the lower chamber.  
IL-17 stimulated BEC supernatant induced significantly higher levels of Th17 cells migration 
compared with unconditioned medium (p=0.0013) and this migration could be blocked by 
adding anti-CCL20 in the stimulated supernatant.  The migration could also be significantly 
reduced by blocking global G-protein with PTX or CXCR3 on Th17. N=4. Student t test was 
used for statistical analysis. 
  
234 
 
 
5.2.12  Positioning of liver infiltrating IL-17 lymphocytes and liver infiltrating 
Treg 
Regulatory T cells and Th17 have a reciprocal relationship in their developmental 
programs. TGF-β is required for expression of both FoxP3 and RORγt. Naive T cells can be 
converted to FoxP3 expressing Treg upon TCR stimulation in the presence of TGF-β.  However, 
in the presence of IL-6, TGF-β promotes the differentiation of naive T lymphocytes into 
proinflammatory IL-17 producing Th17 cells, which promote autoimmunity and inflammation 
(Mucida et al., 2007). Thus, IL-6 plays a pivotal role in dictating whether proinflammatory Th17 
or protective Treg differentiate in inflamed state or steady state of immune system.  
I used confocal analysis of FoxP3 and IL-17 staining to assess the positioning of LITreg 
and liver infiltrating IL17 cells. Both population of cells are present in inflamed human liver 
tissue however, there was no co-staining or double positive cells. Furthermore although both 
subsets were detected in inflammatory infiltrates they were not found in close proximity unlike 
the Treg and DCs for instance suggesting that at least in the inflamed hepatic environment the 
reprogramming of Treg to Th17 cells is probably not taking place (Figure 5.22). 
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Figure 5-22 Confocal images of liver infiltrating IL-17 cells with LITreg cells.  
Confocal microscopy was done on paraffin embedded inflamed liver tissue sections (primary 
biliary cirrhosis). IL-17 goat polyclonal and FoxP3 mouse monoclonal antibodies and DAPI 
(nuclear staining) were used.  Confocal images show the presence of both cells however they 
reside discrete from each other (N=3; AIH, PBC, NASH).  
BA 
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5.3 DISCUSSION 
The discovery of IL-23 extended the Th1/Th2 paradigm to more a complex 
Th1/Th2/Th17 paradigm. IL-23 shares the p40 subunit with IL-12, the heterodimer of IL-12 
being composed of p40 and p35, and that of IL-23 being composed of p40 and p19(Cua et al., 
2003;Oppmann et al.). Murine model of experimental allergic encephalomyelitis (EAE/a model 
of human multiple sclerosis) and collagen induced arthritis (CIA/a model of human rheumatoid 
arthritis) were accepted to have association with unchecked Th1 responses. This is based on 
studies where disease development was ablated by treatment with neutralizing antibodies specific 
for IL-12 p40 or gene targeted mice deficient in the p40 subunit of IL-12. However it turns out 
that these diseases also involve Th17 responses proving the existence of another effector 
pathway.  Subsequently many groups have started to investigate the role of these IL-17 secreting 
cells in human autoimmune and inflammatory diseases (Harada et al., 2009;Lan et al., 
2009;Lemmers, 2009;Zhang et al., 2009b). I hypothesized that the IL-17 pathway may be 
involved in hepatic inflammation either causing injury or repair of hepatocytes and/or biliary 
epithelial cells. This led me to investigate the immunophenotype, migration and positioning of 
human liver infiltrating IL-17 secreting cells. 
Initial lineage commitment for human Th17 requires the combined activity of IL-1β, IL-6 
and TGF-β, and IL-21 as an autocrine loop. Then IL-23 is required for stabilization and survival 
(costa-Rodriguez et al., 2007a;Manel et al., 2008;Volpe et al., 2008;Yang et al., 2008a). Thus, 
following pure Th17 cell isolation I use culture media with all these Th17 polarizing cytokines in 
IMDM media which is enriched with AhR ligands essential for Th17 generation (Veldhoen et al., 
2008a;Veldhoen et al., 2009) to maintain Th17 phenotype. 
Initially, I focussed on Th17 (IL-17 secreting CD4 cells) however, during a collaborative 
investigation with Paul Klenerman group we observed that not only Th17, but Tc17 (IL-17 
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secreting CD8 cells) are present in the inflamed liver. Tc17 cells have been reported to protect 
from lethal influenza infection and neutrophil influx into the lung in murine model (Hamada et 
al., 2009). CD8+ T cells activated in the presence of the cytokines IL-6 or IL-21 plus TGF-β 
develop into Tc17 which display greatly suppressed cytotoxic function along with low levels of T-
box transcription factor Eomesodermin, granzyme B and IFN-γ. Instead, these cells express 
hallmark molecules of the Th17 program including RORγt, RORα, IL-21 and IL-23R (Huber et 
al., 2009). Functionally, both Tc17 cells and IL-17/IFN-γ double-positive cells generated under 
Tc17 conditions lacked lytic activity, expressed similar patterns of cell surface proteins to IL-17-
producing cells. STAT3 signalling pathway is necessary for Tc17 polarization, both in vitro and in 
vivo (Yen et al., 2009). Moreover, adoptive transfer study by Yen and colleagues also 
demonstrated functional plasticity of Tc17cells to Tc1 cells. However, our study is the first to 
report human liver infiltrating Tc17 cells. 
Phenotyping of fresh liver infiltrating Th17 and Tc17 demonstrated that they are mainly 
memory cells expressing CD45RO and, IL-23R. The presence of IL-23 is important because 
once Th17 cells have differentiated from naive T cells, IL-23 is crucial to maintain Th17 
stabilization and survival (Cua et al., 2003;Murphy et al., 2003). The presence of IL23R on Tc17 
cells suggest a similar survival pathway operates in these cells. 
Studies have shown that human Th17 may have a different origin from murine Th17 cells. 
While murine Th17 cells originate from naive T cells in response to IL-6 and TGF-β (Bettelli et 
al., 2006;Bettelli et al., 2007;Mangan et al., 2006), human Th17cells originate from CD161+ naive 
CD4 precursors present in neonatal blood and thymus (Cosmi et al., 2008). CD161 (NKR-P1A) 
is the human homologue of the mouse NK1.1 (Lanier et al., 1994) which is expressed not only 
on NK cells also on NKT cells (Godfrey et al., 2004). During collaborative work to investigate 
the role of Tc17 in hepatitis C (Yu-Hoi Khan, Klenerman, PNAS, 2010), I studied CD161 
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expression on human Th17 and Tc17 isolated from liver tissue. Immunophenotyping of liver 
infiltrating Th17 and Tc17 suggested that both subsets are mainly restricted to CD161high 
population. Thus, our findings of both Th17 and Tc17 cell express CD161 consistent with results 
from the other groups. 
I next investigated the cytokine profiles secreted by both Th17 and Tc17 isolated from 
inflamed liver. They expressed not only IL-17, but also IL-22, TNF-α and IFN-γ. Among these 
cytokines, IL-22 has been shown to have protective effect on liver epithelium (Zenewicz et al., 
2007). Cosmi and colleagues previously reported Th17/Th1 cells co-express IL-17 and IFN-γ 
(Cosmi et al., 2008).  RORC is the human homologue to murine RORγt which is the essential 
transcription factor for Th17 generation (Ivanov et al., 2006;Ivanov et al., 2007) and I found that 
liver infiltrating Th17 and Tc17 cells highly expressed this signature transcription factor, RORC.  
Recent studies have shown that expression of CCR6 and CCR4 together identified human 
memory CD4+ T cells selectively producing IL-17 and expressing RORC transcription factor, 
whereas CCR6 and CXCR3 identified T helper cells producing both IFN-γ and IL-17 (costa-
Rodriguez et al., 2007b). In the present study, the homing receptor and chemokine receptor 
phenotype of liver infiltrating Th17 was found to be CCR6 and CXCR3. Liver infiltrating Th17 
are most likely Th1/Th17 phenotype (CCR6/CXCR3) as they express high levels of these two 
receptors. Liver-infiltrating lymphocytes express high levels of CXCR3 and use this receptor to 
migrate across human hepatic endothelium under flow in vitro (Curbishley et al., 2005;Steinmetz 
et al., 2009). Similar recruitment pattern would be possible for LITh17 cells and this work is 
currently in process. In a murine lupus model, CXCR3 deficiency was shown to attenuate both 
the Th1 and Th17 responses (Steinmetz et al., 2009). 
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The frequency of IL-17 cells in the human liver was also quantified by 
immunohistochemistry. The findings suggested that the frequency was increased in chronic 
inflammatory liver diseases including autoimmune, viral, steatohepatitis or seronegative hepatitis. 
This finding was similar to the studies from other groups (Lan et al., 2009;Lemmers, 2009). 
Interestingly, the highest frequencies were seen in steatohepatitis and fulminant seronegative 
hepatitis. Lemmers and colleagues have shown recently that in alcoholic hepatitis, the frequency 
of Il-17 secreting cells is higher than in alcoholic cirrhosis. My observation of increased IL-17 
secreting cells in autoimmune hepatitis is consistent with previous human studies showing 
increased numbers of Th17 cells in tissues of patients with autoimmune diseases such as 
rheumatoid arthritis, and juvenile idiopathic arthritis (Hirota et al., 2007;Nistala et al., 2008). In 
general, IL-17 cells were present in higher frequencies in the portal tract compared to areas of 
lobular infiltration. However, in steatohepatitis, autoimmune hepatitis and seronegative hepatitis 
there is an enrichment of IL-17 cells in lobules and at areas of interface hepatitis. 
I detected a high concentration of IL-17 secreting cells around intrahepatic bile ducts. 
Similar finding has been reported in a recent study on Th17 involvement in primary biliary 
cirrhosis (Harada et al., 2009). Some of these IL-17 cells are even found to be present on the 
biliary epithelial cells. It has been shown that IL-17 differentiation cytokines IL-1β, IL-6 and 
stabilization cytokines IL23 p19 mRNA and protein are present on biliary epithelial cells (Harada 
et al., 2009). Thus it is possible that biliary epithelial cells may provide a local Th17 polarizing 
cytokine milieu by secreting these cytokines for IL-17 cells generation around bile ducts. 
IL17 receptor is widely express on epithelial cells, endothelial cells and mesenchymal 
tissue. A recent study on alcoholic liver disease suggested that IL-17RA is also expressed on 
fibroblast (Lemmers, 2009). I found IL-17RA receptor expression on biliary epithelial cells at 
both mRNA level and protein level by PCR and flow cytometry. Harada and colleagues also 
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found the presence of mRNA on biliary epithelial cells in human liver (Harada et al., 2009). Thus, 
I have postulated that Il-17 secreted by Th17 and Tc17 cells act on IL-17 receptor on biliary 
epithelial cells leading to downstream cytokines and chemokine secretion from BEC cells further 
attracting IL-17 cells to the portal tracts.  
I have focussed on one chemokine of particular interest, CCL20 because its receptor 
CCR6 is highly expressed on both Th17 and Tc17 cells. Others important chemokines are 
CXCR3 ligands such as CXCL9, CXCL10 and CXCL11, as there is also high expression of 
CXCR3 on liver infiltrating IL-17 cells. De novo generation of CCL20 and IL-17RA messenger 
RNA has been shown on biliary epithelial cells (Harada et al., 2009) and in accordance with 
previous finding, I have confirmed expression of CCL20 protein by immunohistochemical 
staining around bile ducts and CCL20 chemokine secretion by sandwich ELISA in BEC 
supernatants. Our group have shown that chemokines CXCL9-11 were secreted from inflamed 
bile ducts (Curbishley et al., 2005). Chemotaxis studies on freshly isolated Th17 showed that the 
both CCR6 and CXCR3 receptor on Th17 is functional and allows the cells to migrate towards 
CCL20 or CXCL-10 secreted by biliary epithelial cells. The migration could be blocked if the 
chemokine receptor was blocked with global G protein blockade pertussis toxin or if CCL20 was 
removed by using blocking antibodies.  
The balance of effector and regulatory arms determines the outcome of hepatic 
inflammation. I found Treg in inflamed liver along with IL-17 cells in confocal studies. Reciprocal 
relation of frequency between these effector and regulatory subset of cells has been described in 
juvenile chronic arthritis (Nistala et al., 2008). Confocal findings did not suggest that the two 
subsets are in particularly close proximity. It has been described before that double positive 
RORγt and FoxP3 cells were noted in human tonsil (Voo et al., 2009) however, I did not notice 
costaining of Treg markers FoxP3 and IL-17.  
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The reciprocal relation between Treg and Th17 depends on TGF-β and IL-6 and IL-6 
plays a pivotal role in shaping the proinflammatory Th17 dominant or anti-inflammatory Treg 
dominant environment (Mucida et al., 2007). In normal liver, the ability of stellate cells to secrete 
large amounts of TGF-β and retinoic acid (Eksteen et al., 2009) may generate Treg dominant 
microenvironment. However, in the inflamed liver environment where stellate cells differentiate 
into activated liver myofibroblasts resulting in large amounts of IL-6, TGF-β secretion and switch 
to Th17 dominant inflamed microenvironment. 
Our findings demonstrated that both Th17 and Tc17 cells are present in inflamed human 
liver. They expressed IL-23R, homing receptors CCR6 & CXCR3, and were restricted to the 
CD161high population and have signature transcription factor RORC. Both Th17 and Tc17 are 
polysecretor, polyfunctional cells expressing not only IL-17, but IL-22, TNF-α and IFN-γ. These 
IL-17 cells are found around bile ducts which possess the IL-17RA receptor and secrete CCL20 
which could allow them to recruit more functional CCR6+ Th17 cells. Whether IL-17 cells cause 
biliary damage or help promote regeneration of bile ducts is still unclear. Furthermore, whether 
these Th17/Tc17 cells are recruited fully differentiated or generated in the local 
microenvironment by polarising cytokines around the bile ducts will need addressing in future 
studies.  
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CHAPTER 6                                       
GENERAL DISCUSSION 
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In chronic liver disease, the liver is infiltrated by different subsets of lymphocytes that 
make up the characteristic lesion of chronic hepatitis. The infiltrate includes regulatory T cells 
(Treg) that are believed to suppress inflammation and effector T cells that include Th1, Th2 and 
Th17 effector T lymphocytes in addition to innate immune cells. Treg suppress effector T 
lymphocyte proliferation and cytokine secretion thereby providing an important regulatory 
control of immune responses (Sakaguchi, 2004). Thus, the balance between effector and 
regulatory lymphocytes plays a pivotal role in dictating whether an immune response in the liver 
leads to tolerance or resolution on one hand or immunity and persistent inflammation on the 
other (Crispe, 2003).  
It has been proposed that in human disease a quantitative or qualitative Treg failure leads to 
autoimmune liver diseases (Lan, 2006;Longhi et al., 2004;Longhi et al., 2005b), and liver allograft 
rejection (Demirkiran, 2006) whereas too much immune suppression by Treg results in chronicity 
of viral hepatitis (Chang, 2005;Ward, 2007;Xu et al., 2006) and poor anti-tumour immune 
responses to hepatocellular carcinoma (Fu et al., 2007). On the effector arm, the recently 
described IL-17 secreting lymphocytes which include Th17 and Tc17 cells (Veldhoen et al., 2006) 
has been implicated in many human liver diseases such as autoimmune liver diseases (Lan et al., 
2009), hepatocellular carcinoma (Kuang, 2010) and alcoholic liver disease (Lemmers, 2009).  
Treg and Th17 have a close reciprocal developmental relationship (Mucida et al., 
2007;Veldhoen et al., 2006). The potential for translational cell-based therapy by manipulating 
these two subsets of lymphocytes is apparent although for this to become a reality requires a 
greater understanding of their biology in humans and their behaviour in clinical disease. 
Presently, little is known about the phenotypic characteristics of either liver infiltrating Treg or IL-
17 secreting lymphocytes and several questions remain unanswered regarding the recruitment and 
positioning of these cells in inflamed human tissue. Thus, my studies aimed to address these 
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questions by characterising the detailed phenotype of liver infiltrating Treg, IL-17 secreting  
Th17CD4 cells, IL-17 secreting Tc17CD8 cells in different human liver diseases and by 
investigating the molecular basis of their recruitment and positioning within the inflamed human 
liver. 
6.1 Balance between Th17 effectors and regulatory T cells in 
inflamed human liver 
Both effector and regulatory subsets of lymphocytes will play critical role in the generation 
and outcome of immune responses in chronic inflammatory liver disease. Tregs have been shown 
to be essential for the maintenance of peripheral tolerance (Sakaguchi, 2004;Walker & Abbas, 
2002) and Th17 cells can now be added to Th1 and Th2 cells as important players in 
inflammatory liver diseases (Kuang, 2009;Lan et al., 2009;Zhang et al., 2009b). To understand the 
role of Treg and Th17 cells in inflammatory liver diseases, I investigated their frequency, 
distribution in the normal and inflamed human liver.   
I studied the presence and distribution of CD4Th1, CD8Th1, CD4Th17 and CD8Tc17 
effector subsets and regulatory T cells in both normal and inflamed human livers. I found that 
inflamed human liver is infiltrated by TNF-α and IFN-γ secreting CD4Th1 and CD8Th1cells as 
described previously (Adams & Eksteen, 2006;Crispe, 2003;Knolle & Gerken, 2000) and that the 
frequency of CD8Th1 is higher than CD4Th1. In addition to classical Th1 cells, I also detected 
IL-17 secreting cells and found they included IL-22, TNF-α and IFN-γ polysecretor CD4Th17 
cells (costa-Rodriguez et al., 2007b;Wilson et al., 2007) as well as polysecretor CD8Tc17 cells 
(Kondo et al., 2009). I also contributed to work reporting this latter subset of cells in the 
peripheral blood and livers of patients with chronic HCV infection (Billerbeck & Khan, 2010). 
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Similar to effector lymphocytes, CD4+ CD25high CD127low FoxP3+ regulatory T cells are also 
present in normal and a variety of diseased livers. 
I found a significantly higher frequency of both FoxP3+ Treg and IL-17+ cells in inflamed 
liver compared with normal liver. Previous reports suggested that increased frequencies of Treg 
correlate with chronicity of viral hepatitis (Xu et al., 2006) and the reduce numbers of Treg and 
impairment in function occurs in autoimmune hepatitis (Longhi et al., 2004;Longhi et al., 2005b). 
However, my data showed a similar frequency of Th17 and Treg in both chronic HCV infection 
and autoimmune hepatitis. However, I was studying patients with end-stage disease at 
transplantation (explanted liver tissue) thus the situation may differ earlier in disease course. It is 
however interesting that we detected higher frequencies of Treg in autoimmune disease given that 
the aetiopathogenesis is presumed to be breakdown in self-tolerance. This suggests that either 
Treg are overwhelmed by the effector response at site of chronic inflammation or that the Treg are 
defective. This finding implies that not only the number but the functional integrity of 
intrahepatic Treg determines the outcome. The Th17 frequency was greater in inflammatory liver 
diseases as previously reported (Lan et al., 2009;Lemmers, 2009). I found the most intense 
infiltration of IL-17 cells in alcoholic and non alcoholic steatohepatitis suggesting that they are 
important effector cells in steatohepatitis as the tissue injury is associated with the presence of 
neutrophils, a characteristic feature of Th17 immune responses(Lemmers, 2009). 
The similarly increased frequency of Treg and Th17 cells suggests that more regulatory 
activity is present in inflamed liver where there is more severe inflammation. The parallel increase 
in frequency of both populations in inflamed livers suggests that persistent hepatic inflammation 
is not due to a reduction in the number of Treg. Other factors including functional suppression 
defect of these cells in the local microenvironment may explain their failure to control ongoing 
hepatitis. Alternatively the regulatory cells may be fully functional but overwhelmed by the vigour 
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of the effector response. The balance in the liver between Treg and T effector cells during 
homeostasis, infection/inflammation and chronic hepatitis is shown in Figure 6.1. 
 
 
Figure 6-1 The balance (quantity or functional quality) between effector and regulatory 
lymphocytes.  
During the homeostatic state, both regulatory and effector lymphocytes are in balance. However, 
the effector cells outweigh the regulatory T cells during hepatic infection or inflammation. On 
the other hand, increase in frequency of Treg may contribute to the chronicity of hepatitis. 
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Both Treg and IL-17 secreting lymphocytes are detected in portal tracts, inflamed lobules 
and septa. In most liver diseases, there is a predominant portal tract distribution of both subsets 
consistent with the pattern of the hepatitis. However, the highest frequencies of IL-17 staining 
were observed in alcohol and non-alcoholic steatohepatitis and autoimmune hepatitis, all diseases 
where the injury is targeted at hepatocytes. Initial reports of functional roles for Th17 cells were 
in autoimmune models such as EAE and CIA in mice (Harrington et al., 2005;Park et al., 2005). 
More recently Lemmers et al described Th17 cells in human alcoholic hepatitis with a similar 
frequency and distribution to my findings (Lemmers, 2009). Similarly, I detected the highest 
frequency of FoxP3+ Treg in autoimmune hepatitis and seronegative nonAnonB hepatitis, both 
diseases which target hepatocytes. Histologically, lobular hepatitis and interface hepatitis are 
common in both diseases (Hubscher, 1998). Thus it is likely that more Tregs will be required at 
these sites to control effector cell activity. 
Although I have focused on naturally occurring FoxP3+Treg, other subsets of regulatory T 
cells had been reported by other groups including Tr1 and/or Th3 (Bluestone, 2003;Roncarolo et 
al., 2006;Sakaguchi, 2004) and these cells may also be present in the inflamed liver. Interleukin-10 
secreted from liver myeloid dendritic cells (Goddard et al., 2004b) is enriched in the inflamed 
liver and could promote the generation of Tr1 cells. Furthermore, the liver is TGF-β rich 
microenvironment (Adams et al., 1991;Bowen et al., 2005;Crispe, 2009) making it potentially ideal 
milieu for Th3 differentiation. Thus, other subsets of Treg not studied in this thesis would need 
further investigations to determine whether they are also implicated in chronic liver diseases. 
Regarding to Th17 project, I have not had time to study the local generation of these cells in the 
inflamed hepatic microenvironment which is enriched with Th17 polarizing cytokines, TGF-β, 
IL-1β and IL-6. All these experiments should be done in the future. 
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6.2 Liver infiltrating Treg and IL-17 secreting cells characteristics 
It is crucial to define the detailed phenotype and functional properties of intra-hepatic Treg 
and IL-17 secreting cells in order to understand their role in disease pathogenesis. Such findings 
also have translational importance if regulatory T cells are to be manipulated for immunotherapy 
in the future. Our group and others have reported that liver infiltrating T lymphocytes are mainly 
activated and of the memory phenotype (Heydtmann et al., 2006;Volpes et al., 1991). I made 
similar observations with liver infiltrating Treg. Freshly isolated Treg from explanted livers 
expressed CD45RO and CD27 which has been claimed to be characteristic of tissue-infiltrating 
Treg in other organ (Mack et al., 2009;Ruprecht et al., 2005a).  
Treg can suppress immune responses through antigen specific and antigen independent 
mechanisms (Tiegs and Lohse, 2009;Walker & Abbas, 2002) and multiple mechanisms of Treg 
suppression have been reported (Sakaguchi & Powrie, 2007). I noted that the liver infiltrating Treg 
express high level of CD39, the ectonucleotidases which suggest that adenosine play a role in 
intrahepatic Treg suppressor function as previously described (Borsellino et al., 2007). However, I 
did not investigate other potential suppressive mechanisms of intrahepatic Treg including their 
ability to secrete IL-10, IL-35 or TGF-β; determining the secretion of these cytokines by liver 
infiltrating Treg and their effect on responder T cells will be important study in the future. Contact 
dependant molecules such as LAG-3, GITR and IDO and how they promote interactions 
between Treg and hepatic dendritic cells will also require investigation to elucidate the mechanisms 
of intrahepatic Treg suppression. I used proliferation assays to demonstrate that LITreg are 
suppressor in vitro as has been reported for other tissue infiltrating Treg (Ruprecht et al., 2005b) 
but whilst this shows the cells are functional in vitro it does not mean they function fully within 
the inflammatory environment of the liver. 
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I detected both CD4 and CD8 IL-17 secreting cells in the liver which we designated liver 
infiltrating CD4Th17 and CD8Tc17 respectively. Both subsets express the IL-23 receptor. IL-23 
is a recently described member of the IL-12 cytokine family that is critical for the survival and 
maintenance of Th17 cells in chronic inflammation (costa-Rodriguez et al., 2007b;Cua et al., 
2003;Langrish, 2004;Murphy et al., 2003;Oppmann et al.). The fact that I found similar levels of 
IL-23 receptor on Th17 and Tc17 cells within the liver suggests that IL-23 is important for both 
CD4 and CD8 IL-17 secreting cells. Cosmi and colleagues recently reported that peripheral blood 
Th17 cells are all found within a subset of CD161high T cells (Cosmi et al., 2008). I found that 
liver infiltrating CD4Th17 comprise around 1.5% of the intrahepatic T cells population and are 
similarly all CD161high. Collaborative work with Paul Klenerman’s group has allowed me to define 
CD8Tc17 from chronically HCV infected liver and other inflammatory liver diseases. These 
studies confirmed that CD8Tc17 cells are also restricted to the CD161high population (Billerbeck 
& Khan, 2010). They are less frequent than Th17 cells comprising around 0.5% of the 
intrahepatic lymphocyte pool. Both Th17 and Tc17 are polysecretor that not only express IL-17 
and IL-22 but also secrete TNF-α and IFN-γ.  The ability of these cells to secrete a range of 
proinflammatory cytokines suggests that they might activate other effector pathways leading to 
the recruitment of other effector cells and broadening of the inflammatory response (Adams, 
1996a;Curbishley et al., 2005;Eksteen, 2006;Holt et al., 2009). Of interest, IL-22 has been shown 
to be hepatoprotective in murine models and in some circumstances inhibiting IL17 can 
exacerbate liver injury and damage (Radaeva, 2004;Zenewicz et al., 2007).  
The activation of specific transcription factors determines the differentiation of the 
different T cells lineages. For instance, T bet drives Th1 differentiation and GATA-3 leads to 
Th2 differentiation. Liver infiltrating Treg express high levels of FoxP3 and liver infiltrating Th17 
and Tc17 RORC, which are respectively the transcription signature that drive Treg and Th17/Tc17 
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differentiation. Recently, plasticity between T cells lineages has been reported and this is 
especially pertinent to my studies because of the capacity of Treg to transform into Th17 when in 
an inflammatory milieu in both mice (Kitani and Xu, 2008) and human (Voo et al., 2009). These 
cells coexpress both FoxP3 and RORγt transcription factor, however interestingly they maintain 
suppressive function (Voo et al., 2009). I could not detect any IL-17 and FoxP3 co-expression in 
any of the livers studied by confocal microscopy. Furthermore Treg and Th17/Tc17 cells were not 
found in close contact in the infiltrates both of which suggest that plasticity events might not take 
place in the inflamed human liver.  
The increased frequency of liver infiltrating Treg I detected in diseased livers in the face of 
ongoing chronic inflammation suggests that Treg are either suppressed in situ in the inflamed liver 
or overwhelmed by the strength of the effector response. Thus, failure of Treg to function in the 
inflamed hepatic microenvironment rather than an inability to recruit these cells may be the 
reason for parenchyma tissue destruction despite the presence Treg.  This led me to investigate the 
function of LITreg. As discussed above the LITreg were able to suppress T cell activation in vitro 
but these experiments were of course without the inflammatory milieu in the liver. In order to 
assess Treg function in situ we exploited the fact that IL-2 signalling is essential for Treg function 
(Burchill et al., 2007). The effects of IL-2 signalling are mediated via phosphorylation of STAT5 
and downstream activation of the transcription factor FoxP3 which controls Treg development 
and function (Hori et al., 2003). I thus decided to stain liver tissue for FoxP3 and with an 
antibody that detects a phosphorylated form of STAT5. Thus detection of pSTAT5 implies the 
cell has recently received a signal via the IL-2 receptor suggesting it may be functional whereas a 
lack of pSTAT5 suggests a lack of function at that specific time. I found that only a minority of 
liver infiltrating Treg expressed pSTAT5 suggesting that most of them are not functional at that 
time. However, dynamic studies are required to see if the cells are receiving cyclical activation 
251 
 
through the IL-2 receptor which could be missed by studying one time point. This may not be 
the best way of investigating the functional role of LITreg however there are limitations with in 
vitro studies. 
The functional role of IL-17 and Th17 cells in liver disease remain unknown and I was not 
able to investigate the pathogenesis role of IL-17 in this study. It is possible that Th17 cells may 
damage biliary epithelium or hepatocytes via IL-17, IL-23, TNF-α, IFN-γ as they secrete all of 
these cytokines in vitro. However, once again the in vitro intracellular cytokine analysis does not 
mean that the cells secrete these cytokines at sites of inflammation in vivo. On the other hand, 
their ability to secrete IL-22 may be protective and support liver regeneration and repair. The 
precise role of IL-17 in specific liver disease needs to be determined before anti-IL17 therapy is 
translated to the clinic. However, real caution needs to be taken when interpreting murine studies 
on the role of IL-17 as attempts to translate findings on Th17 in mice to humans have generated 
surprising and conflicting results reflecting underlying fundamental differences between the 
human and murine systems with regard to IL-17 and anti p40 therapy. For these reasons, Th17 
mechanistic action will certainly require further investigations in future. 
 
6.3 Role of chemokine receptors and integrins in recruitment 
Naturally occurring Treg and Th17 are thymic derived (Cosmi et al., 2008;Sakaguchi, 2005) 
and T cells that circulate in the blood are recruited to sites of inflammation via endothelium in 
the liver, in the case of liver disease the specialised hepatic sinusoidal endothelium. The migration 
of leukocytes from blood stream or from hepatic sinusoids into and through tissues either during 
homeostasis or in response to inflammation is controlled by the adhesion molecules and 
chemokine receptors on the leukocytes and their ability to bind to and interact with endothelial 
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cells, stroma cells and matrix (Adams & Shaw, 1994;Butcher & Picker, 1996;Ley, 2007). Tissues 
display chemokines and cell adhesion molecules (CAMs) that act like post codes to attract and 
position specific subsets of leukocytes (Butcher & Picker, 1996;Rot, 2004;Shetty, 2008). Such 
signals also determine the recruitment of Treg and Th17 cells to tissues (Sallusto, 2000). At sites of 
inflammation, Treg mediate both bystander and antigen-specific suppression of local immune 
responses to limit tissue injury and prevent collateral tissue damage (Holmen et al., 2006;Ni et al., 
2006;O'Connor et al., 2007;Walker, 2004;Walker & Abbas, 2002). On the other hand, Th17 
subset are implicated in inflammatory, viral and autoimmune related liver diseases (Harada et al., 
2009;Lan et al., 2009;Zhang et al., 2009b). 
I found high levels of chemokine receptors CXCR3 and CCR4 on the majority of liver-
infiltrating Treg in this study. Circulating human Treg have previously been reported to express 
CXCR3 although few studies have examined expression on tissue infiltrating cells (Lim et al., 
2006;Lim et al., 2008). Although the majority of Treg in inflamed human liver expressed high 
levels of CXCR3 it was also detected on 15-20% of Treg from normal liver. Hepatocytes, stroma 
cells and hepatic sinusoidal endothelium secrete the CXCR3 ligands CXCL9, CXCL10 and 
CXCL11 in response to IFN-γ (Curbishley et al., 2005;Holt et al., 2009) and these chemokines 
can be detected on epithelial cells, stroma cells and the glycocalyx of sinusoidal vessels in the 
inflamed human liver (Narumi et al., 1997;Shields et al., 1999;Tamaru et al., 2000) where they 
promote the transendothelial migration of effector T cells (Curbishley et al., 2005). CXCR3 
ligands are low to undetectable in normal liver consistent with them being inflammation induced 
(Curbishley et al., 2005;Harvey et al., 2003). The finding of high levels of CXCR3 on tissue-
infiltrating Treg suggested that this receptor might be involved in the recruitment of Treg across 
hepatic sinusoidal endothelium. Peripheral blood derived regulatory T cells were used as they are 
the closes representation of hepatic sinusoid regularoty T cells. Using flow-based adhesion assays 
with stimulated human sinusoidal endothelial cells, I had demonstrated that activation of CXCR3 
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on Treg promotes their adhesion and transmigration across human liver sinusoidal endothelium 
under condition of flow. These results are similar to those our group previously reported using 
liver infiltrating effector T cells suggesting that common signals recruit both Treg and T effector 
to the inflamed liver. In contrast, neither of the CCR4 ligands, CCL17 and CCL22 could be 
detected on hepatic sinusoidal endothelium at either messenger RNA or protein levels. This 
finding suggested that CCR4 is not involved in recruitment through endothelium.  
I concluded that all three CXCR3 ligands were involved in transendothelial migration 
because blocking individual chemokines had a lesser effect than blocking the common receptor 
CXCR3 (Oo et al., 2010). CXCR3 blockage was as potent as inhibiting all chemokine receptors 
with pertussis toxin suggesting that CXCR3 is the dominant receptor involved in transendothelial 
migration. The findings in this study are consistent with published in vivo studies that report the 
requirement for CXCR3 expression to allow Treg to be recruited to inflamed tissues in GVHD 
(Hasegawa et al., 2008) and, to the brain in EAE (Muller et al., 2007). Recent in vivo studies in 
mice support my findings. Santodomingo-Garzon and colleagues reported that IFN-γ production 
from innate NKT cells promotes homing of CXCR3+ Treg to the murine liver (Santodomingo-
Garzon, 2008). Thus, IFN-γ inducible chemokines CXCL9 and CXCL10 expressed on inflamed 
hepatic sinusoidal endothelium provide a common recruitment signal for both CXCR3 
expressing effector cells (Curbishley et al., 2005) and Treg (Oo et al., 2010).  
I also studied the adhesion molecules involved in Treg adhesion to hepatic sinusoidal 
endothelium. I found that VCAM-1 was required for adhesion but not for transendothelial 
migration and surprisingly I was unable to block either adhesion or migration with anti-ICAM 
antibodies. This is in contrast to previous studies of effector cells using the same system they 
used VCAM-1 for adhesion and both CXCR3 and ICAM-1 were necessary for transmigration 
(Curbishley et al., 2005).  This leads to the question of what role other adhesion molecules might 
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play in Treg transmigration. Two potential candidates are VAP-1 (amine oxidase and adhesion 
receptor that is expressed by endothelium in the human liver) and CLEVER-1 (common 
lymphatic endothelial and vascular endothelial receptor-1) both expressed on the hepatic 
sinusoids. Our group have previously demonstrated that VAP-1 supports adhesion and 
transmigration of lymphocytes across hepatic sinusoids under physiological shear stress (Lalor et 
al., 2002a). CLEVER-1 has also been shown to mediate adhesion and transmigration of 
leukocytes via vascular endothelium (Salmi, 2004). Since completing the work for this thesis I 
have collaborated with my colleague Dr Shishir Shetty to show that both of these receptors are 
involved in Treg transendothelial migration through HSEC under flow. The results with 
CLEVER-1 were particularly interesting because we were unable to found a role for it in the 
recruitment of CD8 T cells or CD4 effector cells suggesting its function is specific to Treg (Shetty 
et al, submitted to J Exp Med). 
 Phenotyping of fresh CD4Th17 and CD8Tc17 from explanted liver tissues demonstrated 
that they express high levels of CCR6 and also expression of CXCR3. Furthermore, Th17 and 
Tc17 cells expressed high levels of LFA-1 and VLA-4 integrins. Previous studies have reported 
expression of CCR6 and CCR4 on circulating CD4Th17 cells whereas CCR6 and CXCR3 were 
identified on CD4 T cells that secrete both IFN-γ and IL-17 so-called Th17/Th1 cells (costa-
Rodriguez et al., 2007b). Based on my findings of both CCR6 and CXCR3 on liver infiltrating 
Th17 cells, I predicted that they would also be Th17/Th1 phenotype and this was indeed the case 
as demonstrated by polysecretor type intracellular cytokine staining.  
Study in murine lupus have shown that CXCR3 deficiency attenuates both the Th1 and 
Th17 responses (Steinmetz et al., 2009) suggesting that CXCR3 plays a role in recruitment of 
Th17 cells. I did not have time to extend my experiments to look into the role of specific 
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chemokines and CAMs in the recruitment of Th17 cells but this is the subject of ongoing 
research in our laboratory.  
CXCR3 and CXCL-10 are potential targets for anti-inflammatory therapy and blocking 
antibodies to both have been developed and tested in preclinical studies. However, my findings 
that not only effector cells (Curbishley et al., 2005) but also regulatory T cells (Oo et al., 2010) 
require CXCR3 to enter inflamed liver makes the outcome of CXCR3 blockade less predictable 
and it may depend on the level of expression of CXCR3 on both subsets of lymphocytes, their 
recovery following therapy and many other factors in the inflamed hepatic microenvironment. 
 
6.4 Hepatic dendritic cells and positioning of liver infiltrating Treg 
Different chemokine receptors play distinct roles in recruiting and positioning cells in 
tissues including the liver. In this study, I found that CCR4 is expressed at high levels on liver-
infiltrating Treg. Because ligands for CCR4 are not detected on hepatic sinusoidal endothelium, I 
investigated the role of CCR4 in positioning of Treg in the inflamed liver once they have 
undergone transendothelial migration. Similar to a previous report by Shields (Shields et al., 
1999), I found that few effector cells expressed CCR4 suggesting that CCR4 is selectively 
expressed on Treg in tissue consistent with findings showing CCR4 expression on Treg in the 
circulation. Studies have reported local control of responder T cells by CCR4+Treg in the skin 
(Iellem et al., 2001b;Sather et al., 2007) and cardiac allograft (Lee et al., 2005a).  I demonstrated 
that CCR4 on liver infiltrating Treg is functional receptor because freshly isolated liver-derived Treg 
migrated in vitro towards the CCR4 ligands CCL17 and CCL22 in chemotaxis assays. CCL17 and 
CCL22 are reported to be secreted by mature dendritic cells and to recruit and retain Treg in 
contact with dendritic cells in lymph nodes (Cardoso et al., 2008b;Curiel et al., 2004;Iellem et al., 
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2001b;Katou et al., 2001;Tang & Cyster, 1999;Vulcano et al., 2001). I demonstrated both 
chemokines in inflamed liver tissue but not in normal liver. Furthermore, I showed that myeloid 
DCs isolated from liver tissue express and secrete both CCL17 and CCL22. Using 
immunohistochemistry and multi-colour immunofluorescense I was able to show that in tissue 
CCL17 and CCL22 expression was restricted to CD11c+DCs within inflammatory infiltrates in 
septal areas and lobules. In addition, confocal microscopy revealed that liver-infiltrating 
FoxP3+Treg are in close proximity to both intrahepatic DCs and CD8 T cells in inflammatory 
infiltrates. Previous studies have shown that Treg exert their function either by contact dependant 
interaction with effector cells or via dendritic cells (Miyara & Sakaguchi, 2007b;Sakaguchi, 
2008;Wing et al., 2008). Thus, my findings are consistent with a model in which intrahepatic 
inflammatory DC secrete CCL17 and CCL22 chemokines and thereby attract CCR4+Treg to the 
infiltrates. The nature of the interactions between intrahepatic DC and Treg are an area of ongoing 
investigation in our group and it will be important to determine whether DCs in the inflamed 
liver inhibit or enhance the function or survival of Treg. 
This study is the first to provide evidence that CXCR3 and CCR4 play distinct role in Treg 
recruitment and positioning in inflamed tissues. However, other groups have demonstrated that 
CCR4 plays a crucial role in Treg positioning either at sites of inflammation or at draining lymph 
nodes in mice in vivo (Haas, 2008;Sather et al., 2007;Yuan, 2007). It would be interesting to see if 
mice that lack the chemokine receptor CCR4 have defective intrahepatic migration of Treg in vivo 
and such studies could be done using models of liver inflammation. However most of these 
models support acute inflammation, for instance the concanavalin-A hepatitis model and there 
are also a few good models that recapitulate the changes of chronic hepatitis model and 
inflammation seen in human disease. 
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6.5 Biliary epithelial cells and IL-17 secreting cells positioning 
I also investigated the role of IL-17 cells in inflamed human liver in this study. Most of 
the IL-17 secreting cells are detected around bile ducts and some are seen in close contact with 
biliary epithelial cells. This is consistent with a previous study on primary biliary cirrhosis (Harada 
et al., 2009). This study also reported that cytokines involved in Th17 differentiation, IL-1β, IL-6 
and IL-23 are present on biliary epithelial cells (Harada et al., 2009). Thus, it is possible that 
human biliary epithelial cells may provide a local Th17 polarizing cytokine milieu by secreting 
these cytokines which maintains or even generate IL-17 cells around bile ducts. 
The IL-17 receptor is widely expressed on epithelial cells, endothelial cells and 
mesenchymal tissue (Korn et al., 2009). A recent study on alcoholic liver disease suggested that 
IL-17RA is also expressed on fibroblasts (Lemmers, 2009). As IL-17 cells are located in the 
vicinity of bile ducts, I looked for IL-17RA expression on bile ducts and isolated human biliary 
epithelial cells in vitro. I detected IL-17RA receptor expression on human biliary epithelial cells at 
both mRNA and protein level in accordance with previous report by Harada and colleagues 
(Harada et al., 2009). Moreover, treatment of biliary epithelial cells with IL-17 lead to secretion of 
CCL20 suggesting that Th17/BEC interaction might amplify further Th17 cell recruitment 
thereby perpetuates the local response. Thus, I hypothesize that Il-17, TNF-α, IFN-γ secreted by 
Th17 and Tc17 cells may act on IL-17 receptor on bile ducts leading to cytokines and chemokine 
secretion from biliary epithelial cells. 
Both Th17 and Tc17 cells express CXCR3 and CCR6. CCL20, also known as LARC 
(liver activation regulated chemokine) is the ligand for CCR6 which is constitutively expressed on 
both Th17 and Tc17 cells. De novo generation of CCL20 mRNA and IL-17RA mRNA was 
reported on biliary epithelial cells in recent study (Harada et al., 2009). Similarly, I have detected 
CCL20 expression by immunohistochemistry around bile ducts and CCL20 secretion by ELISA 
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in biliary epithelial cells supernatant stimulated with IL-17, TNF-α, IFN-γ or combination of 
cytokines. CXCL9-11 are ligands for CXCR3 which is expressed at high levels on liver infiltrating 
Th17 and Tc17 cells. We have described previously that CXCL9-11 secreted from inflamed bile 
ducts recruit activated T cells (Curbishley et al., 2005). I used chemotaxis assays and freshly 
isolated Th17 to show that the both CCR6 and CXCR3 receptors on Th17 cells are functional by 
blocking cells migration with anti-CCL20 in the supernatant of stimulated biliary epithelial cells 
or blocking CXCR3 receptor on Th17 cells. The migration could be blocked by G protein 
blockade with pertussis toxin as well suggesting that other chemokine receptors may be involved. 
Nevertheless, it still remains unanswered whether Th17/Tc17 cells cause biliary damage 
or promote regeneration of bile ducts; whether these cells are recruited fully differentiated or 
generated in the local microenvironment by polarising cytokines around the bile ducts. Both 
these question need addressing with future studies. 
Thus, complex cellular interactions activate networks of chemokine and cytokine secretion 
within the inflamed liver microenvironment that determine which functional subsets are recruited 
to the liver and hereby the balance between intrahepatic immunity and tolerance. Understanding 
these networks may allow us to manipulate the natural anti-inflammatory processes by using 
adoptive transfer of autologous regulatory T cells to suppress immune and inflammatory 
responses in autoimmune hepatitis and chronic inflammatory liver disease. This project also 
provides a better understanding of the distinct roles of specific chemokine receptors in the 
recruitment of intrahepatic regulatory T cells and effector Th17/Tc17 cells. These findings may 
be useful in future to develop new therapeutic tools for the treatment of immune mediated liver 
diseases by for instance blocking the recruitment of damaging Th17 and Tc17 cells whilst 
promoting anti-inflammatory Treg recruitment.  
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6.6 Planned future works  
6.6.1 Autologous Regulatory T cell Infusion Therapy 
Regulatory T cells are physiological regulators of inflammation and immune activation 
and their adoptive transfer should in theory be able to re-establish immune homeostasis and 
resolution of inflammation in autoimmune and inflammatory liver disease and following liver 
transplantation. Regulatory T cell-based therapy has been tested in some clinical settings such as 
GVHD (Hoffmann et al., 2005;Hoffmann et al., 2006;Hoffmann and Edinger, 2006) with 
encouraging outcomes.  
Generation of robust, sterile, reproducible populations of these cells is essential. Antigen 
specificity would avoid generalized immunosuppression (Bluestone et al., 2007) but is not 
practical for most autoimmune inflammatory diseases where the antigens are unknown. 
Preservation of functional regulatory activity and Treg phenotype after selection and expansion ex 
vivo is an absolute prerequisite for safe and successful cell-based therapy and this requires that a) 
the cells home to the right sites on transfer and b) survive and maintain functional differentiation 
at sites of inflammation.  
We are currently exploring the use of adoptive Treg therapy in chronic immune-mediated 
liver disease. We are isolating the Treg from leukapheresis products by using CD19 depletion and 
CD25 positive selection with clinical grade CliniMACS (under good manufacturing 
practice/GMP conditions) to yield highly purified Treg in a closed system which we can then 
expand ex vivo with TCR stimulation by clinical grade CD3/CD28 beads and IL-2. Our group has 
previously reported that CCR9+ effector lymphocytes home to the gut and under some 
circumstances to the inflamed liver where they can drive injury and chronic hepatitis (Adams & 
Eksteen, 2006). Retinoic acid from gut dendritic cells has been shown to induce this phenotype 
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and is also an important factor in driving FoxP3 expression and Treg differentiation (Mora, 
2003;Mora, 2004). Thus, our current studies plan to generate CCR9+ Treg using CD3/CD28 
clinical grade expander beads as artificial dendritic cells together with adding IL-2 and clinical 
grade retinoic acid. The addition of 1-20 ng/ml rapamycin to CD25-enriched cultures has been 
reported to increase the purity and stability of cells with the phenotype and function of 
Treg(Battaglia, 2005;Battaglia, 2006;Keever-Taylor, 2007;Strauss, 2007) and to suppress 
differentiation of pathogenic Th17 cells (Kopf, 2007). Thus, we plan to add rapamycin to our 
isolated Treg culture to ascertain that proliferating cells lineage remain as the regulatory T cells. 
The functional integrity, purity and sterility of cultured Treg would need to be assessed 
before they can be used to treat liver disease patients. As an initial step, we plan to label these 
cells and track their homing with MRI scanning. Following that, if we are convinced that they 
home to the inflamed gut and liver, autologous Treg cell immunotherapy would be an option to 
administer to patients with liver disease and inflammatory bowel disease to see if such therapy 
can ameliorate disease activity.   
6.6.2 Reciprocal relation and local generation of Treg and Th17 cells 
Regulatory T cells have a similar developmental pathway to Th17 and the outcome 
depends on the local cytokine environment. In the liver this will depend on activation of innate 
immune cells and stroma and epithelial cells at sites of chronic hepatitis. TGF-β is critical factor 
in both Treg and Th17 differentiation (Veldhoen & Stockinger, 2006a). The liver is a TGF-β rich 
environment and this cytokine is essential for differentiation of anti-inflammatory Treg on the 
other hand it is required for proinflammatory Th17 generation (Bettelli et al., 2006;Mangan et al., 
2006;Veldhoen et al., 2006).  Thus, I plan to co-culture liver derived CD4 cells with resident DC 
and fibroblasts together with specific cytokines to recapitulate the liver microenvironment and 
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attempt to model its effect on survival and lineage outcome. Hypothesized mechanisms of 
homeostasis in the hepatic microenvironment is shown below in Figure 6.2. 
 
 
Figure 6-2 Hypothesized mechanisms of immune homeostasis in the hepatic 
microenvironment.  
In normal liver, there are low levels of proinflammatory cytokines but high level of TGF-β which 
may drive intrahepatic CD4 lymphocytes towards Treg differentiation. Thus, Treg dominate the 
non-inflamed hepatic microenvironment to control of effector T lymphocytes like Th1 and 
Th17. Retinoic acid which is stored in hepatic stellate or Ito cells may also favour the Treg 
differentiation. 
 
6.6.3 Plasticity of intrahepatic lymphocytes lineage 
The potential plasticity of lymphocyte lineage is of much interest recently. Treg 
differentiation towards Th17 in inflamed microenvironment and the ability of Th17 cells to 
secrete Th1 cytokines may be related to complex interactions between transcription factor genes 
and cytokines. Thus, I plan to investigate the stability of intrahepatic lymphocytes subsets in 
future study for the plasticity and lineage outcome.  
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Abbreviations 
Aa Amino acid 
Ab Antibody 
AhR Aryl hydrocarbon receptor 
AIH Autoimmune hepatitis 
ALD Alcoholic liver diseases 
APC Antigen presenting cell 
BEC Biliary epithelial cells 
BFA Brefeldin A 
BM Basement membrane 
BSA Bovine serum albumin 
CCL CC-chemokine ligand 
CCR CC-chemokine receptor 
CD Cluster of differentiation 
CHC Chronic hepatitis C 
CLA Cutaneous lymphocyte antigen 
CLEVER-1 Common lymphatic endothelial and vascular 
endothelial receptor-1  
CNS Central nervous system 
ConA Concavalin A 
CTLA-4 Cytotoxic T lymphocyte antigen-4 
CXCL CXCL-chemokine ligand 
CXCR CXC-chemokine receptor 
DC Dendritic cell 
DMSO Dimethyl sulfoxide 
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DTH Delayed type hypersensitivity 
EAE Experimental allergic encephalomyelitis 
EDTA Ethylediaminetetraacetic acid 
EGF Epidermal growth factor 
FACS Florescence activated cell sorter 
FCS Foetal calf serum 
FoxP3 Fox head box P3 (master regulator of Treg) 
GITR Glucocorticoid-induced TNF receptor family 
related protein 
GlyCAM-1 Glycosylation–dependent cell adhesion molecule-1 
HEV High endothelial venules 
HGF Hepatocyte growth factor 
HRP Horseradish peroxidise 
HSEC Hepatic sinusoidal endothelial cells 
ICAM Intracellular cell adhesion molecule  
ICOS Inducible costimulator 
IFNγ Interferon gamma 
Ig Immunoglobulin 
IL Interleukin 
iNKT Invariant natural killer T cell 
LFA-1 Lymphocyte function associated antigen-1 
LILs Liver infiltrating lymphocytes 
LITreg Liver infiltrating regulatory T lymphcytes 
LITh17 Liver infiltrating IL-17 secreting CD4 lymphocytes 
LITc17 Liver infiltrating IL-17 secreting CD8 lymphocytes 
LPS Lipopolysaccharide 
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MAdCAM-1 Mucosal addressin cell adhesion molecule-1  
MALT Mucosa associated lymphoid tissue 
MHC Major histocompatibility complex 
MIG Monokine induced by interferon gamma 
MIP Macrophage inflammatory protein 
NK Natural killer cell 
NKT Natural killer T cell 
NL Normal liver 
PAMPs Pathogen associated molecular patterns 
PBC Primary biliary cirrhosis 
PBL Peripheral blood lymphocytes 
PBS Phosphatase buffer saline 
PCR Polymerase chain reaction 
PLN Peripheral lymph node 
PMA Phorbol 12-myristate 13-acetate 
PNAd Peripheral node addressin 
PPs Peyer’s patches 
PRRs Pattern recognition receptor 
PSC Primary sclerosing cholangitis 
PSG Penicillin streptomycin glutamine 
PSGL-1 P–selectin glycoprotein ligand-1 
RANTES Regulated activation normal T–cell expressed and 
secreted 
RA Retinoic acid 
ROR Retinoic acid related orphan receptor 
SCID Severe combined immunodeficiency 
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TBS Tris-buffered saline 
TCR T cell receptor 
Tc17 Interleukin-17 secreting CD8 T effector cell 
Tfh T follicular helper cell 
TGF Transforming growth factor 
Th1 T helper 1 cell 
Th2 T helper 2 cell 
Th3 TGF-β secreting T helper cells 
Th17 Interleukin-17 secreting CD4 T helper cell 
Th9 Interleukin-9 secreting CD4 T helper cell 
TLRs Toll like receptors 
TNF-α Tumour necrosis factor alpha 
Treg T regulatory cell 
Tr1 IL-10 secreting type1 T regulatory cells  
VAP-1 Vasculat adhesion protein-1 
VCAM-1 Vascular cell adhesion molecule-1 
VEGF Vascular endothelial growth factor 
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